GMP-Bios-ab-001 |
Pre-Made Abagovomab biosimilar,
Whole Mab: Anti-CA125/MUC16 therapeutic
antibody |
Abagovomab |
|
CA125/MUC16 |
Whole mAb |
|
GMP-Bios-ab-002 |
Pre-Made Abelacimab biosimilar,
Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA
therapeutic antibody |
Abelacimab |
|
F11 |
Whole mAb |
|
GMP-Bios-ab-003 |
Pre-Made Abituzumab biosimilar,
Whole mAb, Anti-ITGAV Antibody:
Anti-CD51/MSK8/VNRA/VTNR therapeutic
antibody |
Abituzumab |
|
ITGAV |
Whole mAb |
|
GMP-Bios-ab-004 |
Pre-Made Abrezekimab biosimilar,
Fab, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Abrezekimab |
|
IL13 |
Fab |
|
GMP-Bios-ab-005 |
Pre-Made Abrilumab biosimilar,
Whole mAb, Anti-α4β7/Integrin alpha 4 beta 7
Antibody: Anti-LPAM‑1 therapeutic antibody
|
Abrilumab |
|
α4β7/ Integrin alpha 4
beta 7 |
Whole mAb |
|
GMP-Bios-ab-006 |
Pre-Made Acapatamab biosimilar,
Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Acapatamab |
|
FOLH1/GCPII;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-007 |
Pre-Made Acasunlimab
biosimilar, Bispecific mAb,
Anti-CD274/PD-L1;TNFRSF9/CD137
Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1;ILA/4-1BB/CDw137
therapeutic antibody |
Acasunlimab |
|
CD274/PD-L1; TNFRSF9/CD137 |
Bispecific mAb |
|
GMP-Bios-ab-008 |
Pre-Made Actoxumab biosimilar,
Whole Mab: Anti-Toxin A therapeutic antibody
|
Actoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-009 |
Pre-Made Adalimumab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Adalimumab |
|
TNFA/TNF |
Whole mAb |
|
GMP-Bios-ab-010 |
Pre-Made Adebrelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Adebrelimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-011 |
Pre-Made Aducanumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Aducanumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-012 |
Pre-Made Afasevikumab
biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Afasevikumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-013 |
Pre-Made Afutuzumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Afutuzumab |
Obinutuzumab |
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-014 |
Pre-Made Alacizumab biosimilar,
di-Fab, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Alacizumab |
|
KDR |
di-Fab |
|
GMP-Bios-ab-015 |
Pre-Made Alemtuzumab biosimilar,
Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Alemtuzumab |
|
CD52 |
Whole mAb |
|
GMP-Bios-ab-016 |
Pre-Made Alirocumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Alirocumab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-017 |
Pre-Made Alomfilimab biosimilar,
Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Alomfilimab |
|
ICOS |
Whole mAb |
|
GMP-Bios-ab-018 |
Pre-Made Alnuctamab biosimilar,
Bispecific mAb with Domain Crossover,
Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Alnuctamab |
|
TNFRSF17;CD3E |
Bispecific mAb with Domain
Crossover |
|
GMP-Bios-ab-019 |
Pre-Made Alsevalimab biosimilar,
Whole mAb, Anti-VTCN1 Antibody:
Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1
therapeutic antibody |
Alsevalimab |
|
VTCN1 |
Whole mAb |
|
GMP-Bios-ab-020 |
Pre-Made Amatuximab biosimilar,
Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP
therapeutic antibody |
Amatuximab |
|
MSLN |
Whole mAb |
|
GMP-Bios-ab-021 |
Pre-Made Amivantamab biosimilar,
Bispecific mAb, Anti-EGFR;MET Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met
therapeutic antibody |
Amivantamab |
|
EGFR;MET |
Bispecific mAb |
|
GMP-Bios-ab-022 |
Pre-Made Amlitelimab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Amlitelimab |
|
TNFSF4/OX40 |
Whole mAb |
|
GMP-Bios-ab-023 |
Pre-Made Anbenitamab biosimilar,
Bispecific mAb: Anti-ERBB2 (Domain II);ERBB2
(Domain IV) therapeutic antibody |
Anbenitamab |
|
ERBB2 (Domain II); ERBB2
(Domain IV) |
Bispecific mAb |
|
GMP-Bios-ab-024 |
Pre-Made Andecaliximab
biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody:
Anti-CLG4B/GELB/MANDP2 therapeutic antibody
|
Andecaliximab |
|
MMP9/MMP-9 |
Whole mAb |
|
GMP-Bios-ab-025 |
Pre-Made Anetumab biosimilar,
Whole mAb ADC, Anti-MSLN Antibody: Anti-MPF/SMRP
therapeutic antibody |
Anetumab |
|
MSLN |
Whole mAb ADC |
|
GMP-Bios-ab-026 |
Pre-Made Anifrolumab biosimilar,
Whole mAb, Anti-IFNAR1 Antibody:
Anti-AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
therapeutic antibody |
Anifrolumab |
|
IFNAR1 |
Whole mAb |
|
GMP-Bios-ab-027 |
Pre-Made Anrukinzumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Anrukinzumab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-028 |
Pre-Made Ansuvimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic
antibody |
Ansuvimab |
|
Zaire Ebolavirus GP1 |
Whole mAb |
|
GMP-Bios-ab-029 |
Pre-Made Apamistamab biosimilar,
Whole mAb Radiolabelled, Anti-PTPRC Antibody:
Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200
therapeutic antibody |
Apamistamab |
|
PTPRC |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-030 |
Pre-Made Apitegromab biosimilar,
Whole Mab: Anti-pro-GDF-8 therapeutic
antibody |
Apitegromab |
|
pro-GDF-8 |
Whole mAb |
|
GMP-Bios-ab-031 |
Pre-Made Aprutumab biosimilar,
Whole mAb ADC, Anti-FGFR2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody |
Aprutumab |
|
FGFR2 |
Whole mAb ADC |
|
GMP-Bios-ab-032 |
Pre-Made Ascrinvacumab
biosimilar, Whole mAb, Anti-ACVRL1 Antibody:
Anti-ACVRLK1/ALK-1/ALK1/HHT/HHT2/ORW2/SKR3/TSR-I
therapeutic antibody |
Ascrinvacumab |
|
ACVRL1 |
Whole mAb |
|
GMP-Bios-ab-033 |
Pre-Made Astegolimab biosimilar,
Whole mAb, Anti-IL1RL1/ST2 Antibody:
Anti-DER4/FIT-1/IL33R/T1 therapeutic
antibody |
Astegolimab |
|
IL1RL1/ST2 |
Whole mAb |
|
GMP-Bios-ab-034 |
Pre-Made Atezolizumab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Atezolizumab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-035 |
Pre-Made Atibuclimab biosimilar,
Whole Mab: Anti-CD14 therapeutic antibody
|
Atibuclimab |
|
CD14 |
Whole mAb |
|
GMP-Bios-ab-036 |
Pre-Made Atidortoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Atidortoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-037 |
Pre-Made Atinumab biosimilar,
Whole mAb, Anti-RTN4 Antibody:
Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2
therapeutic antibody |
Atinumab |
|
RTN4 |
Whole mAb |
|
GMP-Bios-ab-038 |
Pre-Made Atoltivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Atoltivimab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-039 |
Pre-Made Avdoralimab biosimilar,
Whole mAb, Anti-C5AR1 Antibody:
Anti-C5AR/C5R1/CD88 therapeutic antibody
|
Avdoralimab |
|
C5AR1 |
Whole mAb |
|
GMP-Bios-ab-040 |
Pre-Made Avelumab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Avelumab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-041 |
Pre-Made Avizakimab biosimilar,
Whole mAb, Anti-IL21 Antibody:
Anti-CVID11/IL-21/Za11 therapeutic antibody
|
Avizakimab |
|
IL21 |
Whole mAb |
|
GMP-Bios-ab-042 |
Pre-Made Axatilimab biosimilar,
Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Axatilimab |
|
CSF1R |
Whole mAb |
|
GMP-Bios-ab-043 |
Pre-Made Azintuxizumab
biosimilar, Whole mAb ADC, Anti-SLAMF7/CS1
Antibody: Anti-19A/CD319/CRACC therapeutic
antibody |
Azintuxizumab |
|
SLAMF7/CS1 |
Whole mAb ADC |
|
GMP-Bios-ab-044 |
Pre-Made Balstilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Balstilimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-045 |
Pre-Made Bamlanivimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike
therapeutic antibody |
Bamlanivimab |
|
SARS-CoV-2 Spike |
Whole mAb |
|
GMP-Bios-ab-046 |
Pre-Made Bapineuzumab
biosimilar, Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Bapineuzumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-047 |
Pre-Made Bapotulimab biosimilar,
Whole mAb, Anti-ILDR2 Antibody:
Anti-C1orf32/dJ782G3.1 therapeutic antibody
|
Bapotulimab |
|
ILDR2 |
Whole mAb |
|
GMP-Bios-ab-048 |
Pre-Made Barecetamab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Barecetamab |
|
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-049 |
Pre-Made Basiliximab biosimilar,
Whole mAb, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Basiliximab |
|
IL2RA |
Whole mAb |
|
GMP-Bios-ab-050 |
Pre-Made Batoclimab biosimilar,
Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Batoclimab |
|
FCGRT |
Whole mAb |
|
GMP-Bios-ab-051 |
Pre-Made Bavituximab biosimilar,
Whole Mab: Anti-Phosphatidylserine therapeutic
antibody |
Bavituximab |
|
Phosphatidylserine |
Whole mAb |
|
GMP-Bios-ab-052 |
Pre-Made Bedinvetmab biosimilar,
Canine Whole Mab: Anti-Canine NGFB therapeutic
antibody |
Bedinvetmab |
|
Canine NGFB |
Canine Whole mAb |
|
GMP-Bios-ab-053 |
Pre-Made Befovacimab biosimilar,
Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI
therapeutic antibody |
Befovacimab |
|
TFPI |
Whole mAb |
|
GMP-Bios-ab-054 |
Pre-Made Begelomab biosimilar,
Whole mAb, Anti-DPP4/DPP-4 Antibody:
Anti-ADABP/ADCP2/CD26/DPPIV/TP103 therapeutic
antibody |
Begelomab |
|
DPP4/DPP-4 |
Whole mAb |
|
GMP-Bios-ab-055 |
Pre-Made Belantamab biosimilar,
Whole mAb ADC, Anti-TNFRSF17 Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic
antibody |
Belantamab |
|
TNFRSF17 |
Whole mAb ADC |
|
GMP-Bios-ab-056 |
Pre-Made Belimumab biosimilar,
Whole mAb, Anti-TNFSF13B Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
therapeutic antibody |
Belimumab |
|
TNFSF13B |
Whole mAb |
|
GMP-Bios-ab-057 |
Pre-Made Bemarituzumab
biosimilar, Whole mAb, Anti-FGFR2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody |
Bemarituzumab |
|
FGFR2 |
Whole mAb |
|
GMP-Bios-ab-058 |
Pre-Made Benralizumab
biosimilar, Whole mAb, Anti-IL5RA Antibody:
Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic
antibody |
Benralizumab |
|
IL5RA |
Whole mAb |
|
GMP-Bios-ab-059 |
Pre-Made Bentracimab biosimilar,
Whole Mab: Anti-AR-C124910XX therapeutic
antibody |
Bentracimab |
|
AR-C124910XX |
Whole mAb |
|
GMP-Bios-ab-060 |
Pre-Made Benufutamab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Benufutamab |
|
TNFRSF10B/TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-061 |
Pre-Made Bepranemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Bepranemab |
|
MAPT |
Whole mAb |
|
GMP-Bios-ab-062 |
Pre-Made Berlimatoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Berlimatoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-063 |
Pre-Made Bermekimab biosimilar,
Whole mAb, Anti-IL1A Antibody:
Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha
therapeutic antibody |
Bermekimab |
|
IL1A |
Whole mAb |
|
GMP-Bios-ab-064 |
Pre-Made Bersanlimab biosimilar,
Whole mAb, Anti-ICAM1 Antibody:
Anti-BB2/CD54/P3.58 therapeutic antibody
|
Bersanlimab |
|
ICAM1 |
Whole mAb |
|
GMP-Bios-ab-065 |
Pre-Made Bevacizumab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Bevacizumab |
|
VEGFA |
Whole mAb |
|
GMP-Bios-ab-066 |
Pre-Made Bexmarilimab
biosimilar, Whole mAb, Anti-STAB1 Antibody:
Anti-CLEVER-1/FEEL-1/FEEL1/FELE-1/FEX1/SCARH2/STAB-1
therapeutic antibody |
Bexmarilimab |
|
STAB1 |
Whole mAb |
|
GMP-Bios-ab-067 |
Pre-Made Bezlotoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Bezlotoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-068 |
Pre-Made Bifikafusp biosimilar,
Whole mAb Fusion: Anti-FN extra domain B
therapeutic antibody |
Bifikafusp |
|
FN extra domain B |
Whole mAb Fusion |
|
GMP-Bios-ab-069 |
Pre-Made Bimagrumab biosimilar,
Whole mAb, Anti-ACVR2B Antibody:
Anti-ACTRIIB/ActR-IIB/HTX4 therapeutic
antibody |
Bimagrumab |
|
ACVR2B |
Whole mAb |
|
GMP-Bios-ab-070 |
Pre-Made Bimekizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Bimekizumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-071 |
Pre-Made Bintrafusp biosimilar,
Whole mAb Fusion, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Bintrafusp |
|
CD274/PD-L1 |
Whole mAb Fusion |
|
GMP-Bios-ab-072 |
Pre-Made Birtamimab biosimilar,
Whole mAb, Anti-SAA1 Antibody:
Anti-PIG4/SAA/SAA2/TP53I4 therapeutic
antibody |
Birtamimab |
|
SAA1 |
Whole mAb |
|
GMP-Bios-ab-073 |
Pre-Made Bleselumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Bleselumab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-074 |
Pre-Made Blinatumomab
biosimilar, Bispecific T-Cell Engager,
Anti-CD19;CD3E Antibody:
Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic
antibody |
Blinatumomab |
|
CD19;CD3E |
Bispecific T-Cell Engager
|
|
GMP-Bios-ab-075 |
Pre-Made Blontuvetmab
biosimilar, Canine Whole mAb, Anti-MS4A1/CD20
Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Blontuvetmab |
|
MS4A1/CD20 |
Canine Whole mAb |
|
GMP-Bios-ab-076 |
Pre-Made Blosozumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Blosozumab |
|
SOST |
Whole mAb |
|
GMP-Bios-ab-077 |
Pre-Made Bococizumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Bococizumab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-078 |
Pre-Made Botensilimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Botensilimab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-079 |
Pre-Made Brazikumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Brazikumab |
|
IL23A/IL23 |
Whole mAb |
|
GMP-Bios-ab-080 |
Pre-Made Brentuximab biosimilar,
Whole mAb ADC, Anti-TNFRSF8 Antibody:
Anti-CD30/Ki-1/D1S166E therapeutic antibody
|
Brentuximab |
|
TNFRSF8 |
Whole mAb ADC |
|
GMP-Bios-ab-081 |
Pre-Made Briakinumab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Briakinumab |
|
IL12B |
Whole mAb |
|
GMP-Bios-ab-082 |
Pre-Made Brodalumab biosimilar,
Whole mAb, Anti-IL17RA/IL17R Antibody:
Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R
therapeutic antibody |
Brodalumab |
|
IL17RA/IL17R |
Whole mAb |
|
GMP-Bios-ab-083 |
Pre-Made Brolucizumab
biosimilar, scFv, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Brolucizumab |
|
VEGFA |
scFv |
|
GMP-Bios-ab-084 |
Pre-Made Brontictuzumab
biosimilar, Whole mAb, Anti-NOTCH1 Antibody:
Anti-AOS5/AOVD1/TAN1/hN1 therapeutic
antibody |
Brontictuzumab |
|
NOTCH1 |
Whole mAb |
|
GMP-Bios-ab-085 |
Pre-Made Budigalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Budigalimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-086 |
Pre-Made Burosumab biosimilar,
Whole mAb, Anti-FGF23 Antibody:
Anti-ADHR/FGFN/HFTC2/HPDR2/HYPF/PHPTC
therapeutic antibody |
Burosumab |
|
FGF23 |
Whole mAb |
|
GMP-Bios-ab-087 |
Pre-Made Cabiralizumab
biosimilar, Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Cabiralizumab |
|
CSF1R |
Whole mAb |
|
GMP-Bios-ab-088 |
Pre-Made Cadonilimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-PDCD1/PD-1;CTLA4/CTLA-4 antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Cadonilimab |
|
PDCD1/PD-1; CTLA4/CTLA-4
|
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-089 |
Pre-Made Camidanlumab
biosimilar, Whole mAb ADC, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Camidanlumab |
|
IL2RA |
Whole mAb ADC |
|
GMP-Bios-ab-090 |
Pre-Made Camrelizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Camrelizumab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-091 |
Pre-Made Canakinumab biosimilar,
Whole mAb, Anti-IL1B Antibody:
Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Canakinumab |
|
IL1B |
Whole mAb |
|
GMP-Bios-ab-092 |
Pre-Made Cantuzumab biosimilar,
Whole mAb ADC, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Cantuzumab |
|
MUC1 |
Whole mAb ADC |
|
GMP-Bios-ab-093 |
Pre-Made Caplacizumab
biosimilar, Nanobody, Anti-VWF Antibody:
Anti-F8VWF/VWD therapeutic antibody |
Caplacizumab |
|
VWF |
Nanobody |
|
GMP-Bios-ab-094 |
Pre-Made Carlumab biosimilar,
Whole mAb, Anti-CCL2 Antibody:
Anti-HC11/MCAF/MCP1/MCP-1/SCYA2/GDCF-2/SMC-CF/HSMCR30
therapeutic antibody |
Carlumab |
|
CCL2 |
Whole mAb |
|
GMP-Bios-ab-095 |
Pre-Made Carotuximab biosimilar,
Whole mAb, Anti-ENG Antibody: Anti-END/HHT1/ORW1
therapeutic antibody |
Carotuximab |
|
ENG |
Whole mAb |
|
GMP-Bios-ab-096 |
Pre-Made Casirivimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Casirivimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-097 |
Pre-Made Cemiplimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Cemiplimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-098 |
Pre-Made Cendakimab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Cendakimab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-099 |
Pre-Made Cergutuzumab
biosimilar, Whole mAb Fusion, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Cergutuzumab |
|
CEACAM5/CD66e |
Whole mAb Fusion |
|
GMP-Bios-ab-100 |
Pre-Made Certolizumab
biosimilar, Fab, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Certolizumab |
|
TNFA/TNF |
Fab |
|
GMP-Bios-ab-101 |
Pre-Made Cetrelimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Cetrelimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-102 |
Pre-Made Cetuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Cetuximab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-103 |
Pre-Made Cevostamab biosimilar,
Bispecific mAb: Anti-FCRL5;CD3 therapeutic
antibody |
Cevostamab |
|
FCRL5;CD3 |
Bispecific mAb |
|
GMP-Bios-ab-104 |
Pre-Made Cibisatamab biosimilar,
Bispecific mAb with Domain Crossover:
Anti-CEACAM5;CD3E therapeutic antibody |
Cibisatamab |
|
CEACAM5;CD3E |
Bispecific mAb with Domain
Crossover |
|
GMP-Bios-ab-105 |
Pre-Made Cilgavimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Cilgavimab |
|
SARS-CoV-2 Spike RBD
|
Whole mAb |
|
GMP-Bios-ab-106 |
Pre-Made Cinpanemab biosimilar,
Whole mAb, Anti-SNCA Antibody:
Anti-NACP/PARK1/PARK4/PD1 therapeutic
antibody |
Cinpanemab |
|
SNCA |
Whole mAb |
|
GMP-Bios-ab-107 |
Pre-Made Citatuzumab biosimilar,
Fab Fusion, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Citatuzumab |
|
EPCAM |
Fab Fusion |
|
GMP-Bios-ab-108 |
Pre-Made Cixutumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Cixutumumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-109 |
Pre-Made Claudiximab biosimilar,
Whole mAb, Anti-CLDN18 Antibody:
Anti-SFTA5/SFTPJ therapeutic antibody |
Claudiximab |
zolbetuximab |
CLDN18 |
Whole mAb |
|
GMP-Bios-ab-110 |
Pre-Made Clazakizumab
biosimilar, Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Clazakizumab |
|
IL6 |
Whole mAb |
|
GMP-Bios-ab-111 |
Pre-Made Clervonafusp
biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2
Antibody: Anti-DER12/HNP36 therapeutic
antibody |
Clervonafusp |
|
SLC29A2/ENT2 |
di-Fab Fusion |
|
GMP-Bios-ab-112 |
Pre-Made Clivatuzumab
biosimilar, Whole mAb Radiolabelled, Anti-MUC1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Clivatuzumab |
|
MUC1 |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-113 |
Pre-Made Cobolimab biosimilar,
Whole mAb, Anti-HAVCR2/TIM3 Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Cobolimab |
|
HAVCR2/TIM3 |
Whole mAb |
|
GMP-Bios-ab-114 |
Pre-Made Codrituzumab
biosimilar, Whole mAb, Anti-GPC3 Antibody:
Anti-DGSX/GTR2-2/MXR7/OCI-5/SDYS/SGB/SGBS/SGBS1
therapeutic antibody |
Codrituzumab |
|
GPC3 |
Whole mAb |
|
GMP-Bios-ab-115 |
Pre-Made Cofetuzumab biosimilar,
Whole mAb ADC, Anti-PTK7 Antibody:
Anti-CCK-4/CCK4 therapeutic antibody |
Cofetuzumab |
|
PTK7 |
Whole mAb ADC |
|
GMP-Bios-ab-116 |
Pre-Made Coltuximab biosimilar,
Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Coltuximab |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-ab-117 |
Pre-Made Conatumumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Conatumumab |
|
TNFRSF10B/ TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-118 |
Pre-Made Concizumab biosimilar,
Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI
therapeutic antibody |
Concizumab |
|
TFPI |
Whole mAb |
|
GMP-Bios-ab-119 |
Pre-Made Coprelotamab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Coprelotamab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-120 |
Pre-Made Cosfroviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Cosfroviximab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-121 |
Pre-Made Cosibelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Cosibelimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-122 |
Pre-Made Crenezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Crenezumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-123 |
Pre-Made Crizanlizumab
biosimilar, Whole mAb, Anti-SELP Antibody:
Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
therapeutic antibody |
Crizanlizumab |
|
SELP |
Whole mAb |
|
GMP-Bios-ab-124 |
Pre-Made Crotedumab biosimilar,
Whole mAb, Anti-GCGR Antibody:
Anti-GGR/GL-R/MVAH therapeutic antibody |
Crotedumab |
|
GCGR |
Whole mAb |
|
GMP-Bios-ab-125 |
Pre-Made Crovalimab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Crovalimab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-126 |
Pre-Made Cudarolimab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Cudarolimab |
|
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-127 |
Pre-Made Cusatuzumab biosimilar,
Whole mAb, Anti-CD70/CD27-L Antibody:
Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A
therapeutic antibody |
Cusatuzumab |
|
CD70/CD27-L |
Whole mAb |
|
GMP-Bios-ab-128 |
Pre-Made Dacetuzumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Dacetuzumab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-129 |
Pre-Made Daclizumab biosimilar,
Whole mAb, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Daclizumab |
|
IL2RA |
Whole mAb |
|
GMP-Bios-ab-130 |
Pre-Made Dafsolimab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Dafsolimab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-131 |
Pre-Made Dalotuzumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Dalotuzumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-132 |
Pre-Made Dapirolizumab
biosimilar, Fab, Anti-CD40LG Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Dapirolizumab |
|
CD40LG |
Fab |
|
GMP-Bios-ab-133 |
Pre-Made Daratumumab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Daratumumab |
|
CD38 |
Whole mAb |
|
GMP-Bios-ab-134 |
Pre-Made Datopotamab biosimilar,
Whole mAb, Anti-TACSTD2 Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody |
Datopotamab |
|
TACSTD2 |
Whole mAb |
|
GMP-Bios-ab-135 |
Pre-Made Daxdilimab biosimilar,
Whole mAb, Anti-LILRA4/ILT7 Antibody: Anti-CD85g
therapeutic antibody |
Daxdilimab |
|
LILRA4/ILT7 |
Whole mAb |
|
GMP-Bios-ab-136 |
Pre-Made Dectrekumab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Dectrekumab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-137 |
Pre-Made Demcizumab biosimilar,
Whole mAb, Anti-DLL4 Antibody:
Anti-AOS6/delta4/hdelta2 therapeutic
antibody |
Demcizumab |
|
DLL4 |
Whole mAb |
|
GMP-Bios-ab-138 |
Pre-Made Demupitamab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Demupitamab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-139 |
Pre-Made Denintuzumab
biosimilar, Whole mAb ADC, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Denintuzumab |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-ab-140 |
Pre-Made Denosumab biosimilar,
Whole mAb, Anti-TNFSF11/ODF Antibody:
Anti-OPGL/sCD254/OPTB2/RANKL/TNLG6B/TRANCE/hRANKL2
therapeutic antibody |
Denosumab |
|
TNFSF11/ODF |
Whole mAb |
|
GMP-Bios-ab-141 |
Pre-Made Depatuxizumab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Depatuxizumab |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-ab-142 |
Pre-Made Depemokimab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Depemokimab |
|
IL5 |
Whole mAb |
|
GMP-Bios-ab-143 |
Pre-Made Derlotuximab
biosimilar, Whole mAb Radiolabelled: Anti-DNA/H1
Complex therapeutic antibody |
Derlotuximab |
|
DNA/H1 Complex |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-144 |
Pre-Made Dezamizumab biosimilar,
Whole mAb, Anti-APCS Antibody:
Anti-HEL-S-92n/PTX2/SAP therapeutic antibody
|
Dezamizumab |
|
APCS |
Whole mAb |
|
GMP-Bios-ab-145 |
Pre-Made Dilpacimab biosimilar,
Bispecific mAb, Anti-DLL4;VEGFA Antibody:
Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1
therapeutic antibody |
Dilpacimab |
|
DLL4;VEGFA |
Bispecific mAb |
|
GMP-Bios-ab-146 |
Pre-Made Dinutuximab biosimilar,
Whole Mab: Anti-Ganglioside GD2 therapeutic
antibody |
Dinutuximab |
|
Ganglioside GD2 |
Whole mAb |
|
GMP-Bios-ab-147 |
Pre-Made Diridavumab biosimilar,
Whole Mab: Anti-Influenza A HA2 therapeutic
antibody |
Diridavumab |
|
Influenza A HA2 |
Whole mAb |
|
GMP-Bios-ab-148 |
Pre-Made Disitamab biosimilar,
Whole mAb ADC, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Disitamab |
|
ERBB2/HER2 |
Whole mAb ADC |
|
GMP-Bios-ab-149 |
Pre-Made Divozilimab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Divozilimab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-150 |
Pre-Made Docaravimab biosimilar,
Whole mAb (Mouse): Anti-Rabies Virus Strain ERA
GP Ectodomain Epitope G-III therapeutic
antibody |
Docaravimab |
|
Rabies Virus Strain ERA
GP Ectodomain Epitope G-III |
Whole mAb (Mouse) |
|
GMP-Bios-ab-151 |
Pre-Made Domagrozumab
biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Domagrozumab |
|
MSTN/GDF-8 |
Whole mAb |
|
GMP-Bios-ab-152 |
Pre-Made Domvanalimab
biosimilar, Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Domvanalimab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-153 |
Pre-Made Donanemab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Donanemab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-154 |
Pre-Made Dostarlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Dostarlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-155 |
Pre-Made Dovanvetmab biosimilar,
Feline Whole Mab: Anti-IL31 (Feline) therapeutic
antibody |
Dovanvetmab |
|
IL31 (Feline) |
Feline Whole mAb |
|
GMP-Bios-ab-156 |
Pre-Made Drozitumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Drozitumab |
|
TNFRSF10B /TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-157 |
Pre-Made Duligotuzumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Duligotuzumab |
Duligotumab |
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-158 |
Pre-Made Dupilumab biosimilar,
Whole mAb, Anti-IL4R Antibody: Anti-CD124
therapeutic antibody |
Dupilumab |
|
IL4R |
Whole mAb |
|
GMP-Bios-ab-159 |
Pre-Made Durvalumab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Durvalumab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-160 |
Pre-Made Dusigitumab biosimilar,
Whole mAb, Anti-IGF1;IGF2 Antibody:
Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3
therapeutic antibody |
Dusigitumab |
|
IGF1;IGF2 |
Whole mAb |
|
GMP-Bios-ab-161 |
Pre-Made Duvortuxizumab
biosimilar, Bispecific scFv with Crossover,
Anti-CD19;CD3E antibody:
Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic
antibody |
Duvortuxizumab |
|
CD19;CD3E |
Bispecific scFv with
Crossover |
|
GMP-Bios-ab-162 |
Pre-Made Ebdarokimab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Ebdarokimab |
|
IL12B |
Whole mAb |
|
GMP-Bios-ab-163 |
Pre-Made Ebronucimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ebronucimab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-164 |
Pre-Made Eculizumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Eculizumab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-165 |
Pre-Made Edrecolomab biosimilar,
Whole mAb, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Edrecolomab |
|
EPCAM |
Whole mAb |
|
GMP-Bios-ab-166 |
Pre-Made Efalizumab biosimilar,
Whole mAb, Anti-ITGAL Antibody:
Anti-CD11A/LFA-1/LFA1A therapeutic antibody
|
Efalizumab |
|
ITGAL |
Whole mAb |
|
GMP-Bios-ab-167 |
Pre-Made Efungumab biosimilar,
scFv: Anti-Heat Shock Protein 90 Homolog
therapeutic antibody |
Efungumab |
|
Heat Shock Protein 90
Homolog |
scFv |
|
GMP-Bios-ab-168 |
Pre-Made Eldelumab biosimilar,
Whole mAb, Anti-CXCL10 Antibody:
Anti-C7/IFI10/INP10/IP-10/SCYB10/crg-2/gIP-10/mob-1
therapeutic antibody |
Eldelumab |
|
CXCL10 |
Whole mAb |
|
GMP-Bios-ab-169 |
Pre-Made Elezanumab biosimilar,
Whole mAb, Anti-RGMA Antibody: Anti-RGM
therapeutic antibody |
Elezanumab |
|
RGMA |
Whole mAb |
|
GMP-Bios-ab-170 |
Pre-Made Elgemtumab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Elgemtumab |
|
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-171 |
Pre-Made Elipovimab biosimilar,
Whole Mab: Anti-HIV-1 gp120 therapeutic
antibody |
Elipovimab |
|
HIV-1 gp120 |
Whole mAb |
|
GMP-Bios-ab-172 |
Pre-Made Elotuzumab biosimilar,
Whole mAb, Anti-SLAMF7/CS1 Antibody:
Anti-19A/CD319/CRACC therapeutic antibody
|
Elotuzumab |
|
SLAMF7/CS1 |
Whole mAb |
|
GMP-Bios-ab-173 |
Pre-Made Eluvixtamab biosimilar,
Bispecific scFv, Anti-CD33;CD3E Antibody:
Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18
therapeutic antibody |
Eluvixtamab |
|
CD33;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-174 |
Pre-Made Emactuzumab biosimilar,
Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Emactuzumab |
|
CSF1R |
Whole mAb |
|
GMP-Bios-ab-175 |
Pre-Made Emapalumab biosimilar,
Whole mAb, Anti-IFNG Antibody:
Anti-IFG/IFI/IMD69 therapeutic antibody |
Emapalumab |
|
IFNG |
Whole mAb |
|
GMP-Bios-ab-176 |
Pre-Made Emerfetamab biosimilar,
Bispecific scFv, Anti-CD33;CD3E Antibody:
Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18
therapeutic antibody |
Emerfetamab |
|
CD33;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-177 |
Pre-Made Emicizumab biosimilar,
Bispecific mAb, Anti-F9;F10 Antibody:
Anti-FIX/HEMB/P19/PTC/THPH8;FX/FXA therapeutic
antibody |
Emicizumab |
|
F9;F10 |
Bispecific mAb |
|
GMP-Bios-ab-178 |
Pre-Made Emibetuzumab
biosimilar, Whole mAb, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Emibetuzumab |
|
MET |
Whole mAb |
|
GMP-Bios-ab-179 |
Pre-Made Enapotamab biosimilar,
Whole mAb ADC, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Enapotamab |
|
AXL |
Whole mAb ADC |
|
GMP-Bios-ab-180 |
Pre-Made Enavatuzumab
biosimilar, Whole mAb, Anti-TNFRSF12A Antibody:
Anti-CD2664/TWEAKR therapeutic antibody |
Enavatuzumab |
|
TNFRSF12A |
Whole mAb |
|
GMP-Bios-ab-181 |
Pre-Made Encelimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Encelimab |
|
LAG3 |
Whole mAb |
|
GMP-Bios-ab-182 |
Pre-Made Enfortumab biosimilar,
Whole mAb ADC, Anti-PVRL4/NECTIN4 Antibody:
Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic
antibody |
Enfortumab |
|
PVRL4/NECTIN4 |
Whole mAb ADC |
|
GMP-Bios-ab-183 |
Pre-Made Enibarcimab biosimilar,
Whole mAb, Anti-ADM Antibody: Anti-AM/PAMP
therapeutic antibody |
Enibarcimab |
|
ADM |
Whole mAb |
|
GMP-Bios-ab-184 |
Pre-Made Enoblituzumab
biosimilar, Whole mAb, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Enoblituzumab |
|
CD276 |
Whole mAb |
|
GMP-Bios-ab-185 |
Pre-Made Enokizumab biosimilar,
Whole mAb, Anti-IL9 Antibody: Anti-HP40/IL-9/P40
therapeutic antibody |
Enokizumab |
|
IL9 |
Whole mAb |
|
GMP-Bios-ab-186 |
Pre-Made Enoticumab biosimilar,
Whole mAb, Anti-DLL4 Antibody:
Anti-AOS6/delta4/hdelta2 therapeutic
antibody |
Enoticumab |
|
DLL4 |
Whole mAb |
|
GMP-Bios-ab-187 |
Pre-Made Ensituximab biosimilar,
Whole mAb, Anti-MUC5AC Antibody:
Anti-MUC5/TBM/leBin therapeutic antibody
|
Ensituximab |
|
MUC5AC |
Whole mAb |
|
GMP-Bios-ab-188 |
Pre-Made Envafolimab biosimilar,
Single Domain Variable Fragment;H,
Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1
therapeutic antibody |
Envafolimab |
|
CD274/PD-L1 |
Single Domain Variable
Fragment;H |
|
GMP-Bios-ab-189 |
Pre-Made Epcoritamab biosimilar,
Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Epcoritamab |
|
CD3E;MS4A1/CD20 |
Bispecific mAb |
|
GMP-Bios-ab-190 |
Pre-Made Epratuzumab biosimilar,
Whole mAb, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Epratuzumab |
|
CD22 |
Whole mAb |
|
GMP-Bios-ab-191 |
Pre-Made Eptinezumab biosimilar,
Whole mAb, Anti-CALCA;CALCB Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Eptinezumab |
|
CALCA;CALCB |
Whole mAb |
|
GMP-Bios-ab-192 |
Pre-Made Eramkafusp biosimilar,
Whole mAb Fusion, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Eramkafusp |
|
MS4A1/CD20 |
Whole mAb Fusion |
|
GMP-Bios-ab-193 |
Pre-Made Erenumab biosimilar,
Whole mAb, Anti-CALCRL/CGRPR Antibody:
Anti-CRLR/LMPHM8 therapeutic antibody |
Erenumab |
|
CALCRL/CGRPR |
Whole mAb |
|
GMP-Bios-ab-194 |
Pre-made Erfonrilimab
biosimilar, Bispecific Single Domains
(VH-VH'-CH), Anti-CD274/PD-L1;CTLA4/CTLA-4
Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Erfonrilimab |
|
CD274/PD-L1;CTLA4/CTLA-4
|
Bispecific Single Domains
(VH-VH'-CH) |
|
GMP-Bios-ab-195 |
Pre-Made Etaracizumab
biosimilar, Whole mAb, Anti-ITGAV;ITGB3
Antibody:
Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Etaracizumab |
|
ITGAV;ITGB3 |
Whole mAb |
|
GMP-Bios-ab-196 |
Pre-Made Etesevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Etesevimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-197 |
Pre-Made Etevritamab biosimilar,
Bispecific scFv, Anti-EGFR;CD3E Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18
therapeutic antibody |
Etevritamab |
|
EGFR;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-198 |
Pre-Made Etigilimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Etigilimab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-199 |
Pre-Made Etokimab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Etokimab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-200 |
Pre-Made Etrolizumab biosimilar,
Whole Mab: Anti-ITGA4;ITGB7;ITGAE;ITGB7
therapeutic antibody |
Etrolizumab |
|
ITGA4;ITGB7; ITGAE;ITGB7
|
Whole mAb |
|
GMP-Bios-ab-201 |
Pre-Made Evinacumab biosimilar,
Whole mAb, Anti-ANGPTL3 Antibody:
Anti-ANG-5/ANGPT5/ANL3/FHBL2 therapeutic
antibody |
Evinacumab |
|
ANGPTL3 |
Whole mAb |
|
GMP-Bios-ab-202 |
Pre-Made Evolocumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Evolocumab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-203 |
Pre-Made Ezabenlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Ezabenlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-204 |
Pre-Made Faricimab biosimilar,
Bispecific mAb, Anti-VEGFA;ANGPT2 Antibody:
Anti-VPF/VEGF/MVCD1;AGPT2/ANG2/LMPHM10
therapeutic antibody |
Faricimab |
|
VEGFA;ANGPT2 |
Bispecific mAb |
|
GMP-Bios-ab-205 |
Pre-Made Farletuzumab
biosimilar, Whole mAb, Anti-FOLR1 Antibody:
Anti-FBP/FOLR/FRalpha/NCFTD therapeutic
antibody |
Farletuzumab |
|
FOLR1 |
Whole mAb |
|
GMP-Bios-ab-206 |
Pre-Made Fasinumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Fasinumab |
|
NGFB/NGF |
Whole mAb |
|
GMP-Bios-ab-207 |
Pre-Made Feladilimab biosimilar,
Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Feladilimab |
|
ICOS |
Whole mAb |
|
GMP-Bios-ab-208 |
Pre-Made Felzartamab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Felzartamab |
|
CD38 |
Whole mAb |
|
GMP-Bios-ab-209 |
Pre-Made Fezakinumab biosimilar,
Whole mAb, Anti-IL22 Antibody:
Anti-IL-21/IL-22/IL-D110/IL-TIF/ILTIF/TIFIL-23/TIFa/zcyto18
therapeutic antibody |
Fezakinumab |
|
IL22 |
Whole mAb |
|
GMP-Bios-ab-210 |
Pre-Made Fianlimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Fianlimab |
|
LAG3 |
Whole mAb |
|
GMP-Bios-ab-211 |
Pre-Made Fibatuzumab biosimilar,
Whole mAb, Anti-EPHA3 Antibody:
Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic
antibody |
Fibatuzumab |
Ifabotuzumab |
EPHA3 |
Whole mAb |
|
GMP-Bios-ab-212 |
Pre-Made Ficlatuzumab
biosimilar, Whole mAb, Anti-HGF Antibody:
Anti-DFNB39/F-TCF/HPTA/SF therapeutic
antibody |
Ficlatuzumab |
|
HGF |
Whole mAb |
|
GMP-Bios-ab-213 |
Pre-Made Figitumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Figitumumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-214 |
Pre-Made Firivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Firivumab |
|
Influenza A HA |
Whole mAb |
|
GMP-Bios-ab-215 |
Pre-Made Finotonlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Finotonlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-216 |
Pre-Made Flanvotumab biosimilar,
Whole mAb, Anti-TYRP1 Antibody:
Anti-TRP/CAS2/CATB/GP75/OCA3/TRP1/TYRP/b-PROTEIN
therapeutic antibody |
Flanvotumab |
|
TYRP1 |
Whole mAb |
|
GMP-Bios-ab-217 |
Pre-Made Fletikumab biosimilar,
Whole mAb, Anti-IL20 Antibody:
Anti-IL-20/IL10D/ZCYTO10 therapeutic
antibody |
Fletikumab |
|
IL20 |
Whole mAb |
|
GMP-Bios-ab-218 |
Pre-Made Flotetuzumab
biosimilar, Bispecific scFv with Crossover,
Anti-IL3RA;CD3E Antibody:
Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18
therapeutic antibody |
Flotetuzumab |
|
IL3RA;CD3E |
Bispecific scFv with
Crossover |
|
GMP-Bios-ab-219 |
Pre-Made Fontolizumab
biosimilar, Whole mAb, Anti-IFNG Antibody:
Anti-IFG/IFI/IMD69 therapeutic antibody |
Fontolizumab |
|
IFNG |
Whole mAb |
|
GMP-Bios-ab-220 |
Pre-Made Foralumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Foralumab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-221 |
Pre-Made Foravirumab biosimilar,
Whole Mab: Anti-RV Antigenic Site III
therapeutic antibody |
Foravirumab |
|
RV Antigenic Site III |
Whole mAb |
|
GMP-Bios-ab-222 |
Pre-Made Fremanezumab
biosimilar, Whole mAb, Anti-CALCA;CALCB
Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Fremanezumab |
|
CALCA;CALCB |
Whole mAb |
|
GMP-Bios-ab-223 |
Pre-Made Fresolimumab
biosimilar, Whole mAb, Anti-TGFB/TGFB1 Antibody:
Anti-CED/DPD1/IBDIMDE/LAP therapeutic
antibody |
Fresolimumab |
|
TGFB/TGFB1 |
Whole mAb |
|
GMP-Bios-ab-224 |
Pre-Made Frovocimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Frovocimab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-225 |
Pre-Made Frunevetmab biosimilar,
Feline Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Frunevetmab |
|
NGFB/NGF |
Feline Whole mAb |
|
GMP-Bios-ab-226 |
Pre-Made Fulranumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Fulranumab |
|
NGFB/NGF |
Whole mAb |
|
GMP-Bios-ab-227 |
Pre-Made Futuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Futuximab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-228 |
Pre-Made Galcanezumab
biosimilar, Whole mAb, Anti-CALCA;CALCB
Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Galcanezumab |
|
CALCA;CALCB |
Whole mAb |
|
GMP-Bios-ab-229 |
Pre-Made Galiximab biosimilar,
Whole mAb, Anti-CD80 Antibody:
Anti-B7/BB1/B7-1/B7.1/LAB7/CD28LG/CD28LG1
therapeutic antibody |
Galiximab |
|
CD80 |
Whole mAb |
|
GMP-Bios-ab-230 |
Pre-Made Gancotamab biosimilar,
scFv, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Gancotamab |
|
ERBB2/HER2 |
scFv |
|
GMP-Bios-ab-231 |
Pre-Made Ganitumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Ganitumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-232 |
Pre-Made Gantenerumab
biosimilar, Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Gantenerumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-233 |
Pre-Made Garadacimab biosimilar,
Whole mAb, Anti-F12 Antibody: Anti-HAE3/HAEX/HAF
therapeutic antibody |
Garadacimab |
|
F12 |
Whole mAb |
|
GMP-Bios-ab-234 |
Pre-Made Garetosmab biosimilar,
Whole mAb, Anti-INHBA/ACT Antibody: Anti-EDF/FRP
therapeutic antibody |
Garetosmab |
|
INHBA/ACT |
Whole mAb |
|
GMP-Bios-ab-235 |
Pre-Made Garivulimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Garivulimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-236 |
Pre-Made Gatipotuzumab
biosimilar, Whole mAb, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Gatipotuzumab |
PankoMab |
MUC1 |
Whole mAb |
|
GMP-Bios-ab-237 |
Pre-Made Gatralimab biosimilar,
Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Gatralimab |
|
CD52 |
Whole mAb |
|
GMP-Bios-ab-238 |
Pre-Made Gedivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Gedivumab |
|
Influenza A HA |
Whole mAb |
|
GMP-Bios-ab-239 |
Pre-Made Gemtuzumab biosimilar,
Whole mAb ADC, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Gemtuzumab |
|
CD33 |
Whole mAb ADC |
|
GMP-Bios-ab-240 |
Pre-Made Geptanolimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Geptanolimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-241 |
Pre-Made Gevokizumab biosimilar,
Whole mAb, Anti-IL1B Antibody:
Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Gevokizumab |
|
IL1B |
Whole mAb |
|
GMP-Bios-ab-242 |
Pre-Made Giloralimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Giloralimab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-243 |
Pre-Made Gilvetmab biosimilar,
Canine Whole Mab: Anti-PDCD1 (Canine)
therapeutic antibody |
Gilvetmab |
|
PDCD1 (Canine) |
Canine Whole mAb |
|
GMP-Bios-ab-244 |
Pre-Made Gimsilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Gimsilumab |
|
CSF2 |
Whole mAb |
|
GMP-Bios-ab-245 |
Pre-Made Girentuximab
biosimilar, Whole mAb Radiolabelled,
Anti-CA9/CA-IX Antibody: Anti-CAIX/MN
therapeutic antibody |
Girentuximab |
|
CA9/CA-IX |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-246 |
Pre-Made Glembatumumab
biosimilar, Whole mAb ADC, Anti-GPNMB Antibody:
Anti-HGFIN/NMB/PLCA3 therapeutic antibody
|
Glembatumumab |
|
GPNMB |
Whole mAb ADC |
|
GMP-Bios-ab-247 |
Pre-Made Glenzocimab biosimilar,
Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI
therapeutic antibody |
Glenzocimab |
|
GP6 |
Fab |
|
GMP-Bios-ab-248 |
Pre-Made Glofitamab biosimilar,
Bispecific mAb with Domain Crossover,
Anti-CD3E;MS4A1/CD20 antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7therapeutic
antibody |
Glofitamab |
|
CD3E;MS4A1/CD20 |
Bispecific mAb with Domain
Crossover |
|
GMP-Bios-ab-249 |
Pre-Made Golimumab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Golimumab |
|
TNFA/TNF |
Whole mAb |
|
GMP-Bios-ab-250 |
Pre-Made Gomiliximab biosimilar,
Whole mAb, Anti-FCER2/CD23 Antibody:
Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF
therapeutic antibody |
Gomiliximab |
|
FCER2/CD23 |
Whole mAb |
|
GMP-Bios-ab-251 |
Pre-Made Gontivimab biosimilar,
Bispecific Single Domains (VH-VH'-VH’): Anti-RSV
gpF therapeutic antibody |
Gontivimab |
|
RSV gpF |
Bispecific Single Domains
(VH-VH'-VH’) |
|
GMP-Bios-ab-252 |
Pre-Made Gosuranemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Gosuranemab |
|
MAPT |
Whole mAb |
|
GMP-Bios-ab-253 |
Pre-Made Gremubamab biosimilar,
Bispecific mAb: Anti-PcrV type III secretion
system; Polysaccharide synthesis locus
(Pseudomonas) therapeutic antibody |
Gremubamab |
|
PcrV type III secretion
system; Polysaccharide synthesis
locus (Pseudomonas) |
Bispecific mAb |
|
GMP-Bios-ab-254 |
Pre-Made Grisnilimab biosimilar,
Whole mAb, Anti-CD7 Antibody:
Anti-GP40/TP41/Tp40/LEU-9 therapeutic
antibody |
Grisnilimab |
|
CD7 |
Whole mAb |
|
GMP-Bios-ab-255 |
Pre-Made Guselkumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Guselkumab |
|
IL23A/IL23 |
Whole mAb |
|
GMP-Bios-ab-256 |
Pre-Made Ianalumab biosimilar,
Whole mAb, Anti-TNFRSF13C Antibody:
Anti-BAFF-R/BAFFR/BROMIX/CD268/CVID4/prolixin
therapeutic antibody |
Ianalumab |
|
TNFRSF13C |
Whole mAb |
|
GMP-Bios-ab-257 |
Pre-Made Ibalizumab biosimilar,
Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Ibalizumab |
|
CD4 |
Whole mAb |
|
GMP-Bios-ab-258 |
Pre-Made Icatolimab biosimilar,
Whole mAb, Anti-BTLA Antibody: Anti-CD272
therapeutic antibody |
Icatolimab |
Tifcemalimab |
BTLA |
Whole mAb |
|
GMP-Bios-ab-259 |
Pre-Made Icrucumab biosimilar,
Whole mAb, Anti-FLT1/FLT-1 Antibody:
Anti-VEGFR-1/VEGFR1 therapeutic antibody
|
Icrucumab |
|
FLT1/FLT-1 |
Whole mAb |
|
GMP-Bios-ab-260 |
Pre-Made Idactamab biosimilar,
Whole mAb, Anti-SLC1A5 Antibody:
Anti-AAAT/ASCT2/ATBO/M7V1/M7VS1/R16/RDRC
therapeutic antibody |
Idactamab |
|
SLC1A5 |
Whole mAb |
|
GMP-Bios-ab-261 |
Pre-Made Idarucizumab
biosimilar, Fab: Anti-Dabigatran therapeutic
antibody |
Idarucizumab |
|
Dabigatran |
Fab |
|
GMP-Bios-ab-262 |
Pre-Made Ieramilimab biosimilar,
Whole Mab: Anti-CD223/LAG3 therapeutic
antibody |
Ieramilimab |
|
CD223/LAG3 |
Whole mAb |
|
GMP-Bios-ab-263 |
Pre-Made Ifabotuzumab
biosimilar, Whole mAb, Anti-EPHA3 Antibody:
Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic
antibody |
Ifabotuzumab |
Fibatuzumab |
EPHA3 |
Whole mAb |
|
GMP-Bios-ab-264 |
Pre-Made Iladatuzumab
biosimilar, Whole mAb ADC, Anti-CD79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody |
Iladatuzumab |
|
CD79B |
Whole mAb ADC |
|
GMP-Bios-ab-265 |
Pre-Made Imalumab biosimilar,
Whole mAb, Anti-MIF Antibody: Anti-GIF/GLIF/MMIF
therapeutic antibody |
Imalumab |
|
MIF |
Whole mAb |
|
GMP-Bios-ab-266 |
Pre-Made Imaprelimab biosimilar,
Whole mAb, Anti-MCAM Antibody:
Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic
antibody |
Imaprelimab |
|
MCAM |
Whole mAb |
|
GMP-Bios-ab-267 |
Pre-Made Imdevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Imdevimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-268 |
Pre-Made Imgatuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Imgatuzumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-269 |
Pre-Made Imsidolimab biosimilar,
Whole mAb, Anti-IL36R/IL1RL2 Antibody:
Anti-IL1RRP2/IL-1Rrp2/IL1R-rp2 therapeutic
antibody |
Imsidolimab |
|
IL36R/IL1RL2 |
Whole mAb |
|
GMP-Bios-ab-270 |
Pre-Made Inclacumab biosimilar,
Whole mAb, Anti-SELP Antibody:
Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
therapeutic antibody |
Inclacumab |
|
SELP |
Whole mAb |
|
GMP-Bios-ab-271 |
Pre-Made Indatuximab biosimilar,
Whole mAb ADC, Anti-SDC1 Antibody:
Anti-SDC/CD138/SYND1/syndecan therapeutic
antibody |
Indatuximab |
|
SDC1 |
Whole mAb ADC |
|
GMP-Bios-ab-272 |
Pre-Made Indusatumab biosimilar,
Whole mAb ADC, Anti-GUCY2C Antibody:
Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic
antibody |
Indusatumab |
|
GUCY2C |
Whole mAb ADC |
|
GMP-Bios-ab-273 |
Pre-Made Inebilizumab
biosimilar, Whole mAb, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Inebilizumab |
|
CD19 |
Whole mAb |
|
GMP-Bios-ab-274 |
Pre-Made Infliximab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Infliximab |
|
TNFA/TNF |
Whole mAb |
|
GMP-Bios-ab-275 |
Pre-Made Inotuzumab biosimilar,
Whole mAb ADC, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Inotuzumab |
|
CD22 |
Whole mAb ADC |
|
GMP-Bios-ab-276 |
Pre-Made Intetumumab biosimilar,
Whole mAb, Anti-ITGAV;ITGB3 Antibody:
Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Intetumumab |
|
ITGAV;ITGB3 |
Whole mAb |
|
GMP-Bios-ab-277 |
Pre-Made Ipilimumab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Ipilimumab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-278 |
Pre-Made Iratumumab biosimilar,
Whole mAb, Anti-TNFRSF8 Antibody:
Anti-CD30/Ki-1/D1S166E therapeutic antibody
|
Iratumumab |
|
TNFRSF8 |
Whole mAb |
|
GMP-Bios-ab-279 |
Pre-Made Isatuximab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Isatuximab |
|
CD38 |
Whole mAb |
|
GMP-Bios-ab-280 |
Pre-Made Iscalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Iscalimab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-281 |
Pre-Made Isecarosmab biosimilar,
Bispecific Single Domains (VH-VH'),
Anti-ADAMTSL5;ALB Antibody:
Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Isecarosmab |
|
ADAMTSL5;ALB |
Bispecific Single Domains
(VH-VH') |
|
GMP-Bios-ab-282 |
Pre-Made Istiratumab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-IGF1R;ERBB3/Erbb-3 Antibody:
Anti-IGFR/CD221/IGFIR/JTK13;FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-c-erbB3/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Istiratumab |
|
IGF1R;ERBB3/Erbb-3 |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-283 |
Pre-Made Itepekimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Itepekimab |
|
IL33 |
Whole mAb |
|
GMP-Bios-ab-284 |
Pre-Made Itolizumab biosimilar,
Whole Mab: Anti-CD6/TP120 therapeutic
antibody |
Itolizumab |
|
CD6/TP120 |
Whole mAb |
|
GMP-Bios-ab-285 |
Pre-Made Ivuxolimab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Ivuxolimab |
|
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-286 |
Pre-Made Ixekizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Ixekizumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-287 |
Pre-Made Izuralimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-ICOS;PDCD1/PD-1 antibody:
Anti-AILIM/CD278/CVID1;CD279/SLEB2/hPD-1/hPD-l/hSLE1
therapeutic antibody |
Izuralimab |
|
ICOS;PDCD1/PD-1 |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-288 |
Pre-Made Labetuzumab biosimilar,
Whole mAb ADC, Anti-CEACAM5/CD66e Antibody:
Anti-CEA therapeutic antibody |
Labetuzumab |
|
CEACAM5/CD66e |
Whole mAb ADC |
|
GMP-Bios-ab-289 |
Pre-Made Lacnotuzumab
biosimilar, Whole mAb, Anti-CSF1 Antibody:
Anti-MCSF/CSF-1 therapeutic antibody |
Lacnotuzumab |
|
CSF1 |
Whole mAb |
|
GMP-Bios-ab-290 |
Pre-Made Lacutamab biosimilar,
Whole mAb, Anti-KIR3DL2/CD158k Antibody:
Anti-3DL2/CD158K/KIR-3DL2/NKAT-4/NKAT4/NKAT4B/p140
therapeutic antibody |
Lacutamab |
|
KIR3DL2/CD158k |
Whole mAb |
|
GMP-Bios-ab-291 |
Pre-Made Ladiratuzumab
biosimilar, Whole mAb ADC, Anti-SLC39A6
Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic
antibody |
Ladiratuzumab |
|
SLC39A6 |
Whole mAb ADC |
|
GMP-Bios-ab-292 |
Pre-Made Lambrolizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Lambrolizumab |
pembrolizumab |
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-293 |
Pre-Made Lampalizumab
biosimilar, Fab, Anti-CFD Antibody:
Anti-ADIPSIN/ADN/DF/PFD therapeutic antibody
|
Lampalizumab |
|
CFD |
Fab |
|
GMP-Bios-ab-294 |
Pre-Made Lanadelumab biosimilar,
Whole mAb, Anti-KLKB1 Antibody:
Anti-KLK3/PKK/PKKD/PPK therapeutic antibody
|
Lanadelumab |
|
KLKB1 |
Whole mAb |
|
GMP-Bios-ab-295 |
Pre-Made Landogrozumab
biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Landogrozumab |
|
MSTN/GDF-8 |
Whole mAb |
|
GMP-Bios-ab-296 |
Pre-Made Laprituximab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Laprituximab |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-ab-297 |
Pre-Made Larcaviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Larcaviximab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-298 |
Pre-Made Latozinemab biosimilar,
Whole mAb, Anti-SORT1 Antibody:
Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic
antibody |
Latozinemab |
|
SORT1 |
Whole mAb |
|
GMP-Bios-ab-299 |
Pre-Made Lebrikizumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Lebrikizumab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-300 |
Pre-Made Lecanemab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Lecanemab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-301 |
Pre-Made Lemzoparlimab
biosimilar, Whole mAb, Anti-CD47 Antibody:
Anti-IAP/OA3/MER6 therapeutic antibody |
Lemzoparlimab |
|
CD47 |
Whole mAb |
|
GMP-Bios-ab-302 |
Pre-Made Lenvervimab biosimilar,
Whole Mab: Anti-HBV therapeutic antibody
|
Lenvervimab |
|
HBV |
Whole mAb |
|
GMP-Bios-ab-303 |
Pre-Made Lenzilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Lenzilumab |
|
CSF2 |
Whole mAb |
|
GMP-Bios-ab-304 |
Pre-Made Leronlimab biosimilar,
Whole mAb, Anti-CCR5 Antibody:
Anti-CKR5/CCR-5/CD195/CKR-5/CCCKR5/CMKBR5/IDDM22/CC-CKR-5
therapeutic antibody |
Leronlimab |
|
CCR5 |
Whole mAb |
|
GMP-Bios-ab-305 |
Pre-Made Lesofavumab biosimilar,
Whole Mab: Anti-Influenza B Virus therapeutic
antibody |
Lesofavumab |
|
Influenza B Virus |
Whole mAb |
|
GMP-Bios-ab-306 |
Pre-Made Letaplimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Letaplimab |
|
CD47 |
Whole mAb |
|
GMP-Bios-ab-307 |
Pre-Made Letolizumab biosimilar,
Single Domain Variable Fragment;H, Anti-CD40LG
Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Letolizumab |
|
CD40LG |
Single Domain Variable
Fragment;H |
|
GMP-Bios-ab-308 |
Pre-Made Levilimab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Levilimab |
|
IL6R |
Whole mAb |
|
GMP-Bios-ab-309 |
Pre-Made Lexatumumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Lexatumumab |
|
TNFRSF10B/TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-310 |
Pre-Made Licaminlimab
biosimilar, scFv, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Licaminlimab |
|
TNFA/TNF |
scFv |
|
GMP-Bios-ab-311 |
Pre-Made Lifastuzumab
biosimilar, Whole mAb ADC, Anti-SLC34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody |
Lifastuzumab |
|
SLC34A2 |
Whole mAb ADC |
|
GMP-Bios-ab-312 |
Pre-Made Ligelizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Ligelizumab |
|
IGHE/IgE |
Whole mAb |
|
GMP-Bios-ab-313 |
Pre-Made Lilotomab biosimilar,
Whole mAb ADC, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Lilotomab |
|
CD37 |
Whole mAb ADC |
|
GMP-Bios-ab-314 |
Pre-Made Lintuzumab biosimilar,
Whole mAb Radiolabelled, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Lintuzumab |
|
CD33 |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-315 |
Pre-Made Lirentelimab
biosimilar, Whole mAb, Anti-SIGLEC8/Siglec-8
Antibody: Anti-SAF2 therapeutic antibody
|
Lirentelimab |
|
SIGLEC8/Siglec-8 |
Whole mAb |
|
GMP-Bios-ab-316 |
Pre-Made Lirilumab biosimilar,
Whole Mab: Anti-KIRD2 therapeutic antibody
|
Lirilumab |
|
KIRD2 |
Whole mAb |
|
GMP-Bios-ab-317 |
Pre-Made Lodapolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Lodapolimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-318 |
Pre-Made Lodelcizumab
biosimilar, Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Lodelcizumab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-319 |
Pre-Made Lokivetmab biosimilar,
Canine Whole Mab: Anti-IL31 therapeutic
antibody |
Lokivetmab |
|
IL31 |
Canine Whole mAb |
|
GMP-Bios-ab-320 |
Pre-Made Loncastuximab
biosimilar, Whole mAb ADC, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Loncastuximab |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-ab-321 |
Pre-Made Lonigutamab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Lonigutamab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-322 |
Pre-Made Lorukafusp biosimilar,
Whole mAb Fusion: Anti-Ganglioside GD2
therapeutic antibody |
Lorukafusp |
|
Ganglioside GD2 |
Whole mAb Fusion |
|
GMP-Bios-ab-323 |
Pre-Made Lorvotuzumab
biosimilar, Whole mAb ADC, Anti-NCAM1 Antibody:
Anti-CD56/NCAM/MSK39 therapeutic antibody
|
Lorvotuzumab |
|
NCAM1 |
Whole mAb ADC |
|
GMP-Bios-ab-324 |
Pre-Made Losatuxizumab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Losatuxizumab |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-ab-325 |
Pre-Made Lucatumumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Lucatumumab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-326 |
Pre-Made Lulizumab biosimilar,
Single Domain Variable Fragment;L, Anti-CD28
Antibody: Anti-Tp44 therapeutic antibody
|
Lulizumab |
|
CD28 |
Single Domain Variable
Fragment;L |
|
GMP-Bios-ab-327 |
Pre-Made Lumiliximab biosimilar,
Whole mAb, Anti-FCER2/CD23 Antibody:
Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF
therapeutic antibody |
Lumiliximab |
|
FCER2/CD23 |
Whole mAb |
|
GMP-Bios-ab-328 |
Pre-Made Lumretuzumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Lumretuzumab |
|
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-329 |
Pre-Made Lupartumab biosimilar,
Whole mAb ADC, Anti-LYPD3 Antibody: Anti-C4.4A
therapeutic antibody |
Lupartumab |
|
LYPD3 |
Whole mAb ADC |
|
GMP-Bios-ab-330 |
Pre-Made Lusvertikimab
biosimilar, Whole mAb, Anti-IL7R Antibody:
Anti-CD127/CDW127 therapeutic antibody |
Lusvertikimab |
|
IL7R |
Whole mAb |
|
GMP-Bios-ab-331 |
Pre-Made Lutikizumab biosimilar,
Bispecific Dual Variable Domain IG,
Anti-IL1A;IL1B Antibody:
Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1
alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Lutikizumab |
|
IL1A;IL1B |
Bispecific Dual Variable
Domain IG |
|
GMP-Bios-ab-332 |
Pre-Made Maftivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Maftivimab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-333 |
Pre-Made Magrolimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Magrolimab |
|
CD47 |
Whole mAb |
|
GMP-Bios-ab-334 |
Pre-Made Manelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Manelimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-335 |
Pre-Made Margetuximab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Margetuximab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-336 |
Pre-Made Marstacimab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Marstacimab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-337 |
Pre-Made Matuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Matuzumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-338 |
Pre-Made Mavezelimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Mavezelimab |
Favezelimab |
LAG3 |
Whole mAb |
|
GMP-Bios-ab-339 |
Pre-Made Mavrilimumab
biosimilar, Whole mAb, Anti-CSF2RA Antibody:
Anti-GMR/CD116/CSF2R/SMDP4/CDw116GMR-alpha/GMCSFR-alpha/GM-CSF-R-alpha
therapeutic antibody |
Mavrilimumab |
|
CSF2RA |
Whole mAb |
|
GMP-Bios-ab-340 |
Pre-Made Melrilimab biosimilar,
Whole mAb, Anti-IL1RL1/ST2 Antibody:
Anti-DER4/FIT-1/IL33R/T1 therapeutic
antibody |
Melrilimab |
|
IL1RL1/ST2 |
Whole mAb |
|
GMP-Bios-ab-341 |
Pre-Made Mepolizumab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Mepolizumab |
|
IL5 |
Whole mAb |
|
GMP-Bios-ab-342 |
Pre-Made Mezagitamab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Mezagitamab |
|
CD38 |
Whole mAb |
|
GMP-Bios-ab-343 |
Pre-Made Mibavademab biosimilar,
Whole mAb, Anti-LEPR Antibody:
Anti-CD295/OB-R/OBR therapeutic antibody
|
Mibavademab |
|
LEPR |
Whole mAb |
|
GMP-Bios-ab-344 |
Pre-Made Milatuzumab biosimilar,
Whole mAb, Anti-CD74 Antibody:
Anti-CLIP/DHLAG/HLADG/II/Ia-GAMMA/p33
therapeutic antibody |
Milatuzumab |
|
CD74 |
Whole mAb |
|
GMP-Bios-ab-345 |
Pre-Made Mipasetamab biosimilar,
Whole mAb, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Mipasetamab |
|
AXL |
Whole mAb |
|
GMP-Bios-ab-346 |
Pre-Made Miptenalimab
biosimilar, Whole mAb, Anti-LAG3 Antibody:
Anti-CD223 therapeutic antibody |
Miptenalimab |
|
LAG3 |
Whole mAb |
|
GMP-Bios-ab-347 |
Pre-Made Mirikizumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Mirikizumab |
|
IL23A/IL23 |
Whole mAb |
|
GMP-Bios-ab-348 |
Anti-Rabies Virus Strain ERA GP
Ectodomain Epitope G-II therapeutic antibody
(Pre-made Miromavimab biosimilar,Whole mAb
(Mouse)) |
Miromavimab |
|
Rabies Virus Strain ERA
GP Ectodomain Epitope G-II |
Whole mAb (Mouse) |
|
GMP-Bios-ab-349 |
Pre-Made Mirvetuximab
biosimilar, Whole mAb ADC, Anti-FOLR1 Antibody:
Anti-FBP/FOLR/FRalpha/NCFTD therapeutic
antibody |
Mirvetuximab |
|
FOLR1 |
Whole mAb ADC |
|
GMP-Bios-ab-350 |
Pre-Made Mirzotamab biosimilar,
Whole mAb, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Mirzotamab |
|
CD276 |
Whole mAb |
|
GMP-Bios-ab-351 |
Pre-Made Mitazalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Mitazalimab |
Vanalimab |
CD40 |
Whole mAb |
|
GMP-Bios-ab-352 |
Pre-Made Modakafusp biosimilar,
Whole mAb Fusion: Anti-ADPRC therapeutic
antibody |
Modakafusp |
|
ADPRC |
Whole mAb Fusion |
|
GMP-Bios-ab-353 |
Pre-Made Modotuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Modotuximab |
Zatuximab |
EGFR |
Whole mAb |
|
GMP-Bios-ab-354 |
Pre-Made Mogamulizumab
biosimilar, Whole mAb, Anti-CCR4 Antibody:
Anti-CKR4/K5-5/CD194/CMKBR4/ChemR13/CC-CKR-4/HGCN:14099
therapeutic antibody |
Mogamulizumab |
|
CCR4 |
Whole mAb |
|
GMP-Bios-ab-355 |
Pre-Made Monalizumab biosimilar,
Whole mAb, Anti-KLRC1/NKG2A Antibody:
Anti-CD159A/NKG2 therapeutic antibody |
Monalizumab |
|
KLRC1/NKG2A |
Whole mAb |
|
GMP-Bios-ab-356 |
Pre-Made Mosunetuzumab
biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20
Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Mosunetuzumab |
|
CD3E;MS4A1/CD20 |
Bispecific mAb |
|
GMP-Bios-ab-357 |
Pre-Made Motavizumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Motavizumab |
|
RSV gpF |
Whole mAb |
|
GMP-Bios-ab-358 |
Pre-Made Moxetumomab biosimilar,
Fv Fusion, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Moxetumomab |
|
CD22 |
Fv Fusion |
|
GMP-Bios-ab-359 |
Pre-Made Murlentamab biosimilar,
Whole mAb, Anti-AMHR2 Antibody:
Anti-AMHR/MISR2/MISRII/MRII therapeutic
antibody |
Murlentamab |
|
AMHR2 |
Whole mAb |
|
GMP-Bios-ab-360 |
Pre-Made Muromonab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Muromonab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-361 |
Pre-Made Nadecnemab biosimilar,
Whole mAb, Anti-GFRA3 Antibody: Anti-GDNFR3
therapeutic antibody |
Nadecnemab |
|
GFRA3 |
Whole mAb |
|
GMP-Bios-ab-362 |
Pre-Made Namilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Namilumab |
|
CSF2 |
Whole mAb |
|
GMP-Bios-ab-363 |
Pre-Made Naptumomab biosimilar,
Fab Fusion, Anti-TPBG Antibody:
Anti-5T4/M6P1/5T4AG/WAIF1 therapeutic
antibody |
Naptumomab |
|
TPBG |
Fab Fusion |
|
GMP-Bios-ab-364 |
Pre-Made Naratuximab biosimilar,
Whole mAb ADC, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Naratuximab |
|
CD37 |
Whole mAb ADC |
|
GMP-Bios-ab-365 |
Pre-Made Narnatumab biosimilar,
Whole mAb, Anti-MST1R/RON Antibody:
Anti-RON/SEA/PTK8/CD136/NPCA3/CDw136 therapeutic
antibody |
Narnatumab |
|
MST1R/RON |
Whole mAb |
|
GMP-Bios-ab-366 |
Pre-Made Narsoplimab biosimilar,
Whole mAb, Anti-MASP2 Antibody:
Anti-MAP-2/MAP19/MASP-2/MASP1P1/sMAP therapeutic
antibody |
Narsoplimab |
|
MASP2 |
Whole mAb |
|
GMP-Bios-ab-367 |
Pre-Made Natalizumab biosimilar,
Whole mAb, Anti-ITGA4 Antibody: Anti-CD49D/IA4
therapeutic antibody |
Natalizumab |
|
ITGA4 |
Whole mAb |
|
GMP-Bios-ab-368 |
Pre-Made Navivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Navivumab |
|
Influenza A HA |
Whole mAb |
|
GMP-Bios-ab-369 |
Pre-Made Navicixizumab
biosimilar, Bispecific mAb, Anti-DLL4;VEGFA
Antibody:
Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1
therapeutic antibody |
Navicixizumab |
|
DLL4;VEGFA |
Bispecific mAb |
|
GMP-Bios-ab-370 |
Pre-Made Naxitamab biosimilar,
Whole Mab: Anti-Ganglioside GD2 therapeutic
antibody |
Naxitamab |
|
Ganglioside GD2 |
Whole mAb |
|
GMP-Bios-ab-371 |
Pre-Made Necitumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Necitumumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-372 |
Pre-Made Nemolizumab biosimilar,
Whole mAb, Anti-IL31RA/IL31R Antibody:
Anti-CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/PLCA2/PRO21384/hGLM-R/zcytoR17
therapeutic antibody |
Nemolizumab |
|
IL31RA/IL31R |
Whole mAb |
|
GMP-Bios-ab-373 |
Pre-Made Nesvacumab biosimilar,
Whole mAb, Anti-ANGPT2 Antibody:
Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody
|
Nesvacumab |
|
ANGPT2 |
Whole mAb |
|
GMP-Bios-ab-374 |
Pre-Made Netakimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Netakimab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-375 |
Pre-Made Nidanilimab biosimilar,
Whole mAb, Anti-IL1RAP Antibody:
Anti-C3orf13/IL-1RAcP/IL1R3 therapeutic
antibody |
Nidanilimab |
Nadunolimab |
IL1RAP |
Whole mAb |
|
GMP-Bios-ab-377 |
Pre-Made Nimotuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Nimotuzumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-378 |
Pre-Made Nipocalimab biosimilar,
Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Nipocalimab |
|
FCGRT |
Whole mAb |
|
GMP-Bios-ab-379 |
Pre-Made Nirsevimab biosimilar,
Whole Mab: Anti-RSV therapeutic antibody
|
Nirsevimab |
|
RSV |
Whole mAb |
|
GMP-Bios-ab-380 |
Pre-Made Nivatrotamab
biosimilar, Bispecific Mixed mAb and scFv,
Anti-GD2;CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Nivatrotamab |
|
GD2;CD3E |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-381 |
Pre-Made Nivolumab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Nivolumab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-382 |
Pre-Made Nurulimab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Nurulimab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-383 |
Pre-Made Obexelimab biosimilar,
Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Obexelimab |
|
CD19 |
Whole mAb |
|
GMP-Bios-ab-384 |
Pre-Made Obiltoxaximab
biosimilar, Whole Mab: Anti-Anthrax Protective
Antigen therapeutic antibody |
Obiltoxaximab |
|
Anthrax Protective
Antigen |
Whole mAb |
|
GMP-Bios-ab-385 |
Pre-Made Obinutuzumab
biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Obinutuzumab |
Afutuzumab |
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-386 |
Pre-Made Obrindatamab
biosimilar, Bispecific scFv with Domain
Crossover, Anti-CD276;CD3E Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2;T3E/TCRE/IMD18
therapeutic antibody |
Obrindatamab |
|
CD276;CD3E |
Bispecific scFv with Domain
Crossover |
|
GMP-Bios-ab-387 |
Pre-Made Ocaratuzumab
biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ocaratuzumab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-388 |
Pre-Made Ociperlimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Ociperlimab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-389 |
Pre-Made Ocrelizumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ocrelizumab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-390 |
Pre-Made Odesivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Odesivimab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-391 |
Pre-Made Odronextamab
biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E
Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18
therapeutic antibody |
Odronextamab |
|
MS4A1/CD20;CD3E |
Bispecific mAb |
|
GMP-Bios-ab-392 |
Pre-Made Ofatumumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ofatumumab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-393 |
Pre-Made Olaratumab biosimilar,
Whole mAb, Anti-PDGFRA Antibody:
Anti-CD140A/PDGFR-2/PDGFR2 therapeutic
antibody |
Olaratumab |
|
PDGFRA |
Whole mAb |
|
GMP-Bios-ab-394 |
Pre-Made Oleclumab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Oleclumab |
|
NT5E/CD73 |
Whole mAb |
|
GMP-Bios-ab-395 |
Pre-Made Olendalizumab
biosimilar, Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Olendalizumab |
Lendalizumab |
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-396 |
Pre-Made Olinvacimab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Olinvacimab |
Tanibirumab |
KDR |
Whole mAb |
|
GMP-Bios-ab-397 |
Pre-Made Olokizumab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Olokizumab |
|
IL6 |
Whole mAb |
|
GMP-Bios-ab-398 |
Pre-Made Omalizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Omalizumab |
|
IGHE/IgE |
Whole mAb |
|
GMP-Bios-ab-399 |
Pre-Made Omburtamab biosimilar,
Whole mAb Radiolabelled, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Omburtamab |
|
CD276 |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-400 |
Pre-Made Omodenbamab biosimilar,
Whole Mab: Anti-SpA therapeutic antibody
|
Omodenbamab |
|
SpA |
Whole mAb |
|
GMP-Bios-ab-401 |
Pre-Made Onartuzumab biosimilar,
Fab + di-Fc, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Onartuzumab |
|
MET |
Fab + di-Fc |
|
GMP-Bios-ab-402 |
Pre-Made Onfekafusp biosimilar,
Whole mAb Fusion: Anti-FN extra domain B
therapeutic antibody |
Onfekafusp |
|
FN extra domain B |
Whole mAb Fusion |
|
GMP-Bios-ab-403 |
Pre-Made Ongericimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ongericimab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-404 |
Pre-Made Ontamalimab biosimilar,
Whole Mab: Anti-MADCAM1 therapeutic antibody
|
Ontamalimab |
|
MADCAM1 |
Whole mAb |
|
GMP-Bios-ab-405 |
Pre-Made Ontuxizumab biosimilar,
Whole mAb, Anti-CD248 Antibody:
Anti-CD164L1/TEM1 therapeutic antibody |
Ontuxizumab |
|
CD248 |
Whole mAb |
|
GMP-Bios-ab-406 |
Pre-Made Onvatilimab biosimilar,
Whole mAb, Anti-VSIR Antibody:
Anti-B7-H5/B7H5/C10orf54/DD1alpha/Dies1/GI24/PD-1H/PP2135/SISP1/VISTA
therapeutic antibody |
Onvatilimab |
|
VSIR |
Whole mAb |
|
GMP-Bios-ab-407 |
Pre-Made Opicinumab biosimilar,
Whole mAb, Anti-LINGO1 Antibody:
Anti-LERN1/LRRN6A/MRT64/UNQ201 therapeutic
antibody |
Opicinumab |
|
LINGO1 |
Whole mAb |
|
GMP-Bios-ab-408 |
Pre-Made Oportuzumab biosimilar,
scFv, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Oportuzumab |
|
EPCAM |
scFv |
|
GMP-Bios-ab-409 |
Pre-Made Opucolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Opucolimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-410 |
Pre-Made Ordesekimab biosimilar,
Whole Mab: Anti-IL15 therapeutic antibody
|
Ordesekimab |
|
IL15 |
Whole mAb |
|
GMP-Bios-ab-411 |
Pre-Made Orilanolimab
biosimilar, Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Orilanolimab |
|
FCGRT |
Whole mAb |
|
GMP-Bios-ab-412 |
Pre-Made Orticumab biosimilar,
Whole Mab: Anti-OxLDL therapeutic antibody
|
Orticumab |
|
OxLDL |
Whole mAb |
|
GMP-Bios-ab-413 |
Pre-Made Osocimab biosimilar,
Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA
therapeutic antibody |
Osocimab |
|
F11 |
Whole mAb |
|
GMP-Bios-ab-414 |
Pre-Made Otelixizumab
biosimilar, Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Otelixizumab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-415 |
Pre-Made Otilimab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Otilimab |
|
CSF2 |
Whole mAb |
|
GMP-Bios-ab-416 |
Pre-Made Otlertuzumab
biosimilar, di-scFv+Fc, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Otlertuzumab |
|
CD37 |
di-scFv+Fc |
|
GMP-Bios-ab-417 |
Pre-Made Oxelumab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Oxelumab |
|
TNFSF4/OX40 |
Whole mAb |
|
GMP-Bios-ab-418 |
Pre-Made Ozanezumab biosimilar,
Whole mAb, Anti-RTN4 Antibody:
Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2
therapeutic antibody |
Ozanezumab |
|
RTN4 |
Whole mAb |
|
GMP-Bios-ab-419 |
Pre-Made Ozoralizumab
biosimilar, Bispecific Single Domains
(VH-VH'-VH), Anti-TNFA/TNF;ALB Antibody:
Anti-DIF/TNF-alpha/TNFSF2/TNLG1F;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Ozoralizumab |
|
TNFA/TNF;ALB |
Bispecific Single Domains
(VH-VH'-VH) |
|
GMP-Bios-ab-420 |
Pre-Made Pabinafusp biosimilar,
Whole mAb Fusion, Anti-TFRC Antibody:
Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
therapeutic antibody |
Pabinafusp |
|
TFRC |
Whole mAb Fusion |
|
GMP-Bios-ab-421 |
Pre-Made Pacanalotamab
biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E
Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Pacanalotamab |
|
TNFRSF17; CD3E |
Bispecific scFv |
|
GMP-Bios-ab-422 |
Pre-Made Pacmilimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Pacmilimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-423 |
Pre-Made Palivizumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Palivizumab |
|
RSV gpF |
Whole mAb |
|
GMP-Bios-ab-424 |
Pre-Made Pamrevlumab biosimilar,
Whole mAb, Anti-CTGF/CCN2 Antibody:
Anti-HCS24/IGFBP8/NOV2 therapeutic antibody
|
Pamrevlumab |
|
CTGF/CCN2 |
Whole mAb |
|
GMP-Bios-ab-425 |
Pre-Made Panitumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Panitumumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-426 |
Pre-Made PankoMab biosimilar,
Whole mAb, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
PankoMab |
gatipotuzumab |
MUC1 |
Whole mAb |
|
GMP-Bios-ab-427 |
Pre-Made Panobacumab biosimilar,
Whole Mab: Anti-Serotype IATS O11 therapeutic
antibody |
Panobacumab |
|
Serotype IATS O11 |
Whole mAb |
|
GMP-Bios-ab-428 |
Pre-Made Parsatuzumab
biosimilar, Whole mAb, Anti-EGFL7 Antibody:
Anti-NEU1/VE-STATIN/ZNEU1 therapeutic
antibody |
Parsatuzumab |
|
EGFL7 |
Whole mAb |
|
GMP-Bios-ab-429 |
Pre-Made Pasotuxizumab
biosimilar, Bispecific scFv,
Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Pasotuxizumab |
|
FOLH1/GCPII;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-430 |
Pre-Made Pateclizumab
biosimilar, Whole mAb, Anti-LTA Antibody:
Anti-LT/TNFB/TNFSF1/TNLG1E therapeutic
antibody |
Pateclizumab |
|
LTA |
Whole mAb |
|
GMP-Bios-ab-431 |
Pre-Made Patritumab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Patritumab |
|
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-432 |
Pre-Made Pavunalimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-LAG3;CTLA4/CTLA-4 Antibody:
Anti-CD223;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Pavunalimab |
Bavunalimab |
LAG3;CTLA4/CTLA-4 |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-433 |
Pre-Made Pavurutamab biosimilar,
Bispecific scFv, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Pavurutamab |
|
TNFRSF17; CD3E |
Bispecific scFv |
|
GMP-Bios-ab-434 |
Pre-Made Pelgifatamab
biosimilar, Whole mAb ADC, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Pelgifatamab |
|
FOLH1/GCPII |
Whole mAb ADC |
|
GMP-Bios-ab-435 |
Pre-Made Pembrolizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pembrolizumab |
Lambrolizumab |
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-436 |
Pre-Made Penpulimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Penpulimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-437 |
Pre-Made Pepinemab biosimilar,
Whole mAb, Anti-SEMA4D Antibody:
Anti-A8/BB18/C9orf164/CD100/COLL4/GR3/M-sema-G/SEMAJ/coll-4
therapeutic antibody |
Pepinemab |
|
SEMA4D |
Whole mAb |
|
GMP-Bios-ab-438 |
Pre-Made Perakizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Perakizumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-439 |
Pre-Made Pertuzumab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Pertuzumab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-440 |
Pre-Made Petosemtamab
biosimilar, Bispecific mAb, Anti-EGFR;LGR5
Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;FEX/GPR49/GPR67/GRP49/HG38
therapeutic antibody |
Petosemtamab |
|
EGFR;LGR5 |
Bispecific mAb |
|
GMP-Bios-ab-441 |
Pre-Made Pidilizumab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pidilizumab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-442 |
Pre-Made Pimivalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pimivalimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-443 |
Pre-Made Pimurutamab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Pimurutamab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-444 |
Pre-Made Pinatuzumab biosimilar,
Whole mAb ADC, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Pinatuzumab |
|
CD22 |
Whole mAb ADC |
|
GMP-Bios-ab-445 |
Pre-Made Placulumab biosimilar,
Single Domain Variable Fragment (VL + Fc),
Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F
therapeutic antibody |
Placulumab |
|
TNFA/TNF |
Single Domain Variable
Fragment (VL) + Fc |
|
GMP-Bios-ab-446 |
Pre-Made Plamotamab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-MS4A1/CD20;CD3E Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18
therapeutic antibody |
Plamotamab |
|
MS4A1/CD20;CD3E |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-447 |
Pre-Made Plozalizumab
biosimilar, Whole mAb, Anti-CCR2 Antibody:
Anti-CKR2/CD192/CKR2A/CKR2B/CMKBR2/MCP-1-R/CC-CKR-2
therapeutic antibody |
Plozalizumab |
|
CCR2 |
Whole mAb |
|
GMP-Bios-ab-448 |
Pre-Made Pogalizumab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Pogalizumab |
Vonlerolizumab |
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-449 |
Pre-Made Polatuzumab biosimilar,
Whole mAb ADC, Anti-CD79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody |
Polatuzumab |
|
CD79B |
Whole mAb ADC |
|
GMP-Bios-ab-450 |
Pre-Made Ponezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Ponezumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-451 |
Pre-Made Ponsegromab biosimilar,
Whole mAb, Anti-GDF15 Antibody:
Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB
therapeutic antibody |
Ponsegromab |
|
GDF15 |
Whole mAb |
|
GMP-Bios-ab-452 |
Pre-Made Porgaviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Porgaviximab |
|
Zaire Ebolavirus GP |
Whole mAb |
|
GMP-Bios-ab-453 |
Pre-Made Plonmarlimab
biosimilar, Whole mAb, Anti-CSF2 Antibody:
Anti-CSF/GMCSF therapeutic antibody |
Plonmarlimab |
|
CSF2 |
Whole mAb |
|
GMP-Bios-ab-454 |
Pre-Made Praluzatamab
biosimilar, Whole mAb, Anti-CD166/ALCAM
Antibody: Anti-MEMD therapeutic antibody
|
Praluzatamab |
|
CD166/ALCAM |
Whole mAb |
|
GMP-Bios-ab-455 |
Pre-Made Prasinezumab
biosimilar, Whole mAb, Anti-SNCA Antibody:
Anti-NACP/PARK1/PARK4/PD1 therapeutic
antibody |
Prasinezumab |
|
SNCA |
Whole mAb |
|
GMP-Bios-ab-456 |
Pre-Made Prezalumab biosimilar,
Whole mAb, Anti-ICOSLG/B7RP1 Antibody:
Anti-B7-H2/B7H2/B7h/CD275/GL50/ICOS-L/ICOSL/LICOS
therapeutic antibody |
Prezalumab |
|
ICOSLG/B7RP1 |
Whole mAb |
|
GMP-Bios-ab-457 |
Pre-Made Pritoxaximab
biosimilar, Whole Mab: Anti-Shiga Toxin Type 1
therapeutic antibody |
Pritoxaximab |
|
Shiga Toxin Type 1 |
Whole mAb |
|
GMP-Bios-ab-458 |
Pre-Made Prolgolimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Prolgolimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-459 |
Pre-Made Pucotenlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pucotenlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-460 |
Pre-Made Quavonlimab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Quavonlimab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-461 |
Pre-Made Quetmolimab biosimilar,
Whole mAb, Anti-CX3CL1 Antibody:
Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin
therapeutic antibody |
Quetmolimab |
|
CX3CL1 |
Whole mAb |
|
GMP-Bios-ab-462 |
Pre-Made Quilizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Quilizumab |
|
IGHE/IgE |
Whole mAb |
|
GMP-Bios-ab-463 |
Pre-Made Racotumomab biosimilar,
Whole Mab: Anti-Idiotope of
Anti-NeuGc-ganliosides therapeutic antibody
|
Racotumomab |
|
Idiotope of
anti-NeuGc-ganliosides |
Whole mAb |
|
GMP-Bios-ab-464 |
Pre-Made Radretumab biosimilar,
di-scFv + CH4: Anti-FN extra domain B
therapeutic antibody |
Radretumab |
|
FN extra domain B |
di-scFv + CH4 |
|
GMP-Bios-ab-465 |
Pre-Made Rafivirumab biosimilar,
Whole Mab: Anti-RV Antigenic Site III
therapeutic antibody |
Rafivirumab |
|
RV Antigenic Site III |
Whole mAb |
|
GMP-Bios-ab-466 |
Pre-Made Ragifilimab biosimilar,
Whole mAb, Anti-TNFRSF18 Antibody:
Anti-AITR/CD357/ENERGEN/GITR/GITR-D therapeutic
antibody |
Ragifilimab |
|
TNFRSF18 |
Whole mAb |
|
GMP-Bios-ab-467 |
Pre-Made Ralpancizumab
biosimilar, Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ralpancizumab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-468 |
Pre-Made Ramucirumab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Ramucirumab |
|
KDR |
Whole mAb |
|
GMP-Bios-ab-469 |
Pre-Made Ranevetmab biosimilar,
Canine Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Ranevetmab |
|
NGFB/NGF |
Canine Whole mAb |
|
GMP-Bios-ab-470 |
Pre-Made Ranibizumab biosimilar,
Fab, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1
therapeutic antibody |
Ranibizumab |
|
VEGFA |
Fab |
|
GMP-Bios-ab-471 |
Pre-Made Ravagalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Ravagalimab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-472 |
Pre-Made Ravulizumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Ravulizumab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-473 |
Pre-Made Recaticimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Recaticimab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-474 |
Pre-Made Refanezumab biosimilar,
Whole mAb, Anti-MAG Antibody:
Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75
therapeutic antibody |
Refanezumab |
|
MAG |
Whole mAb |
|
GMP-Bios-ab-476 |
Pre-Made Relatlimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Relatlimab |
|
LAG3 |
Whole mAb |
|
GMP-Bios-ab-477 |
Pre-Made Relfovetmab biosimilar,
Feline Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Relfovetmab |
|
NGFB/NGF |
Feline Whole mAb |
|
GMP-Bios-ab-478 |
Pre-Made Remtolumab biosimilar,
Bispecific Dual Variable Domain IG:
Anti-IL17A/IL17;TNFA/TNF therapeutic
antibody |
Remtolumab |
|
IL17A/IL17; TNFA/TNF |
Bispecific Dual Variable
Domain IG |
|
GMP-Bios-ab-479 |
Pre-Made Reslizumab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Reslizumab |
|
IL5 |
Whole mAb |
|
GMP-Bios-ab-480 |
Pre-Made Retifanlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Retifanlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-481 |
Pre-Made Retlirafusp biosimilar,
Whole mAb Fusion, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Retlirafusp |
|
CD274/PD-L1 |
Whole mAb Fusion |
|
GMP-Bios-ab-482 |
Pre-Made Revdofilimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Revdofilimab |
|
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-483 |
Pre-Made Rilotumumab biosimilar,
Whole mAb, Anti-HGF Antibody:
Anti-DFNB39/F-TCF/HPTA/SF therapeutic
antibody |
Rilotumumab |
|
HGF |
Whole mAb |
|
GMP-Bios-ab-484 |
Pre-Made Rinucumab biosimilar,
Whole mAb, Anti-PDGFRB Antibody:
Anti-IMF1/KOGS/IBGC4/JTK12/PDGFR/PENTT/CD140B/PDGFR1/PDGFR-1
therapeutic antibody |
Rinucumab |
|
PDGFRB |
Whole mAb |
|
GMP-Bios-ab-485 |
Pre-Made Ripertamab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ripertamab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-486 |
Pre-Made Risankizumab
biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Risankizumab |
|
IL23A/IL23 |
Whole mAb |
|
GMP-Bios-ab-487 |
Pre-Made Rituximab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Rituximab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-488 |
Pre-Made Rivabazumab biosimilar,
Fab: Anti-PcrV type III secretion system
therapeutic antibody |
Rivabazumab |
|
PcrV type III secretion
system |
Fab |
|
GMP-Bios-ab-489 |
Pre-Made Robatumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Robatumumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-490 |
Pre-Made Roledumab biosimilar,
Whole mAb, Anti-RHD Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI
therapeutic antibody |
Roledumab |
|
RHD |
Whole mAb |
|
GMP-Bios-ab-491 |
Pre-Made Rolinsatamab
biosimilar, Whole mAb ADC, Anti-PRLR Antibody:
Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic
antibody |
Rolinsatamab |
|
PRLR |
Whole mAb ADC |
|
GMP-Bios-ab-492 |
Pre-Made Romilkimab biosimilar,
Bispecific Dual Variable Domain IG,
Anti-IL13;IL4 Antibody:
Anti-IL-13/P600;BCGF-1/BCGF1/BSF-1/BSF1/IL-4
therapeutic antibody |
Romilkimab |
|
IL13;IL4 |
Bispecific Dual Variable
Domain IG |
|
GMP-Bios-ab-493 |
Pre-Made Romosozumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Romosozumab |
|
SOST |
Whole mAb |
|
GMP-Bios-ab-494 |
Pre-Made Rontalizumab
biosimilar, Whole mAb, Anti-IFNA1 Antibody:
Anti-IFL/IFN3/leIF DD therapeutic antibody
|
Rontalizumab |
|
IFNA1 |
Whole mAb |
|
GMP-Bios-ab-495 |
Pre-Made Rosmantuzumab
biosimilar, Whole mAb, Anti-RSPO3 Antibody:
Anti-CRISTIN1/PWTSR/THSD2 therapeutic
antibody |
Rosmantuzumab |
|
RSPO3 |
Whole mAb |
|
GMP-Bios-ab-496 |
Pre-Made Rosopatamab biosimilar,
Whole mAb, Anti-FOLH1/GCPII Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Rosopatamab |
|
FOLH1/GCPII |
Whole mAb |
|
GMP-Bios-ab-497 |
Pre-Made Rovalpituzumab
biosimilar, Whole mAb ADC, Anti-DLL3 Antibody:
Anti-SCDO1 therapeutic antibody |
Rovalpituzumab |
|
DLL3 |
Whole mAb ADC |
|
GMP-Bios-ab-498 |
Pre-Made Rozanolixizumab
biosimilar, Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Rozanolixizumab |
|
FCGRT |
Whole mAb |
|
GMP-Bios-ab-499 |
Pre-Made Rozibafusp biosimilar,
Whole mAb Fusion, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Rozibafusp |
|
ICOS |
Whole mAb Fusion |
|
GMP-Bios-ab-500 |
Pre-Made Runimotamab biosimilar,
Bispecific mAb, Anti-ERBB2/HER2;CD3E Antibody:
Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;T3E/TCRE/IMD18 therapeutic
antibody |
Runimotamab |
|
ERBB2/HER2;CD3E |
Bispecific mAb |
|
GMP-Bios-ab-501 |
Pre-Made Ruplizumab biosimilar,
Whole mAb, Anti-CD40LG Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Ruplizumab |
|
CD40LG |
Whole mAb |
|
GMP-Bios-ab-502 |
Pre-Made Sabatolimab biosimilar,
Whole mAb, Anti-HAVCR2/TIM3 Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Sabatolimab |
|
HAVCR2/TIM3 |
Whole mAb |
|
GMP-Bios-ab-503 |
Pre-Made Sacituzumab biosimilar,
Whole mAb ADC, Anti-TACSTD2 Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody |
Sacituzumab |
|
TACSTD2 |
Whole mAb ADC |
|
GMP-Bios-ab-504 |
Pre-Made Samalizumab biosimilar,
Whole mAb, Anti-CD200 Antibody:
Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody
|
Samalizumab |
|
CD200 |
Whole mAb |
|
GMP-Bios-ab-505 |
Pre-Made Samrotamab biosimilar,
Whole mAb ADC, Anti-LRRC15 Antibody: Anti-LIB
therapeutic antibody |
Samrotamab |
|
LRRC15 |
Whole mAb ADC |
|
GMP-Bios-ab-506 |
Pre-Made Sapelizumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Sapelizumab |
Satralizumab |
IL6R |
Whole mAb |
|
GMP-Bios-ab-507 |
Pre-Made Sarilumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Sarilumab |
|
IL6R |
Whole mAb |
|
GMP-Bios-ab-508 |
Pre-Made Sasanlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Sasanlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-509 |
Pre-Made Satralizumab
biosimilar, Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Satralizumab |
Sapelizumab |
IL6R |
Whole mAb |
|
GMP-Bios-ab-510 |
Pre-Made Secukinumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Secukinumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-511 |
Pre-Made Selicrelumab
biosimilar, Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Selicrelumab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-512 |
Pre-Made Semorinemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Semorinemab |
|
MAPT |
Whole mAb |
|
GMP-Bios-ab-513 |
Pre-Made Serclutamab biosimilar,
Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Serclutamab |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-ab-514 |
Pre-Made Seribantumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Seribantumab |
|
ERBB3/Erbb-3 |
Whole mAb |
|
GMP-Bios-ab-515 |
Pre-Made Serplulimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Serplulimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-516 |
Pre-Made Setoxaximab biosimilar,
Whole Mab: Anti-Shiga Toxin Type 2 therapeutic
antibody |
Setoxaximab |
|
Shiga Toxin Type 2 |
Whole mAb |
|
GMP-Bios-ab-517 |
Pre-Made Setrusumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Setrusumab |
|
SOST |
Whole mAb |
|
GMP-Bios-ab-518 |
Pre-Made Sibeprenlimab
biosimilar, Whole mAb, Anti-TNFSF13/APRIL
Antibody:
Anti-CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2
therapeutic antibody |
Sibeprenlimab |
|
TNFSF13/APRIL |
Whole mAb |
|
GMP-Bios-ab-519 |
Pre-Made Sifalimumab biosimilar,
Whole mAb, Anti-IFNA1 Antibody:
Anti-IFL/IFN3/leIF DD therapeutic antibody
|
Sifalimumab |
|
IFNA1 |
Whole mAb |
|
GMP-Bios-ab-520 |
Pre-Made Siltuximab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Siltuximab |
|
IL6 |
Whole mAb |
|
GMP-Bios-ab-521 |
Pre-Made Simlukafusp biosimilar,
Whole mAb Fusion, Anti-FAP Antibody:
Anti-FAPA/SIMP/DPPIV/FAPalpha therapeutic
antibody |
Simlukafusp |
|
FAP |
Whole mAb Fusion |
|
GMP-Bios-ab-522 |
Pre-Made Simtuzumab biosimilar,
Whole mAb, Anti-LOXL2 Antibody:
Anti-LOR/LOR2/WS9-14 therapeutic antibody
|
Simtuzumab |
|
LOXL2 |
Whole mAb |
|
GMP-Bios-ab-523 |
Pre-Made Sintilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Sintilimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-524 |
Pre-Made Sirtratumab biosimilar,
Whole mAb ADC, Anti-SLITRK6 Antibody:
Anti-DFNMYP therapeutic antibody |
Sirtratumab |
|
SLITRK6 |
Whole mAb ADC |
|
GMP-Bios-ab-525 |
Pre-Made Sirukumab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Sirukumab |
|
IL6 |
Whole mAb |
|
GMP-Bios-ab-526 |
Pre-Made Sofituzumab biosimilar,
Whole mAb ADC, Anti-MUC16 Antibody: Anti-CA125
therapeutic antibody |
Sofituzumab |
|
MUC16 |
Whole mAb ADC |
|
GMP-Bios-ab-527 |
Pre-Made Solanezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Solanezumab |
|
APP |
Whole mAb |
|
GMP-Bios-ab-528 |
Pre-Made Solitomab biosimilar,
Bispecific scFv, Anti-EPCAM;CD3E Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1;T3E/TCRE/IMD18
therapeutic antibody |
Solitomab |
|
EPCAM;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-529 |
Pre-Made Sotigalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Sotigalimab |
|
CD40 |
Whole mAb |
|
GMP-Bios-ab-530 |
Pre-Made Sotrovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Sotrovimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-531 |
Pre-Made Spartalizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Spartalizumab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-532 |
Pre-Made Spesolimab biosimilar,
Whole mAb, Anti-IL36RN/IL-36R Antibody:
Anti-FIL1/FIL1(DELTA)/FIL1D/IL1F5/IL1HY1/IL1L1/IL1RP3/IL36RA/PSORP/PSORS14
therapeutic antibody |
Spesolimab |
|
IL36RN/IL-36R |
Whole mAb |
|
GMP-Bios-ab-533 |
Pre-Made Sudubrilimab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Sudubrilimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-534 |
Pre-Made Sugemalimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Sugemalimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-535 |
Pre-Made Suptavumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Suptavumab |
|
RSV gpF |
Whole mAb |
|
GMP-Bios-ab-536 |
Pre-Made Surzebiclimab
biosimilar, Whole mAb, Anti-HAVCR2/TIM3
Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Surzebiclimab |
|
HAVCR2/TIM3 |
Whole mAb |
|
GMP-Bios-ab-537 |
Pre-Made Sutimlimab biosimilar,
Whole mAb, Anti-C1S Antibody: Anti-EDSPD2
therapeutic antibody |
Sutimlimab |
|
C1S |
Whole mAb |
|
GMP-Bios-ab-538 |
Pre-Made Suvizumab biosimilar,
Whole Mab: Anti-HIV-1 gp120 therapeutic
antibody |
Suvizumab |
|
HIV-1 gp120 |
Whole mAb |
|
GMP-Bios-ab-539 |
Pre-Made Suvratoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Suvratoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-540 |
Pre-Made Tabalumab biosimilar,
Whole mAb, Anti-TNFSF13B Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
therapeutic antibody |
Tabalumab |
|
TNFSF13B |
Whole mAb |
|
GMP-Bios-ab-541 |
Pre-Made Tabituximab biosimilar,
Whole mAb ADC, Anti-FZD10 Antibody:
Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic
antibody |
Tabituximab |
|
FZD10 |
Whole mAb ADC |
|
GMP-Bios-ab-542 |
Pre-Made Tadocizumab biosimilar,
Fab, Anti-ITGA2B;ITGB3 Antibody:
Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Tadocizumab |
|
ITGA2B;ITGB3 |
Fab |
|
GMP-Bios-ab-543 |
Pre-Made Tafasitamab biosimilar,
Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Tafasitamab |
|
CD19 |
Whole mAb |
|
GMP-Bios-ab-544 |
Pre-Made Tafolecimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Tafolecimab |
|
PCSK9 |
Whole mAb |
|
GMP-Bios-ab-545 |
Pre-Made Talacotuzumab
biosimilar, Whole mAb, Anti-IL3RA Antibody:
Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody |
Talacotuzumab |
|
IL3RA |
Whole mAb |
|
GMP-Bios-ab-546 |
Pre-Made Talquetamab biosimilar,
Bispecific mAb, Anti-GPRC5D;CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Talquetamab |
|
GPRC5D;CD3E |
Bispecific mAb |
|
GMP-Bios-ab-547 |
Pre-Made Tamrintamab biosimilar,
Whole mAb ADC, Anti-DPEP3 Antibody: Anti-MBD3
therapeutic antibody |
Tamrintamab |
|
DPEP3 |
Whole mAb ADC |
|
GMP-Bios-ab-548 |
Pre-Made Tamtuvetmab biosimilar,
Canine Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Tamtuvetmab |
|
CD52 |
Canine Whole mAb |
|
GMP-Bios-ab-549 |
Pre-Made Tanezumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Tanezumab |
|
NGFB/NGF |
Whole mAb |
|
GMP-Bios-ab-550 |
Pre-Made Tanibirumab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Tanibirumab |
olinvacimab |
KDR |
Whole mAb |
|
GMP-Bios-ab-551 |
Pre-Made Tarextumab biosimilar,
Whole mAb, Anti-NOTCH2&3 Antibody:
Anti-AGS2/HJCYS/hN2;CADASIL/CADASIL1/CASIL/IMF2/LMNS
therapeutic antibody |
Tarextumab |
|
NOTCH2&3 |
Whole mAb |
|
GMP-Bios-ab-552 |
Pre-Made Tarlatamab biosimilar,
Bispecific scFv, Anti-DLL3;CD3E Antibody:
Anti-SCDO1;T3E/TCRE/IMD18 therapeutic
antibody |
Tarlatamab |
|
DLL3;CD3E |
Bispecific scFv |
|
GMP-Bios-ab-553 |
Pre-Made Tavolimab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Tavolimab |
Tavolixizumab |
TNFSF4/OX40 |
Whole mAb |
|
GMP-Bios-ab-554 |
Pre-Made Tavolixizumab
biosimilar, Whole mAb, Anti-TNFSF4/OX40
Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Tavolixizumab |
Tavolimab |
TNFSF4/OX40 |
Whole mAb |
|
GMP-Bios-ab-555 |
Pre-Made Tebentafusp biosimilar,
scFv Fusion, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Tebentafusp |
|
CD3E |
scFv Fusion |
|
GMP-Bios-ab-556 |
Pre-Made Tebotelimab biosimilar,
Bispecific scFv with Crossover,
Anti-PDCD1/PD-1;LAG3 Antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD223
therapeutic antibody |
Tebotelimab |
|
PDCD1/PD-1;LAG3 |
Bispecific scFv with
Crossover |
|
GMP-Bios-ab-557 |
Pre-Made Teclistamab biosimilar,
Bispecific mAb, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Teclistamab |
|
TNFRSF17;CD3E |
Bispecific mAb |
|
GMP-Bios-ab-558 |
Pre-Made Telazorlimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Telazorlimab |
|
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-559 |
Pre-Made Telisotuzumab
biosimilar, Whole mAb ADC, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Telisotuzumab |
|
MET |
Whole mAb ADC |
|
GMP-Bios-ab-561 |
Pre-Made Tenatumomab biosimilar,
Whole mAb Radiolabelled, Anti-TNC Antibody:
Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C
therapeutic antibody |
Tenatumomab |
|
TNC |
Whole mAb Radiolabelled |
|
GMP-Bios-ab-562 |
Pre-Made Teplizumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Teplizumab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-563 |
Pre-Made Tepoditamab biosimilar,
Bispecific mAb, Anti-CLEC12A/CD371;CD3E
Antibody:
Anti-CLL-1/CLL1/DCAL-2/MICL;T3E/TCRE/IMD18
therapeutic antibody |
Tepoditamab |
|
CLEC12A/CD371;CD3E |
Bispecific mAb |
|
GMP-Bios-ab-564 |
Pre-Made Teprotumumab
biosimilar, Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Teprotumumab |
|
IGF1R |
Whole mAb |
|
GMP-Bios-ab-565 |
Pre-Made Tesidolumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Tesidolumab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-566 |
Pre-Made Tesnatilimab
biosimilar, Whole mAb, Anti-KLRK1 Antibody:
Anti-CD314/D12S2489E/KLR/NKG2-D/NKG2D
therapeutic antibody |
Tesnatilimab |
|
KLRK1 |
Whole mAb |
|
GMP-Bios-ab-567 |
Pre-Made Tezepelumab biosimilar,
Whole Mab: Anti-TSLP therapeutic antibody
|
Tezepelumab |
|
TSLP |
Whole mAb |
|
GMP-Bios-ab-568 |
Pre-Made Tibulizumab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-TNFSF13B;IL17A/IL17 Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A
therapeutic antibody |
Tibulizumab |
|
TNFSF13B;IL17A/IL17 |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-569 |
Pre-Made Ticilimumab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Ticilimumab |
tremelimumab |
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-570 |
Pre-Made Tidutamab biosimilar,
Bispecific Mixed mAb and scFv, Anti-SSTR2;CD3E
Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon
therapeutic antibody |
Tidutamab |
|
SSTR2;CD3E |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-571 |
Pre-Made Tigatuzumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Tigatuzumab |
|
TNFRSF10B/TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-572 |
Pre-Made Tilavonemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Tilavonemab |
|
MAPT |
Whole mAb |
|
GMP-Bios-ab-573 |
Pre-Made Tildrakizumab
biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Tildrakizumab |
|
IL23A/IL23 |
Whole mAb |
|
GMP-Bios-ab-574 |
Pre-Made Tilogotamab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Tilogotamab |
|
TNFRSF10B/TRAIL-R2 |
Whole mAb |
|
GMP-Bios-ab-575 |
Pre-Made Tilvestamab biosimilar,
Whole mAb, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Tilvestamab |
|
AXL |
Whole mAb |
|
GMP-Bios-ab-576 |
Pre-Made Timigutuzumab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Timigutuzumab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-577 |
Pre-Made Timolumab biosimilar,
Whole mAb, Anti-AOC3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Timolumab |
|
AOC3 |
Whole mAb |
|
GMP-Bios-ab-578 |
Pre-Made Tinurilimab biosimilar,
Whole mAb, Anti-CEACAM6/CD66c Antibody:
Anti-CEAL/NCA therapeutic antibody |
Tinurilimab |
|
CEACAM6/CD66c |
Whole mAb |
|
GMP-Bios-ab-579 |
Pre-Made Tiragolumab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Tiragolumab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-580 |
Pre-Made Tirnovetmab biosimilar,
Whole mAb (Canine): Anti-IL31 (Canine)
therapeutic antibody |
Tirnovetmab |
|
IL31 (Canine) |
Whole mAb (Canine) |
|
GMP-Bios-ab-581 |
Pre-Made Tislelizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Tislelizumab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-582 |
Pre-Made Tisotumab biosimilar,
Whole mAb, Anti-F3 Antibody: Anti-CD142/TF/TFA
therapeutic antibody |
Tisotumab |
|
F3 |
Whole mAb |
|
GMP-Bios-ab-583 |
Pre-Made Tixagevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Tixagevimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-584 |
Pre-Made Tocilizumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Tocilizumab |
|
IL6R |
Whole mAb |
|
GMP-Bios-ab-585 |
Pre-Made Tomaralimab biosimilar,
Whole mAb, Anti-TLR2 Antibody: Anti-CD282/TIL4
therapeutic antibody |
Tomaralimab |
|
TLR2 |
Whole mAb |
|
GMP-Bios-ab-586 |
Pre-Made Tomuzotuximab
biosimilar, Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Tomuzotuximab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-587 |
Pre-Made Toripalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Toripalimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-588 |
Pre-Made Torudokimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Torudokimab |
|
IL33 |
Whole mAb |
|
GMP-Bios-ab-589 |
Pre-Made Tosatoxumab biosimilar,
Whole Mab: Anti-Toxin A therapeutic antibody
|
Tosatoxumab |
|
Toxin A |
Whole mAb |
|
GMP-Bios-ab-590 |
Pre-Made Tovetumab biosimilar,
Whole mAb, Anti-PDGFRA Antibody:
Anti-CD140A/PDGFR-2/PDGFR2 therapeutic
antibody |
Tovetumab |
|
PDGFRA |
Whole mAb |
|
GMP-Bios-ab-591 |
Pre-Made Tozorakimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Tozorakimab |
|
IL33 |
Whole mAb |
|
GMP-Bios-ab-592 |
Pre-Made Tralokinumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Tralokinumab |
|
IL13 |
Whole mAb |
|
GMP-Bios-ab-593 |
Pre-Made Trastuzumab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Trastuzumab |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-ab-594 |
Pre-Made Tregalizumab
biosimilar, Whole mAb, Anti-CD4 Antibody:
Anti-IMD79/OKT4D therapeutic antibody |
Tregalizumab |
|
CD4 |
Whole mAb |
|
GMP-Bios-ab-595 |
Pre-Made Tremelimumab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Tremelimumab |
Ticilimumab |
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-596 |
Pre-Made Trevogrumab biosimilar,
Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Trevogrumab |
|
MSTN/GDF-8 |
Whole mAb |
|
GMP-Bios-ab-597 |
Pre-Made Tusamitamab biosimilar,
Whole mAb, Anti-CEACAM5/CD66e Antibody: Anti-CEA
therapeutic antibody |
Tusamitamab |
|
CEACAM5/CD66e |
Whole mAb |
|
GMP-Bios-ab-598 |
Pre-Made Ublituximab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ublituximab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-599 |
Pre-Made Uliledlimab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Uliledlimab |
|
NT5E/CD73 |
Whole mAb |
|
GMP-Bios-ab-600 |
Pre-Made Ulocuplumab biosimilar,
Whole mAb, Anti-CXCR4 Antibody:
Anti-FB22/HM89/LAP3/LCR1/NPYR/WHIM/CD184/LAP-3/LESTR/NPY3R/NPYRL/WHIMS/HSY3RR/NPYY3R/WHIMS1/D2S201E
therapeutic antibody |
Ulocuplumab |
|
CXCR4 |
Whole mAb |
|
GMP-Bios-ab-602 |
Pre-Made Upifitamab biosimilar,
Whole mAb, Anti-SLC34A2 Antibody:
Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic
antibody |
Upifitamab |
|
SLC34A2 |
Whole mAb |
|
GMP-Bios-ab-603 |
Pre-Made Urabrelimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Urabrelimab |
|
CD47 |
Whole mAb |
|
GMP-Bios-ab-604 |
Pre-Made Urelumab biosimilar,
Whole mAb, Anti-TNFRSF9/CD137 Antibody:
Anti-ILA/4-1BB/CDw137 therapeutic antibody
|
Urelumab |
|
TNFRSF9/CD137 |
Whole mAb |
|
GMP-Bios-ab-605 |
Pre-Made Ustekinumab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Ustekinumab |
|
IL12B |
Whole mAb |
|
GMP-Bios-ab-606 |
Pre-Made Utomilumab biosimilar,
Whole mAb, Anti-TNFRSF9/CD137 Antibody:
Anti-ILA/4-1BB/CDw137 therapeutic antibody
|
Utomilumab |
|
TNFRSF9/CD137 |
Whole mAb |
|
GMP-Bios-ab-607 |
Pre-Made Vadastuximab
biosimilar, Whole mAb ADC, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Vadastuximab |
|
CD33 |
Whole mAb ADC |
|
GMP-Bios-ab-608 |
Pre-Made Valanafusp biosimilar,
Whole mAb Fusion, Anti-INSR Antibody:
Anti-CD220/HHF5 therapeutic antibody |
Valanafusp |
|
INSR |
Whole mAb Fusion |
|
GMP-Bios-ab-609 |
Pre-Made Vanalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Vanalimab |
Mitazalimab |
CD40 |
Whole mAb |
|
GMP-Bios-ab-610 |
Pre-Made Vandortuzumab
biosimilar, Whole mAb ADC, Anti-STEAP1 Antibody:
Anti-PRSS24/STEAP therapeutic antibody |
Vandortuzumab |
|
STEAP1 |
Whole mAb ADC |
|
GMP-Bios-ab-611 |
Pre-Made Vantictumab biosimilar,
Whole Mab: Anti-FZD Family therapeutic
antibody |
Vantictumab |
|
FZD Family |
Whole mAb |
|
GMP-Bios-ab-612 |
Pre-Made Vanucizumab biosimilar,
Bispecific mAb, Anti-ANGPT2;VEGFA Antibody:
Anti-AGPT2/ANG2/LMPHM10;VPF/VEGF/MVCD1
therapeutic antibody |
Vanucizumab |
|
ANGPT2;VEGFA |
Bispecific mAb |
|
GMP-Bios-ab-613 |
Pre-Made Varisacumab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Varisacumab |
|
VEGFA |
Whole mAb |
|
GMP-Bios-ab-614 |
Pre-Made Varlilumab biosimilar,
Whole mAb, Anti-CD27 Antibody:
Anti-T14/S152/Tp55/TNFRSF7/S152. LPFS2
therapeutic antibody |
Varlilumab |
|
CD27 |
Whole mAb |
|
GMP-Bios-ab-615 |
Pre-Made Vatelizumab biosimilar,
Whole mAb, Anti-ITGA2 Antibody:
Anti-BR/CD49B/GPIa/HPA-5/VLA-2/VLAA2 therapeutic
antibody |
Vatelizumab |
|
ITGA2 |
Whole mAb |
|
GMP-Bios-ab-616 |
Pre-Made Vedolizumab biosimilar,
Whole mAb, Anti-ITGA4;ITGB7 Antibody:
Anti-CD49D/IA4 therapeutic antibody |
Vedolizumab |
|
ITGA4;ITGB7 |
Whole mAb |
|
GMP-Bios-ab-617 |
Pre-Made Veltuzumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Veltuzumab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-618 |
Pre-Made Vesencumab biosimilar,
Whole mAb, Anti-NRP1 Antibody:
Anti-BDCA4/CD304/NP1/NRP/VEGF165R therapeutic
antibody |
Vesencumab |
|
NRP1 |
Whole mAb |
|
GMP-Bios-ab-619 |
Pre-Made Vibecotamab biosimilar,
Bispecific Mixed mAb and scFv, Anti-IL3RA;CD3E
Antibody:
Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18
therapeutic antibody |
Vibecotamab |
|
IL3RA;CD3E |
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-620 |
Pre-Made Vibostolimab
biosimilar, Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Vibostolimab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-621 |
Pre-Made Vilobelimab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Vilobelimab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-ab-622 |
Pre-Made Visilizumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Visilizumab |
|
CD3E |
Whole mAb |
|
GMP-Bios-ab-623 |
Pre-Made Vixarelimab biosimilar,
Whole mAb, Anti-OSMR Antibody:
Anti-IL-31R-beta/IL-31RB/OSMRB/OSMRbeta/PLCA1
therapeutic antibody |
Vixarelimab |
|
OSMR |
Whole mAb |
|
GMP-Bios-ab-624 |
Pre-Made Vixtimotamab
biosimilar, Bispecific Homodimer (VK-VH-VL'-VH',
Tandem diabody)), Anti-CD3E;CD33 Antibody:
Anti-T3E/TCRE/IMD18;p67/SIGLEC3/SIGLEC-3
therapeutic antibody |
Vixtimotamab |
|
CD3E;CD33 |
Bispecific Homodimer
(VK-VH-VL'-VH', Tandem diabody) |
|
GMP-Bios-ab-625 |
Pre-Made Vobarilizumab
biosimilar, Bispecific Single Domains (VH-VH'),
Anti-IL6R;ALB Antibody:
Anti-CD126/HIES5/IL-1Ra/IL-6R/IL-6R-1/IL-6RA/IL6Q/IL6QTL/IL6RA/IL6RQ/gp80;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Vobarilizumab |
|
IL6R;ALB |
Bispecific Single Domains
(VH-VH') |
|
GMP-Bios-ab-626 |
Pre-Made Vofatamab biosimilar,
Whole mAb, Anti-FGFR3 Antibody:
Anti-ACH/CEK2/JTK4/CD333/HSFGFR3EX therapeutic
antibody |
Vofatamab |
|
FGFR3 |
Whole mAb |
|
GMP-Bios-ab-627 |
Pre-Made Volagidemab biosimilar,
Whole mAb, Anti-GCCR/NR3C1 Antibody:
Anti-GCR/GCRST/GR/GRL therapeutic antibody
|
Volagidemab |
|
GCCR/NR3C1 |
Whole mAb |
|
GMP-Bios-ab-628 |
Pre-Made Vonlerolizumab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Vonlerolizumab |
Pogalizumab |
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-629 |
Pre-Made Vopratelimab
biosimilar, Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Vopratelimab |
|
ICOS |
Whole mAb |
|
GMP-Bios-ab-630 |
Pre-Made Vorsetuzumab
biosimilar, Whole mAb ADC, Anti-CD70/CD27-L
Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A
therapeutic antibody |
Vorsetuzumab |
|
CD70/CD27-L |
Whole mAb ADC |
|
GMP-Bios-ab-631 |
Pre-Made Vudalimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-CTLA4/CTLA-4;PDCD1/PD-1 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3;CD279/SLEB2/hPD-1/hPD-l/hSLE1
therapeutic antibody |
Vudalimab |
|
CTLA4/CTLA-4; PDCD1/PD-1
|
Bispecific Mixed mAb and
scFv |
|
GMP-Bios-ab-632 |
Pre-Made Vulinacimab biosimilar,
Whole mAb, Anti-VEGFR2/KDR Antibody:
Anti-CD309/FLK1/VEGFR therapeutic antibody
|
Vulinacimab |
|
VEGFR2/KDR |
Whole mAb |
|
GMP-Bios-ab-633 |
Pre-Made Vunakizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Vunakizumab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-634 |
Pre-Made Xentuzumab biosimilar,
Whole mAb, Anti-IGF1;IGF2 Antibody:
Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3
therapeutic antibody |
Xentuzumab |
|
IGF1;IGF2 |
Whole mAb |
|
GMP-Bios-ab-635 |
Pre-Made Zagotenemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Zagotenemab |
|
MAPT |
Whole mAb |
|
GMP-Bios-ab-636 |
Pre-Made Zalifrelimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Zalifrelimab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-637 |
Pre-Made Zalutumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Zalutumumab |
|
EGFR |
Whole mAb |
|
GMP-Bios-ab-638 |
Pre-Made Zampilimab biosimilar,
Whole mAb, Anti-TGM2/TG2 Antibody:
Anti-G(h)/TG(C)/TGC/hTG2/tTG therapeutic
antibody |
Zampilimab |
|
TGM2/TG2 |
Whole mAb |
|
GMP-Bios-ab-639 |
Pre-Made Zanidatamab biosimilar,
Bispecific mAb, Anti-ERBB2/HER2;ERBB2/HER2
Antibody: Anti-CD340/HER-2/MLN
19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Zanidatamab |
|
ERBB2/HER2; ERBB2/HER2
|
Bispecific mAb |
|
GMP-Bios-ab-640 |
Pre-Made Zanolimumab biosimilar,
Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Zanolimumab |
|
CD4 |
Whole mAb |
|
GMP-Bios-ab-641 |
Pre-Made Zansecimab biosimilar,
Whole mAb, Anti-ANGPT2 Antibody:
Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody
|
Zansecimab |
|
ANGPT2 |
Whole mAb |
|
GMP-Bios-ab-642 |
Pre-Made Zatuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Zatuximab |
modotuximab |
EGFR |
Whole mAb |
|
GMP-Bios-ab-643 |
Pre-Made Zelminemab biosimilar,
Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody:
Anti-PAC1/PACAPR/PACAPRI therapeutic
antibody |
Zelminemab |
|
ADCYAP1R1/PAC1R |
Whole mAb |
|
GMP-Bios-ab-644 |
Pre-Made Zeluvalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zeluvalimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-645 |
Pre-Made Zenocutuzumab
biosimilar, Bispecific mAb,
Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody:
Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Zenocutuzumab |
|
ERBB3/Erbb-3; ERBB2/HER2
|
Bispecific mAb |
|
GMP-Bios-ab-646 |
Pre-Made Ziltivekimab
biosimilar, Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Ziltivekimab |
|
IL6 |
Whole mAb |
|
GMP-Bios-ab-647 |
Pre-Made Zilovertamab
biosimilar, Whle mAb, Anti-ROR1 Antibody:
Anti-NTRKR1/dJ537F10.1 therapeutic antibody
|
Zilovertamab |
|
ROR1 |
Whle mAb |
|
GMP-Bios-ab-648 |
Pre-Made Zimberelimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zimberelimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-649 |
Pre-Made Zolbetuximab
biosimilar, Whole mAb, Anti-CLDN18 Antibody:
Anti-SFTA5/SFTPJ therapeutic antibody |
Zolbetuximab |
Claudiximab |
CLDN18 |
Whole mAb |
|
GMP-Bios-ab-650 |
Pre-Made Zolimomab biosimilar,
Whole mAb, Anti-CD5 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Zolimomab |
|
CD5 |
Whole mAb |
|
GMP-Bios-ab-651 |
Pre-Made Zuberitamab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Zuberitamab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-ab-652 |
Pre-Made Adintrevimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike
therapeutic antibody |
Adintrevimab |
|
SARS-CoV-2 Spike |
Whole mAb |
|
GMP-Bios-ab-653 |
Pre-Made Amubarvimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Amubarvimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-654 |
Pre-Made Anselamimab biosimilar,
Whole mAb, Anti-SAA1 Antibody:
Anti-PIG4/SAA/SAA2/TP53I4 therapeutic
antibody |
Anselamimab |
|
SAA1 |
Whole mAb |
|
GMP-Bios-ab-655 |
Pre-Made Anumigilimab
biosimilar, Whole mAb, Anti-CSF3R/G-CSF-R
Antibody: Anti-CD114/GCSFR/SCN7 therapeutic
antibody |
Anumigilimab |
|
CSF3R/G-CSF-R |
Whole mAb |
|
GMP-Bios-ab-656 |
Pre-Made Bafisontamab
biosimilar, Whole mAb, Anti-EGFR;MET Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met
therapeutic antibody |
Bafisontamab |
|
EGFR;MET |
Bispecific Mixed mAb and Fab
|
|
GMP-Bios-ab-657 |
Pre-Made Barzolvolimab
biosimilar, Whole mAb, Anti-KIT Antibody:
Anti-C-Kit/CD117/MASTC/PBT/SCFR therapeutic
antibody |
Barzolvolimab |
|
KIT |
Whole mAb |
|
GMP-Bios-ab-658 |
Pre-Made Beludavimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Beludavimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-659 |
Pre-Made Dalutrafusp biosimilar,
Whole mAb, Anti-TGFBR2 Antibody:
Anti-AAT3/FAA3/LDS1B/LDS2/LDS2B/MFS2/RIIC/TAAD2/TBR-ii/TBRII/TGFR-2-RII
therapeutic antibody |
Dalutrafusp |
|
TGFBR2 |
Whole mAb Fusion |
|
GMP-Bios-ab-660 |
Pre-Made Dresbuxelimab
biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Dresbuxelimab |
|
NT5E/CD73 |
Whole mAb |
|
GMP-Bios-ab-661 |
Pre-Made Eblasakimab biosimilar,
Whole mAb, Anti-IL13RA1 Antibody:
Anti-CD213A1/CT19/IL-13Ra/NR4 therapeutic
antibody |
Eblasakimab |
|
IL13RA1 |
Whole mAb |
|
GMP-Bios-ab-662 |
Pre-Made Ecleralimab biosimilar,
Whole Mab: Anti-TSLP therapeutic antibody
|
Ecleralimab |
|
TSLP |
Whole mAb |
|
GMP-Bios-ab-663 |
Pre-Made Elranatamab biosimilar,
Whole mAb, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Elranatamab |
|
TNFRSF17;CD3E |
Bispecific Whole mAb |
|
GMP-Bios-ab-664 |
Pre-Made Ensomafusp Biosimilar,
Fusion Protein targeting CD19: Recombinant
therapeutic protein targeting B4/CVID3 |
Ensomafusp |
|
CD19 |
Fusion Protein |
|
GMP-Bios-ab-665 |
Pre-Made Enuzovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Enuzovimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-667 |
Pre-Made Fidasimtamab
biosimilar, Whole mAb,
Anti-PDCD1/PD-1;ERBB2/HER2 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Fidasimtamab |
|
PDCD1/PD-1; ERBB2/HER2
|
Bispecific Whole mAb |
|
GMP-Bios-ab-668 |
Pre-Made Galegenimab biosimilar,
Whole mAb, Anti-HTRA1 Antibody:
Anti-ARMD7/CADASIL2/CARASIL/HtrA/L56/ORF480/PRSS11
therapeutic antibody |
Galegenimab |
|
HTRA1 |
Whole mAb |
|
GMP-Bios-ab-669 |
Pre-Made Ginisortamab
biosimilar, Whole mAb, Anti-GREM1/Gremlin-1
Antibody:
Anti-C15DUPq/CKTSF1B1/CRAC1/CRCS4/DAND2/DRM/DUP15q/GREMLIN/HMPS/HMPS1/IHG-2/MPSH/PIG2
therapeutic antibody |
Ginisortamab |
|
GREM1/Gremlin-1 |
Whole mAb |
|
GMP-Bios-ab-670 |
Pre-Made Gresonitamab
biosimilar, Whole mAb, Anti-CLDN18;CD3E
Antibody: Anti-SFTA5/SFTPJ;T3E/TCRE/IMD18
therapeutic antibody |
Gresonitamab |
|
CLDN18;CD3E |
Bispecific scFv-scFv-scFc
|
|
GMP-Bios-ab-671 |
Pre-Made Gumokimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Gumokimab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-672 |
Pre-Made Iparomlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Iparomlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-673 |
Pre-Made Ivicentamab biosimilar,
Whole mAb, Anti-CD37;CD37 Antibody:
Anti-GP52-40/TSPAN26;GP52-40/TSPAN26 therapeutic
antibody |
Ivicentamab |
|
CD37;CD37 |
Bispecific Whole mAb |
|
GMP-Bios-ab-674 |
Pre-Made Ivonescimab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Ivonescimab |
|
VEGFA |
scFv-IGHC |
|
GMP-Bios-ab-675 |
Pre-Made Lepunafusp biosimilar,
Whole mAb, Anti-TfR1/TFRC Antibody:
Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
therapeutic antibody |
Lepunafusp |
|
TfR1/TFRC |
Whole mAb Fusion |
|
GMP-Bios-ab-676 |
Pre-Made Ligufalimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Ligufalimab |
|
CD47 |
Whole mAb |
|
GMP-Bios-ab-677 |
Pre-Made Livmoniplimab
biosimilar, Whole mAb, Anti-LRRC32 Antibody:
Anti-CPPRDD/D11S833E/GARP therapeutic
antibody |
Livmoniplimab |
|
LRRC32 |
Whole mAb |
|
GMP-Bios-ab-678 |
Pre-Made Lomtegovimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Lomtegovimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-679 |
Pre-Made Lorigerlimab
biosimilar, Whole mAb,
Anti-PDCD1/PD-1;CTLA4/CTLA-4 Antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Lorigerlimab |
|
PDCD1/PD-1; CTLA4/CTLA-4
|
Bispecific Mixed scFv
(scFv-CH2-CH3-scFv) |
|
GMP-Bios-ab-680 |
Pre-Made Manfidokimab
biosimilar, Whole mAb, Anti-IL4R Antibody:
Anti-CD124 therapeutic antibody |
Manfidokimab |
|
IL4R |
Whole mAb |
|
GMP-Bios-ab-681 |
Pre-Made Mazorelvimab
biosimilar, Whole Mab: Anti-Rabies Virus Spike
Glycoprotein G therapeutic antibody |
Mazorelvimab |
|
Rabies Virus Spike
Glycoprotein G |
Whole mAb |
|
GMP-Bios-ab-682 |
Pre-Made Melredableukin
biosimilar, Whole Mab: Anti-Non-Binding
therapeutic antibody |
Melredableukin |
|
Non-Binding |
Whole mAb Fusion |
|
GMP-Bios-ab-683 |
Pre-Made Mupadolimab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Mupadolimab |
|
NT5E/CD73 |
Whole mAb |
|
GMP-Bios-ab-684 |
Pre-Made Nofazinlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Nofazinlimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-685 |
Pre-Made Ormutivimab biosimilar,
Whole Mab: Anti-Rabies Virus Surface
Glycoprotein 4 (gp4) Epitope 1 therapeutic
antibody |
Ormutivimab |
|
Rabies Virus Surface
Glycoprotein 4 (gp4) Epitope 1 |
Whole mAb |
|
GMP-Bios-ab-686 |
Pre-Made Pivekimab biosimilar,
Whole mAb, Anti-IL3RA Antibody:
Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody |
Pivekimab |
|
IL3RA |
Whole mAb |
|
GMP-Bios-ab-687 |
Pre-Made Pulocimab biosimilar,
Whole mAb, Anti-VEGFR2/KDR Antibody:
Anti-CD309/FLK1/VEGFR therapeutic antibody
|
Pulocimab |
|
VEGFR2/KDR |
Whole mAb |
|
GMP-Bios-ab-688 |
Pre-Made Quisovalimab
biosimilar, Whole mAb, Anti-TNFSF14/CD258
Antibody: Anti-HVEML/LIGHT/LTg therapeutic
antibody |
Quisovalimab |
|
TNFSF14/CD258 |
Whole mAb |
|
GMP-Bios-ab-689 |
Pre-Made Rimteravimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Rimteravimab |
|
SARS-CoV-2 Spike RBD |
Mixed Nanobody (VHH-CH2-CH3
dimer) |
|
GMP-Bios-ab-690 |
Pre-Made Rocatinlimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Rocatinlimab |
|
TNFRSF4/CD134 |
Whole mAb |
|
GMP-Bios-ab-691 |
Pre-Made Romlusevimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Romlusevimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-692 |
Pre-Made Rulonilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Rulonilimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-ab-693 |
Pre-Made Simridarlimab
biosimilar, Whole mAb, Anti-CD47;CD274/PD-L1
Antibody:
Anti-IAP/OA3/MER6;B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1
therapeutic antibody |
Simridarlimab |
|
CD47;CD274/PD-L1 |
Bispecific Mixed
mAb/VH-VH-CH2-CH3 |
|
GMP-Bios-ab-694 |
Pre-Made Sirexatamab biosimilar,
Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1
therapeutic antibody |
Sirexatamab |
|
DKK1 |
Whole mAb |
|
GMP-Bios-ab-695 |
Pre-Made Socazolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Socazolimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-696 |
Pre-Made Sotevtamab biosimilar,
Whole mAb, Anti-CLU/Clusterinm Antibody:
Anti-AAG4/APO-J/APOJ/CLI/KUB1/NA1/NA2/SGP-2/SGP2/SP-40/TRPM-2/TRPM2
therapeutic antibody |
Sotevtamab |
|
CLU/Clusterin |
Whole mAb |
|
GMP-Bios-ab-697 |
Pre-Made Suciraslimab
biosimilar, Whole mAb, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Suciraslimab |
|
CD22 |
Whole mAb |
|
GMP-Bios-ab-698 |
Pre-Made Tagitanlimab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Tagitanlimab |
|
CD274/PD-L1 |
Whole mAb |
|
GMP-Bios-ab-699 |
Pre-Made Tamgiblimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Tamgiblimab |
|
TIGIT |
Whole mAb |
|
GMP-Bios-ab-700 |
Pre-Made Tarcolimab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Tarcolimab |
|
VEGFA |
Whole mAb |
|
GMP-Bios-ab-701 |
Pre-Made Tecaginlimab
biosimilar, Whole mAb, Anti-CD40;TNFRSF9/CD137
Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5;ILA/4-1BB/CDw137
therapeutic antibody |
Tecaginlimab |
|
CD40;TNFRSF9/CD137 |
Bispecific Whole mAb |
|
GMP-Bios-ab-702 |
Pre-Made Teropavimab biosimilar,
Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic
antibody |
Teropavimab |
|
HIV-1 gp120 CD4bs |
Whole mAb |
|
GMP-Bios-ab-703 |
Pre-Made Trinbelimab biosimilar,
Whole mAb, Anti-RhD Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Trinbelimab |
|
RhD |
Whole mAb |
|
GMP-Bios-ab-704 |
Pre-Made Tuvonralimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Tuvonralimab |
|
CTLA4/CTLA-4 |
Whole mAb |
|
GMP-Bios-ab-705 |
Pre-Made Ubamatamab biosimilar,
Whole mAb, Anti-MUC16;CD3E Antibody:
Anti-CA125;T3E/TCRE/IMD18 therapeutic
antibody |
Ubamatamab |
|
MUC16;CD3E |
Bispecific Whole mAb |
|
GMP-Bios-ab-706 |
Pre-Made Ulenistamab biosimilar,
Whole Mab: Anti-PAUF therapeutic antibody
|
Ulenistamab |
|
PAUF |
Whole mAb |
|
GMP-Bios-ab-707 |
Pre-Made Upanovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Upanovimab |
|
SARS-CoV-2 Spike RBD |
Whole mAb |
|
GMP-Bios-ab-708 |
Pre-Made Vepsitamab biosimilar,
Whole mAb, Anti-MUC17;CD3E Antibody:
Anti-MUC-17/MUC-3/MUC3;T3E/TCRE/IMD18
therapeutic antibody |
Vepsitamab |
|
MUC17;CD3E |
Bispecific scFv-scFv-scFc
|
|
GMP-Bios-ab-709 |
Pre-Made Voxalatamab biosimilar,
Whole mAb, Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Voxalatamab |
|
FOLH1/GCPII;CD3E |
Bispecific Whole mAb |
|
GMP-Bios-ab-710 |
Pre-Made Xeligekimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Xeligekimab |
|
IL17A/IL17 |
Whole mAb |
|
GMP-Bios-ab-711 |
Pre-Made Zamerovimab biosimilar,
Whole Mab: Anti-Rabies Virus Spike Glycoprotein
G therapeutic antibody |
Zamerovimab |
|
Rabies Virus Spike
Glycoprotein G |
Whole mAb |
|
GMP-Bios-INN-712 |
Pre-Made Abatacept Biosimilar,
Fusion Protein targeting CTLA4/CTLA-4 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 |
Abatacept |
|
CTLA-4 |
Fusion Protein |
|
GMP-Bios-INN-713 |
Pre-Made Abciximab Biosimilar,
Fab Fusion, Anti-Itga2B/Itgb3 Antibody:
Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Abciximab |
|
ITGA2B;ITGB3 |
Fab Fusion |
|
GMP-Bios-INN-715 |
Pre-Made Acazicolcept
Biosimilar, Fusion Protein targeting CD28 fused
with human IGHG1 Fc (Fragment constant) via a
peptidyl linker: Recombinant therapeutic protein
targeting Tp44 |
Acazicolcept |
|
CD28 |
Fusion Protein |
|
GMP-Bios-INN-717 |
Pre-Made Actinium (225Ac)
Lintuzumab Satetraxetan Biosimilar, Whole Mab
Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Actinium (225Ac) Lintuzumab
Satetraxetan |
|
CD33 |
Whole mAb ADC |
|
GMP-Bios-INN-718 |
Pre-Made Adalimumab Beta
Biosimilar, Whole Mab, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Adalimumab Beta |
|
TNF |
Whole mAb |
|
GMP-Bios-INN-719 |
Pre-Made Adecatumumab
Biosimilar, Whole Mab, Anti-Epcam Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Adecatumumab |
|
EPCAM |
Whole mAb |
|
GMP-Bios-INN-721 |
Pre-Made Afelimomab Biosimilar,
Fab Fusion, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Afelimomab |
|
TNF |
Fab Fusion |
|
GMP-Bios-INN-722 |
Pre-Made Aflibercept Biosimilar,
Fusion Protein targeting VEGFA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting MVCD1/VEGF/VPF
|
Aflibercept |
|
VEGFA |
Fusion Protein |
|
GMP-Bios-INN-724 |
Pre-Made Albiglutide Biosimilar,
Peptide Protein Fusion targeting GLP1R: (Glp-1)2
Peptide-Albumin(Alb) Fusion Protein
targetingGLP-1-R/GLP-1R |
Albiglutide |
|
GLP1R |
Peptide Protein fusion |
|
GMP-Bios-INN-725 |
Pre-Made Albinterferon Alfa- 2B
Biosimilar, Fusion Protein targeting IFNAR1
fused with ALB (albumin, human serum albumin,
HSA): Recombinant therapeutic protein targeting
AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC |
Albinterferon Alfa- 2B |
|
IFNAR1 |
Fusion Protein |
|
GMP-Bios-INN-726 |
Pre-Made Albutrepenonacog Alfa
Biosimilar, Fusion Protein targeting F9 fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Albutrepenonacog Alfa |
|
F9 |
Fusion Protein |
|
GMP-Bios-INN-727 |
Pre-Made Aldafermin Biosimilar,
Recombinant Protein targeting FGFR4: Recombinant
therapeutic protein targeting CD334/JTK2/TKF
|
Aldafermin |
|
FGFR4 |
Recombinant Protein |
|
GMP-Bios-INN-728 |
Pre-Made Aldesleukin biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting IL2 |
Aldesleukin |
|
IL2
|
Recombinant Protein |
|
GMP-Bios-INN-729 |
Pre-Made Alefacept Biosimilar,
Fusion Protein targeting CD2 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting LFA-2/SRBC/T11
|
Alefacept |
|
CD2 |
Fusion Protein |
|
GMP-Bios-INN-730 |
Pre-Made Altumomab Biosimilar,
Radiolabelled Antibody, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Altumomab |
|
CEACAM5/CD66e |
Radiolabelled antibody |
|
GMP-Bios-INN-731 |
Pre-Made Alvircept Sudotox
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting HIV-1 gp120 fused
with Pseudomonas aeruginosa exotoxin A |
Alvircept Sudotox |
|
HIV-1 gp120 |
Fusion Protein |
|
GMP-Bios-INN-732 |
Pre-Made Anakinra Biosimilar,
Recombinant Protein targeting IL1R1: Recombinant
therapeutic protein targeting
CD121A/D2S1473/IL-1R-alpha/IL1R/IL1RA/P80
|
Anakinra |
|
IL1R1 |
Recombinant Protein |
|
GMP-Bios-INN-733 |
Anatumomab-Anti-TAG-72
therapeutic antibody fused with Staphylococcus
aureus
enterotoxin A (Pre-made Anatumomab Mafenatox
biosimilar, Fusion Protein) |
Anatumomab Mafenatox |
|
TAG-72 |
Fusion Protein |
|
GMP-Bios-INN-734 |
Pre-Made Anetumab Corixetan
Biosimilar, Whole Mab Adc, Anti-Msln Antibody:
Anti-MPF/SMRP therapeutic antibody Drug
Conjugate |
Anetumab Corixetan |
|
MSLN |
Whole mAb ADC |
|
GMP-Bios-INN-735 |
Pre-Made Anetumab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Msln Antibody:
Anti-MPF/SMRP therapeutic antibody Drug
Conjugate |
Anetumab Ravtansine |
|
MSLN |
Whole mAb ADC |
|
GMP-Bios-INN-736 |
Pre-Made Apolizumab Biosimilar,
Whole Mab, Anti-HLA-DRB/HLA-DRB1 Antibody:
Anti-DRB1/SS1 therapeutic antibody |
Apolizumab |
|
HLA-DRB/HLA-DRB1 |
Whole mAb |
|
GMP-Bios-INN-737 |
Pre-Made Aprutumab Ixadotin
Biosimilar, Whole Mab Adc, Anti-Fgfr2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody Drug Conjugate |
Aprutumab Ixadotin |
|
FGFR2 |
Whole mAb ADC |
|
GMP-Bios-INN-738 |
Pre-Made Arcitumomab Biosimilar,
Radiolabelled Antibody, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Arcitumomab |
|
CEACAM5/CD66e |
Radiolabelled antibody |
|
GMP-Bios-INN-739 |
Pre-Made Aselizumab Biosimilar,
Whole Mab, Anti-Sell Antibody:
Anti-CD62L/LAM1/LECAM1/LEU8/LNHR/LSEL/LYAM1/PLNHR/TQ1
therapeutic antibody |
Aselizumab |
|
SELL |
Whole mAb |
|
GMP-Bios-INN-740 |
Pre-Made Asfotase Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting Enzyme fused with
human IGHG1 Fc (Fragment constant) |
Asfotase Alfa |
|
Enzyme |
Fusion Protein |
|
GMP-Bios-INN-741 |
Pre-Made Asunercept Biosimilar,
Fusion Protein targeting FASLG/CD178 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
ALPS1B/APT1LG1/APTL/CD95-L/CD95L/FASL/TNFSF6/TNLG1A
|
Asunercept |
|
FASLG/CD178 |
Fusion Protein |
|
GMP-Bios-INN-742 |
Pre-Made Atacicept Biosimilar,
Fusion Protein targeting TNFSF13/APRIL fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2
|
Atacicept |
|
TNFSF13/APRIL |
Fusion Protein |
|
GMP-Bios-INN-743 |
Pre-Made Atorolimumab
Biosimilar, Whole Mab, Anti-Rhd Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Atorolimumab |
|
RHD |
Whole mAb |
|
GMP-Bios-INN-746 |
Pre-Made Azintuxizumab Vedotin
Biosimilar, Whole Mab Adc, Anti-SLAMF7/CS1
Antibody: Anti-19A/CD319/CRACC therapeutic
antibody Drug Conjugate |
Azintuxizumab Vedotin |
|
SLAMF7/CS1 |
Whole mAb ADC |
|
GMP-Bios-INN-748 |
Pre-Made Balugrastim Biosimilar,
Fusion Protein targeting CSF3R/G-CSF-R fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
CD114/GCSFR/SCN7 |
Balugrastim |
|
CSF3R/G-CSF-R |
Fusion Protein |
|
GMP-Bios-INN-749 |
Pre-Made Baminercept Biosimilar,
Fusion Protein targeting LTA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
LT/TNFB/TNFSF1/TNLG1E |
Baminercept |
|
LTA |
Fusion Protein |
|
GMP-Bios-INN-750 |
Pre-Made Batiraxcept Biosimilar,
Fusion Protein targeting GAS6 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting AXLLG/AXSF
|
Batiraxcept |
|
GAS6 |
Fusion Protein |
|
GMP-Bios-INN-751 |
Pre-Made Bectumomab Biosimilar,
Fab Fusion, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody
|
Bectumomab |
|
CD22 |
Fab Fusion |
|
GMP-Bios-INN-752 |
Pre-Made Belantamab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Tnfrsf17
Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A
therapeutic antibody Drug Conjugate |
Belantamab Mafodotin |
|
TNFRSF17 |
Whole mAb ADC |
|
GMP-Bios-INN-753 |
Pre-Made Belatacept Biosimilar,
Fusion Protein targeting CD80 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
B7/B7-1/B7.1/BB1/CD28LG/CD28LG1/LAB7 |
Belatacept |
|
CD80 |
Fusion Protein |
|
GMP-Bios-INN-755 |
Pre-Made Bertilimumab
Biosimilar, Whole Mab, Anti-Ccl11 Antibody:
Anti-SCYA11 therapeutic antibody |
Bertilimumab |
|
CCL11 |
Whole mAb |
|
GMP-Bios-INN-756 |
Pre-Made Besilesomab Biosimilar,
Radiolabelled Antibody, Anti-Ceacam8/NCA-95
Antibody: Anti-CD66b/CD67/CGM6 therapeutic
antibody |
Besilesomab |
|
CEACAM8/NCA-95 |
Radiolabelled antibody |
|
GMP-Bios-INN-757 |
Pre-Made Bevacizumab Beta
Biosimilar, Whole Mab, Anti-Vegfa Antibody:
Anti-MVCD1/VEGF/VPF therapeutic antibody
|
Bevacizumab Beta |
|
VEGFA |
Whole mAb |
|
GMP-Bios-INN-758 |
Pre-Made Bevifimod biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting Staphylococcal protein A
|
Bevifimod |
|
Staphylococcal protein A
|
Recombinant Protein |
|
GMP-Bios-INN-759 |
Pre-Made Biciromab Biosimilar,
Radiolabelled Antibody: Anti-Fibrin Ii
therapeutic antibody |
Biciromab |
|
fibrin II |
Radiolabelled antibody |
|
GMP-Bios-INN-760 |
Pre-Made Bifarcept Biosimilar,
Recombinant Protein targeting IFNA1: Recombinant
therapeutic protein targeting
IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D
|
Bifarcept |
|
IFNA1 |
Recombinant Protein |
|
GMP-Bios-INN-761 |
Pre-Made Bifikafusp Alfa
Biosimilar, Fusion Protein targeting FN/FN1
fused with human IL2 (interleukin 2, IL-2)
Pr21-153 (100%) (1:1), noncovalent dimer:
Recombinant therapeutic protein targeting
CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF
|
Bifikafusp Alfa |
|
FN/FN1 |
Fusion Protein |
|
GMP-Bios-INN-762 |
Pre-Made Bintrafusp Alfa
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human TGFBR2 (transforming growth
factor beta receptor 2) (1:2) via a peptidyl
linker: Recombinant therapeutic protein
targeting B7-H/B7H1/PDCD1L1/PDCD1LG1 |
Bintrafusp Alfa |
|
CD274/PD-L1 |
Fusion Protein |
|
GMP-Bios-INN-763 |
Pre-Made Bivatuzumab Biosimilar,
Whole Mab, Anti-Cd44 Antibody:
Anti-CDW44/CSPG8/ECMR-III/HCELL/HUTCH-I/IN/LHR/MC56/MDU2/MDU3/MIC4/Pgp1
therapeutic antibody |
Bivatuzumab |
|
CD44 |
Whole mAb |
|
GMP-Bios-INN-764 |
Pre-Made Blisibimod Biosimilar,
Fusion Protein targeting TNFSF13B fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Blisibimod |
|
TNFSF13B |
Fusion Protein |
|
GMP-Bios-INN-765 |
Pre-Made Brentuximab Vedotin
Biosimilar, Whole Mab Adc, Anti-Tnfrsf8
Antibody: Anti-CD30/D1S166E/Ki-1 therapeutic
antibody Drug Conjugate |
Brentuximab Vedotin |
|
TNFRSF8 |
Whole mAb ADC |
|
GMP-Bios-INN-767 |
Pre-Made Briobacept Biosimilar,
Fusion Protein targeting TNFSF13B fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Briobacept |
|
TNFSF13B |
Fusion Protein |
|
GMP-Bios-INN-768 |
Pre-Made Camidanlumab Tesirine
Biosimilar, Whole Mab Adc, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody Drug Conjugate |
Camidanlumab Tesirine |
|
IL2RA |
Whole mAb ADC |
|
GMP-Bios-INN-769 |
Pre-Made Cantuzumab Mertansine
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Cantuzumab Mertansine |
|
MUC1 |
Whole mAb ADC |
|
GMP-Bios-INN-770 |
Pre-Made Cantuzumab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Cantuzumab Ravtansine |
|
MUC1 |
Whole mAb ADC |
|
GMP-Bios-INN-771 |
Pre-Made Capromab Biosimilar,
Radiolabelled Antibody, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Capromab |
|
FOLH1/GCPII |
Radiolabelled antibody |
|
GMP-Bios-INN-772 |
Pre-Made Catumaxomab Biosimilar,
Bispecific, Anti-Cd3E; Epcam Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Catumaxomab |
|
CD3E;EPCAM |
Bispecific |
|
GMP-Bios-INN-773 |
Pre-Made Cedelizumab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Cedelizumab |
|
CD4 |
Whole mAb |
|
GMP-Bios-INN-775 |
Pre-Made Cergutuzumab
Amunaleukin biosimilar, Fusion Protein,
Cergutuzumab-Anti-CEACAM5/CD66e Antibody:
Anti-CEA therapeutic antibody fused with human
IL2 (interleukin 2, IL-2) Pr21-153 |
Cergutuzumab Amunaleukin
|
|
CEACAM5/CD66e |
Fusion Protein |
|
GMP-Bios-INN-777 |
Pre-Made Cetuximab Sarotalocan
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Cetuximab Sarotalocan |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-INN-778 |
Pre-Made Choriogonadotropin Beta
Biosimilar, Recombinant Protein targeting LHCGR:
Recombinant therapeutic protein targeting
HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5
|
Choriogonadotropin Beta |
|
LHCGR |
Recombinant Protein |
|
GMP-Bios-INN-780 |
Pre-Made Cinrebafusp Alfa P
Alfaiosimilar, Bispecific,
Anti-ERBB2/HER2;TNFRSF9 Antibody: Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;ILA/4-1BB/CDw137
therapeutic antibody |
Cinrebafusp Alfa |
|
ERBB2/HER2; TNFRSF9 |
Bispecific |
|
GMP-Bios-INN-781 |
Pre-Made Citatuzumab Bogatox
biosimilar, Fusion Protein,
Citatuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with Bougainvillea
spectabilis Willd bouganin |
Citatuzumab Bogatox |
|
EPCAM |
Fusion Protein |
|
GMP-Bios-INN-782 |
Pre-Made Clenoliximab
Biosimilar, Whole Mab, Anti-Cd4 Antibody:
Anti-IMD79/OKT4D therapeutic antibody |
Clenoliximab |
|
CD4 |
Whole mAb |
|
GMP-Bios-INN-783 |
Pre-Made Clervonafusp Alfa
Biosimilar, Fusion Protein targeting
SLC29A2/ENT2 fused with human GAA (glucosidase
alpha, acid, lysosomal alpha-glucosidase
)(Pr67-952) (1:2) Enzyme substitute: Recombinant
therapeutic protein targeting DER12/HNP36
|
Clervonafusp Alfa |
|
SLC29A2/ENT2 |
Fusion Protein |
|
GMP-Bios-INN-784 |
Pre-Made Clivatuzumab Tetraxetan
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Clivatuzumab Tetraxetan |
|
MUC1 |
Whole mAb ADC |
|
GMP-Bios-INN-785 |
Pre-Made Cofetuzumab Pelidotin
Biosimilar, Whole Mab Adc, Anti-Ptk7 Antibody:
Anti-CCK-4/CCK4 therapeutic antibody Drug
Conjugate |
Cofetuzumab Pelidotin |
|
PTK7 |
Whole mAb ADC |
|
GMP-Bios-INN-786 |
Pre-Made Coltuximab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Coltuximab Ravtansine |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-INN-787 |
Pre-Made Conbercept Biosimilar,
Fusion Protein targeting VEGFA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting MVCD1/VEGF/VPF
|
Conbercept |
|
VEGFA |
Fusion Protein |
|
GMP-Bios-INN-788 |
Pre-Made Corifollitropin Alfa
Biosimilar, Fusion Protein targeting FSHR fused
with CTP (C-terminal peptide of hCG):
Recombinant therapeutic protein targeting
FSHRO/LGR1/ODG1 |
Corifollitropin Alfa |
|
FSHR |
Fusion Protein |
|
GMP-Bios-INN-789 |
Pre-Made Daclizumab Beta
Biosimilar, Whole Mab, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Daclizumab Beta |
|
IL2RA |
Whole mAb |
|
GMP-Bios-INN-790 |
Pre-Made Dafsolimab Setaritox
Biosimilar, Whole Mab Adc, Anti-Cd3E Antibody:
Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic
antibody Drug Conjugate |
Dafsolimab Setaritox |
|
CD3E |
Whole mAb ADC |
|
GMP-Bios-INN-791 |
Pre-Made Dalantercept
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting BMP10 fused with
human IGHG1 Fc (Fragment constant) |
Dalantercept |
|
BMP10 |
Fusion Protein |
|
GMP-Bios-INN-792 |
Pre-Made Dalcinonacog Alfa
Biosimilar, Recombinant Protein targeting F9:
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Dalcinonacog Alfa |
|
F9 |
Recombinant Protein |
|
GMP-Bios-INN-793 |
Pre-Made Dalutrafusp Alfa P
Alfaiosimilar, Bispecific,
Anti-NT5E/CD73;TGFB1;TGFB3 Antibody:
Anti-eN/NTE/eNT/CALJA;CED/DPD1/IBDIMDE/LAP/TGF-beta1/TGFbeta;ARVD/ARVD1/LDS5/RNHF
therapeutic antibody |
Dalutrafusp Alfa |
|
NT5E/CD73; TGFB1;TGFB3
|
Bispecific |
|
GMP-Bios-INN-795 |
Pre-Made Darbepoetin Alfa
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting EPOR |
Darbepoetin Alfa |
|
EPOR |
Recombinant Protein |
|
GMP-Bios-INN-796 |
Pre-Made Datopotamab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-Tacstd2
Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody Drug Conjugate |
Datopotamab Deruxtecan |
|
TACSTD2 |
Whole mAb ADC |
|
GMP-Bios-INN-797 |
Pre-Made Davoceticept
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human IGHG1 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting B7-H/B7H1/PDCD1L1/PDCD1LG1
|
Davoceticept |
|
CD274/PD-L1 |
Fusion Protein |
|
GMP-Bios-INN-798 |
Pre-Made Dazodalibep Biosimilar,
Fusion Protein targeting CD40LG fused with ALB
(albumin, human serum albumin, HSA): Recombinant
therapeutic protein targeting
CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L
|
Dazodalibep |
|
CD40LG |
Fusion Protein |
|
GMP-Bios-INN-799 |
Pre-Made Denileukin Diftitox
Biosimilar, Fusion Protein targeting IL1RL2
fused with human IL2 (interleukin 2, IL-2):
Recombinant therapeutic protein targeting
IL-1Rrp2/IL-36R/IL1R-rp2/IL1RRP2 |
Denileukin Diftitox |
|
IL1RL2 |
Fusion Protein |
|
GMP-Bios-INN-800 |
Pre-Made Denintuzumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Denintuzumab Mafodotin |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-INN-801 |
Pre-Made Depatuxizumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Depatuxizumab Mafodotin |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-INN-802 |
Pre-Made Detumomab biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting human B-cell lymphoma |
Detumomab |
|
human B-cell lymphoma |
Recombinant Protein |
|
GMP-Bios-INN-803 |
Pre-Made Dinutuximab Beta
Biosimilar, Whole Mab: Anti-Ganglioside Gd2
therapeutic antibody |
Dinutuximab Beta |
|
ganglioside GD2 |
Whole mAb |
|
GMP-Bios-INN-804 |
Pre-Made Disitamab Vedotin
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Disitamab Vedotin |
|
ERBB2/HER2 |
Whole mAb ADC |
|
GMP-Bios-INN-805 |
Pre-Made Dorlimomab Aritox
Biosimilar, Whole Mab Adc: Anti-40S Ribosomal
Protein S18 therapeutic antibody |
Dorlimomab Aritox |
|
40S ribosomal protein S18
|
ADC |
|
GMP-Bios-INN-806 |
Pre-Made Dulaglutide Biosimilar,
Peptide Protein Fusion targeting GLP1R: (Glp-12)
Peptide-Human Igg4 Fc Fusion Protein targeting
GLP-1/GLP-1-R/GLP-1R |
Dulaglutide |
|
GLP1R |
Peptide Protein fusion |
|
GMP-Bios-INN-807 |
Pre-Made Ecromeximab Biosimilar,
Whole Mab: Anti-Ganglioside Gd3 therapeutic
antibody |
Ecromeximab |
|
ganglioside GD3 |
Whole mAb |
|
GMP-Bios-INN-808 |
Pre-Made Edobacomab Biosimilar,
Whole Mab: Anti-Endotoxin (Lipid A, Domain Of
Lipopolyaccharide, Lps) [Gram Negative Bacteria]
therapeutic antibody |
Edobacomab |
|
endotoxin (lipid A,
domain of lipopolyaccharide, LPS) [gram
negative bacteria] |
Whole mAb |
|
GMP-Bios-INN-809 |
Pre-Made Efanesoctocog Alfa
Biosimilar, Fusion Protein targeting F8 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Efanesoctocog Alfa |
|
F8 |
Fusion Protein |
|
GMP-Bios-INN-810 |
Pre-Made Efaprinermin Alfa
Biosimilar, Fusion Protein targeting TNFRSF18
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AITR/CD357/ENERGEN/GITR/GITR-D |
Efaprinermin Alfa |
|
TNFRSF18 |
Fusion Protein |
|
GMP-Bios-INN-811 |
Pre-Made Efavaleukin Alfa
Biosimilar, Fusion Protein targeting IL2 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
IL-2/TCGF/lymphokine |
Efavaleukin Alfa |
|
IL2 |
Fusion Protein |
|
GMP-Bios-INN-812 |
Pre-Made Efbemalenograstim Alfa
Biosimilar, Fusion Protein targeting
CSF3R/G-CSF-R fused with human IGHG2 Fc
(Fragment constant) via a peptidyl linker:
Recombinant therapeutic protein targeting
CD114/GCSFR/SCN7 |
Efbemalenograstim Alfa |
|
CSF3R/G-CSF-R |
Fusion Protein |
|
GMP-Bios-INN-813 |
Pre-Made Efdamrofusp Alfa P
Alfaiosimilar, Bispecific, Anti-C3/CO3;C4B;VEGFA
Antibody:
Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1
therapeutic antibody |
Efdamrofusp Alfa |
|
C3/CO3;C4B;VEGFA |
Bispecific |
|
GMP-Bios-INN-814 |
Pre-Made Efgartigimod Alfa
Biosimilar, Recombinant Protein targeting FCGRT:
Recombinant therapeutic protein targeting
FCRN/FcgammaRn/alpha-chain |
Efgartigimod Alfa |
|
FCGRT |
Recombinant Protein |
|
GMP-Bios-INN-815 |
Pre-Made Efgivanermin Alfa
Biosimilar, Fusion Protein targeting TNFRSF18
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AITR/CD357/ENERGEN/GITR/GITR-D |
Efgivanermin Alfa |
|
TNFRSF18 |
Fusion Protein |
|
GMP-Bios-INN-816 |
Pre-Made Efineptakin Alfa
Biosimilar, Fusion Protein targeting IL7R fused
with human IGHG4 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD127/CDW127 |
Efineptakin Alfa |
|
IL7R |
Fusion Protein |
|
GMP-Bios-INN-819 |
Pre-Made Eflepedocokin Alfa
Biosimilar, Fusion Protein targeting IL10RB
fused with human IGHG2 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting
CDW210B/CRF2-4/CRFB4/D21S58/D21S66/IL-10R2
|
Eflepedocokin Alfa |
|
IL10RB |
Fusion Protein |
|
GMP-Bios-INN-820 |
Pre-Made Eflimrufusp Alfa
Biosimilar, Fusion Protein targeting FGF2 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BFGF/FGF-2/FGFB/HBGF-2 |
Eflimrufusp Alfa |
|
FGF2 |
Fusion Protein |
|
GMP-Bios-INN-821 |
Pre-Made Efmarodocokin Alfa
Biosimilar, Fusion Protein targeting
IL22RA1/IL22R1 fused with human IGHG4 Fc
(Fragment constant): Recombinant therapeutic
protein targeting CRF2-9 |
Efmarodocokin Alfa |
|
IL22RA1/IL22R1 |
Fusion Protein |
|
GMP-Bios-INN-822 |
Pre-Made Efmitermant Alfa
Biosimilar, Fusion Protein targeting MSTN/GDF-8
fused with human IGHG2 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting GDF8/MSLHP |
Efmitermant Alfa |
|
MSTN/GDF-8 |
Fusion Protein |
|
GMP-Bios-INN-823 |
Pre-Made Efmoroctocog Alfa
Biosimilar, Fusion Protein targeting F8 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Efmoroctocog Alfa |
|
F8 |
Fusion Protein |
|
GMP-Bios-INN-826 |
Pre-Made Efruxifermin
Biosimilar, Fusion Protein targeting FGFR1 fused
with human IGHG1 Fc (Fragment constant) via a
peptidyl linker: Recombinant therapeutic protein
targeting
BFGFR/CD331/CEK/ECCL/FGFBR/FGFR-1/FLG/FLT-2/FLT2/HBGFR/HH2/HRTFDS/KAL2/N-SAM/OGD/bFGF-R-1
|
Efruxifermin |
|
FGFR1 |
Fusion Protein |
|
GMP-Bios-INN-827 |
Pre-Made Eftansomatropin Alfa
Biosimilar, Fusion Protein targeting GHR fused
with human IGHG4 Fc (Fragment constant):
Recombinant therapeutic protein targeting
GHBP/GHIP |
Eftansomatropin Alfa |
|
GHR |
Fusion Protein |
|
GMP-Bios-INN-828 |
Pre-Made Eftilagimod Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting MH2 fused with
human IGHG1 Fc (Fragment constant) |
Eftilagimod Alfa |
|
MH2 |
Fusion Protein |
|
GMP-Bios-INN-829 |
Pre-Made Eftozanermin Alfa
Biosimilar, Fusion Protein targeting
TNFRSF10B/TRAIL-R2 fused with human IGHG1 Fc
(Fragment constant): Recombinant therapeutic
protein targeting
CD262/DR5/KILLER/KILLER/DR5/TRICK2/TRICK2A/TRICK2B/TRICKB/ZTNFR9
|
Eftozanermin Alfa |
|
TNFRSF10B/TRAIL-R2 |
Fusion Protein |
|
GMP-Bios-INN-830 |
Pre-Made Eftrenonacog Alfa
Biosimilar, Fusion Protein targeting F9 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Eftrenonacog Alfa |
|
F9 |
Fusion Protein |
|
GMP-Bios-INN-831 |
Pre-Made Elsilimomab Biosimilar,
Whole Mab, Anti-Il6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Elsilimomab |
|
IL6 |
Whole mAb |
|
GMP-Bios-INN-832 |
Pre-Made Enapotamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Axl Antibody:
Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody
Drug Conjugate |
Enapotamab Vedotin |
|
AXL |
Whole mAb ADC |
|
GMP-Bios-INN-833 |
Pre-Made Enfortumab Vedotin
Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4
Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4
therapeutic antibody Drug Conjugate |
Enfortumab Vedotin |
|
PVRL4/NECTIN4 |
Whole mAb ADC |
|
GMP-Bios-INN-834 |
Pre-Made Enlimomab Biosimilar,
Whole Mab, Anti-ICAM1 Antibody:
Anti-BB2/CD54/P3.58 therapeutic antibody
|
Enlimomab |
|
ICAM1 |
Whole mAb |
|
GMP-Bios-INN-836 |
Pre-Made Ensomafusp Alfa
Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9
Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137
therapeutic antibody |
Ensomafusp Alfa |
|
CD19;TNFRSF9 |
Bispecific |
|
GMP-Bios-INN-837 |
Pre-Made Ensovibep biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting Severe acute respiratory
syndrome coronavirus 2 RBD |
Ensovibep |
|
Severe acute respiratory
syndrome coronavirus 2 RBD |
Recombinant Protein |
|
GMP-Bios-INN-838 |
Pre-Made Epitumomab Biosimilar,
Whole Mab, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Epitumomab |
|
MS4A1/CD20 |
Whole mAb |
|
GMP-Bios-INN-839 |
Pre-Made Epitumomab Cituxetan
Biosimilar, Radiolabelled Antibody, Anti-Muc1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Epitumomab Cituxetan |
|
MUC1 |
Radiolabelled antibody |
|
GMP-Bios-INN-840 |
Pre-Made Epoetin Alfa
biosimilar, Recombinant Protein: Recombinant
EPO(erythropoietin) therapeutic protein
targeting EPOR |
Epoetin Alfa |
|
EPOR |
Recombinant Protein |
|
GMP-Bios-INN-842 |
Pre-Made Eptacog Alfa (Actived
Biosimilar, Recombinant Protein targeting F7:
Recombinant therapeutic protein targeting
SPCA |
Eptacog Alfa (Actived) |
|
F7 |
Recombinant Protein |
|
GMP-Bios-INN-843 |
Pre-Made Eramkafusp Alfa
Biosimilar, Fusion Protein targeting MS4A1/CD20
fused with human IFNA2 (interferon alpha 2) via
a peptidyl linker: Recombinant therapeutic
protein targeting
B1/Bp35/CVID5/FMC7/LEU-16/S7 |
Eramkafusp Alfa |
|
MS4A1/CD20 |
Fusion Protein |
|
GMP-Bios-INN-844 |
Pre-Made Erlizumab Biosimilar,
Whole Mab, Anti-Itgb2 Antibody:
Anti-CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7
therapeutic antibody |
Erlizumab |
|
ITGB2 |
Whole mAb |
|
GMP-Bios-INN-845 |
Pre-Made Ertumaxomab Biosimilar,
Bispecific, Anti-Cd3E;Erbb2 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Ertumaxomab |
|
CD3E;ERBB2 |
Bispecific |
|
GMP-Bios-INN-846 |
Pre-Made Etanercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Etanercept |
|
TNF |
Fusion Protein |
|
GMP-Bios-INN-848 |
Pre-Made Exbivirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface
Antigen (Hbsag) [Hepatitis B Virus] therapeutic
antibody |
Exbivirumab |
|
HBV (hepatitis B virus)
surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
|
GMP-Bios-INN-849 |
Pre-Made Faralimomab Biosimilar,
Whole Mab, Anti-Ifna1 Antibody:
Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D
therapeutic antibody |
Faralimomab |
|
IFNA1 |
Whole mAb |
|
GMP-Bios-INN-850 |
Pre-Made Farletuzumab
Ecteribulin Biosimilar, Whole Mab Adc,
Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD
therapeutic antibody Drug Conjugate |
Farletuzumab Ecteribulin
|
|
FOLR1 |
Whole mAb ADC |
|
GMP-Bios-INN-851 |
Pre-Made Felvizumab Biosimilar,
Whole Mab: Anti-Rsv (Respiratory Syncytial
Virus) Glycoprotein F [Respiratory Syncytial
Virus] therapeutic antibody |
Felvizumab |
|
RSV (respiratory syncytial
virus) glycoprotein F [Respiratory syncytial virus] |
Whole mAb |
|
GMP-Bios-INN-852 |
Pre-Made Filgrastim Biosimilar,
Recombinant Protein targeting CSF3R: Recombinant
therapeutic protein targeting
CD114/GCSFR/SCN7 |
Filgrastim |
|
CSF3R/G-CSF-R |
Recombinant Protein |
|
GMP-Bios-INN-853 |
Pre-Made Gavilimomab Biosimilar,
Whole Mab, Anti-Bsg Antibody:
Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF
therapeutic antibody |
Gavilimomab |
|
BSG |
Whole mAb |
|
GMP-Bios-INN-855 |
Pre-Made Gemtuzumab Ozogamicin
Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Gemtuzumab Ozogamicin |
|
CD33 |
Whole mAb ADC |
|
GMP-Bios-INN-856 |
Pre-Made Glembatumumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Gpnmb Antibody:
Anti-HGFIN/NMB/PLCA3 therapeutic antibody Drug
Conjugate |
Glembatumumab Vedotin |
|
GPNMB |
Whole mAb ADC |
|
GMP-Bios-INN-857 |
Pre-Made Glucagon Biosimilar,
Recombinant Protein targeting GCGR: Recombinant
therapeutic protein targeting GGR/GL-R/MVAH
|
Glucagon |
|
GCGR |
Recombinant Protein |
|
GMP-Bios-INN-858 |
Pre-Made Grisnilimab Setaritox
Biosimilar, Whole Mab Adc, Anti-Cd7 Antibody:
Anti-GP40/LEU-9/TP41/Tp40 therapeutic antibody
Drug Conjugate |
Grisnilimab Setaritox |
|
CD7 |
Whole mAb ADC |
|
GMP-Bios-INN-859 |
Pre-Made Ibritumomab Tiuxetan
Biosimilar, Radiolabelled Antibody,
Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ibritumomab Tiuxetan |
|
MS4A1/CD20 |
Radiolabelled antibody |
|
GMP-Bios-INN-861 |
Pre-Made Igovomab Biosimilar,
Radiolabelled Antibody, Anti-Muc16 Antibody:
Anti-CA125 therapeutic antibody |
Igovomab |
|
MUC16 |
Radiolabelled antibody |
|
GMP-Bios-INN-862 |
Pre-Made Iladatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody Drug
Conjugate |
Iladatuzumab Vedotin |
|
CD79B |
Whole mAb ADC |
|
GMP-Bios-INN-863 |
Pre-Made Imciromab Biosimilar,
Radiolabelled Antibody: Anti-Myosin therapeutic
antibody |
Imciromab |
|
myosin |
Radiolabelled antibody |
|
GMP-Bios-INN-864 |
Pre-Made Inbakicept biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting IL15 fused with human IGHG1 Fc
(Fragment constant) |
Inbakicept |
|
IL15 |
Fusion Protein |
|
GMP-Bios-INN-865 |
Pre-Made Indatuximab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Sdc1 Antibody:
Anti-CD138/SDC/SYND1/syndecan therapeutic
antibody Drug Conjugate |
Indatuximab Ravtansine |
|
SDC1 |
Whole mAb ADC |
|
GMP-Bios-INN-866 |
Pre-Made Indusatumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Gucy2C Antibody:
Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic
antibody Drug Conjugate |
Indusatumab Vedotin |
|
GUCY2C |
Whole mAb ADC |
|
GMP-Bios-INN-867 |
Pre-Made Inolimomab Biosimilar,
Whole Mab, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Inolimomab |
|
IL2RA |
Whole mAb |
|
GMP-Bios-INN-868 |
Pre-Made Inotuzumab Ozogamicin
Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug
Conjugate |
Inotuzumab Ozogamicin |
|
CD22 |
Whole mAb ADC |
|
GMP-Bios-INN-869 |
Pre-Made Insulin Biosimilar,
Recombinant Protein targeting INSR: Recombinant
therapeutic protein targeting CD220/HHF5
|
Insulin |
|
INSR |
Recombinant Protein |
|
GMP-Bios-INN-870 |
Pre-Made Insulin Efsitora Alfa
Biosimilar, Fusion Protein targeting INSR fused
with human IGHG2 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD220/HHF5 |
Insulin Efsitora Alfa |
|
INSR |
Fusion Protein |
|
GMP-Bios-INN-871 |
Pre-Made Interferon Alfa
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Alfa |
|
IFNAR1 |
Recombinant Protein |
|
GMP-Bios-INN-872 |
Pre-Made Interferon Alfacon-1
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Alfacon-1 |
|
IFNAR1 |
Recombinant Protein |
|
GMP-Bios-INN-873 |
Pre-Made Interferon Beta
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Beta |
|
IFNAR1 |
Recombinant Protein |
|
GMP-Bios-INN-874 |
Pre-Made Interferon Gamma
Biosimilar, Recombinant Protein targeting
IFNGR1: Recombinant therapeutic protein
targeting CD119/IFNGR/IMD27A/IMD27B |
Interferon Gamma |
|
IFNGR1 |
Recombinant Protein |
|
GMP-Bios-INN-875 |
Pre-Made Iodine (131I)
Apamistamab Biosimilar, Radiolabelled Antibody,
Anti-Ptprc Antibody:
Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200
therapeutic antibody |
Iodine (131I) Apamistamab
|
|
PTPRC |
Radiolabelled antibody |
|
GMP-Bios-INN-876 |
Pre-Made Iodine (131I)
Derlotuximab Biotin Biosimilar, Radiolabelled
Antibody: Anti-Dna/Histone (H1) Complex
therapeutic antibody |
Iodine (131I) Derlotuximab
Biotin |
|
DNA;histone (H1) complex
|
Radiolabelled antibody |
|
GMP-Bios-INN-877 |
Pre-Made Iodo (124I)
Girentuximab Biosimilar, Radiolabelled Antibody,
Anti-CA9/CA-IX Antibody: Anti-CAIX/MN
therapeutic antibody |
Iodo (124I) Girentuximab
|
|
CA9/CA-IX |
Radiolabelled antibody |
|
GMP-Bios-INN-878 |
Pre-Made Ipafricept biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting Wnt fused with human IGHG1 Fc
(Fragment constant) |
Ipafricept |
|
Wnt |
Fusion Protein |
|
GMP-Bios-INN-881 |
Pre-Made Keliximab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Keliximab |
|
CD4 |
Whole mAb |
|
GMP-Bios-INN-882 |
Pre-Made Labetuzumab Govitecan
Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody Drug
Conjugate |
Labetuzumab Govitecan |
|
CEACAM5/CD66e |
Whole mAb ADC |
|
GMP-Bios-INN-883 |
Pre-Made Ladiratuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slc39A6
Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic
antibody Drug Conjugate |
Ladiratuzumab Vedotin |
|
SLC39A6 |
Whole mAb ADC |
|
GMP-Bios-INN-884 |
Pre-Made Laprituximab Emtansine
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Laprituximab Emtansine |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-INN-885 |
Pre-Made Ledelabricin Alfa
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting PRG4(PROTEOGLYCAN
4) |
Ledelabricin Alfa |
|
PRG4 (PROTEOGLYCAN 4)
|
Recombinant Protein |
|
GMP-Bios-INN-886 |
Pre-Made Lemalesomab Biosimilar,
Whole Mab: Anti-Nca-90 (Nonspecific Cross-
Reacting Antigens 90Kda Glycoproteins,
Granulocyte Cell Antigen) [human] therapeutic
antibody |
Lemalesomab |
|
NCA-90 (nonspecific cross-
reacting antigens 90kDa glycoproteins, granulocyte cell
antigen) [human] |
Whole mAb |
|
GMP-Bios-INN-887 |
Pre-Made Lenercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Lenercept |
|
TNF |
Fusion Protein |
|
GMP-Bios-INN-888 |
Pre-Made Lepunafusp Alfa
Biosimilar, Fusion Protein targeting TFRC fused
with human IDUA (iduronidase, alpha-L-) isoform
1 via a peptidyl linker: Recombinant therapeutic
protein targeting
CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 |
Lepunafusp Alfa |
|
TFRC |
Fusion Protein |
|
GMP-Bios-INN-889 |
Pre-Made Lerdelimumab
Biosimilar, Whole Mab, Anti-Tgfb2 Antibody:
Anti-G-TSF/LDS4/TGF-beta2 therapeutic
antibody |
Lerdelimumab |
|
TGFB2 |
Whole mAb |
|
GMP-Bios-INN-890 |
Pre-Made Lerodalcibep
Biosimilar, Fusion Protein targeting PCSK9 fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
|
Lerodalcibep |
|
PCSK9 |
Fusion Protein |
|
GMP-Bios-INN-892 |
Pre-Made Libivirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface
Antigen (Hbsag) [Hepatitis B Virus] therapeutic
antibody |
Libivirumab |
|
HBV (hepatitis B virus)
surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
|
GMP-Bios-INN-893 |
Pre-Made Lifastuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slc34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody Drug Conjugate |
Lifastuzumab Vedotin |
|
SLC34A2 |
Whole mAb ADC |
|
GMP-Bios-INN-896 |
Pre-Made Loncastuximab Tesirine
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Loncastuximab Tesirine |
|
CD19 |
Whole mAb ADC |
|
GMP-Bios-INN-897 |
Pre-Made Lonigutamab Ugodotin
Biosimilar, Whole Mab Adc, Anti-Igf1R Antibody:
Anti-CD221/IGFIR/IGFR/JTK13 therapeutic antibody
Drug Conjugate |
Lonigutamab Ugodotin |
|
IGF1R |
Whole mAb ADC |
|
GMP-Bios-INN-898 |
Pre-Made Lorukafusp Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting ganglioside GD2
fused with human IL2 (interleukin 2, IL-2)
|
Lorukafusp Alfa |
|
ganglioside GD2 |
Fusion Protein |
|
GMP-Bios-INN-899 |
Pre-Made Lorvotuzumab Mertansine
Biosimilar, Whole Mab Adc, Anti-Ncam1 Antibody:
Anti-CD56/MSK39/NCAM therapeutic antibody Drug
Conjugate |
Lorvotuzumab Mertansine |
|
NCAM1 |
Whole mAb ADC |
|
GMP-Bios-INN-900 |
Pre-Made Losatuxizumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Losatuxizumab Vedotin |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-INN-902 |
Pre-Made Lupartumab Amadotin
Biosimilar, Whole Mab Adc, Anti-Lypd3 Antibody:
Anti-C4.4A therapeutic antibody Drug
Conjugate |
Lupartumab Amadotin |
|
LYPD3 |
Whole mAb ADC |
|
GMP-Bios-INN-903 |
Pre-Made Luspatercept
Biosimilar, Fusion Protein targeting GDF11 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BMP-11/BMP11/VHO |
Luspatercept |
|
GDF11 |
Fusion Protein |
|
GMP-Bios-INN-904 |
Pre-Made Lutetium (177Lu)
Lilotomab Satetraxetan Biosimilar, Radiolabelled
Antibody, Anti-Cd37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Lutetium (177Lu) Lilotomab
Satetraxetan |
|
CD37 |
Radiolabelled antibody |
|
GMP-Bios-INN-905 |
Pre-Made Mapatumumab Biosimilar,
Whole Mab, Anti-TNFRSF10A/TRAIL-R1 Antibody:
Anti-APO2/CD261/DR4/TRAILR-1/TRAILR1 therapeutic
antibody |
Mapatumumab |
|
TNFRSF10A/TRAIL-R1 |
Whole mAb |
|
GMP-Bios-INN-906 |
Pre-Made Maslimomab Biosimilar,
Whole Mab: Anti-T Cell Receptor (Tr, Tr
Alpha_Beta) [human] therapeutic antibody
|
Maslimomab |
|
T cell receptor (TR, TR
alpha_beta) [human] |
Whole mAb |
|
GMP-Bios-INN-907 |
Pre-Made Melredableukin Alfa
Biosimilar, Fusion Protein targeting IL2RA fused
with human IL2 (interleukin 2, IL-2) via a
peptidyl linker: Recombinant therapeutic protein
targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55
|
Melredableukin Alfa |
|
IL2RA |
Fusion Protein |
|
GMP-Bios-INN-908 |
Pre-Made Metelimumab Biosimilar,
Whole Mab, Anti-Tgfb1 Antibody:
Anti-CED/DPD1/IBDIMDE/LAP therapeutic
antibody |
Metelimumab |
|
TGFB1 |
Whole mAb |
|
GMP-Bios-INN-909 |
Pre-Made Minretumomab
Biosimilar, Whole Mab: Anti-Tag-72 therapeutic
antibody |
Minretumomab |
|
TAG-72 |
Whole mAb |
|
GMP-Bios-INN-910 |
Pre-Made Mipasetamab Uzoptirine
Biosimilar, Whole Mab Adc, Anti-Axl Antibody:
Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody
Drug Conjugate |
Mipasetamab Uzoptirine |
|
AXL |
Whole mAb ADC |
|
GMP-Bios-INN-913 |
Pre-Made Mirococept biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting C3b/C4b |
Mirococept |
|
C3b/CO3;C4b |
Recombinant Protein |
|
GMP-Bios-INN-914 |
Pre-Made Mirvetuximab
Soravtansine Biosimilar, Whole Mab Adc,
Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD
therapeutic antibody Drug Conjugate |
Mirvetuximab Soravtansine
|
|
FOLR1 |
Whole mAb ADC |
|
GMP-Bios-INN-915 |
Pre-Made Mirzotamab Clezutoclax
Biosimilar, Whole Mab Adc, Anti-Cd276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody Drug Conjugate |
Mirzotamab Clezutoclax |
|
CD276 |
Whole mAb ADC |
|
GMP-Bios-INN-916 |
Pre-Made Mitumomab Biosimilar,
Whole Mab: Anti-Ganglioside Gd3 therapeutic
antibody |
Mitumomab |
|
ganglioside GD3 |
Whole mAb |
|
GMP-Bios-INN-917 |
Pre-Made Modakafusp Alfa
Biosimilar, Fusion Protein targeting CD38 fused
with human IFNA2 (interferon alpha 2) *b
(R46,H57) 24-188: Recombinant therapeutic
protein targeting ADPRC 1/ADPRC1 |
Modakafusp Alfa |
|
CD38 |
Fusion Protein |
|
GMP-Bios-INN-918 |
Pre-Made Morolimumab Biosimilar,
Whole Mab, Anti-Rhd Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Morolimumab |
|
RHD |
Whole mAb |
|
GMP-Bios-INN-920 |
Pre-Made Moxetumomab Pasudotox
biosimilar, Fusion Protein,
Moxetumomab-Anti-CD22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody fused
with Pseudomonas aeruginosa exotoxin A |
Moxetumomab Pasudotox |
|
CD22 |
Fusion Protein |
|
GMP-Bios-INN-921 |
Pre-Made Muromonab-Cd3
3Iosimilar, Whole Mab, Anti-Cd3E Antibody:
Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic
antibody |
Muromonab-Cd3 |
|
CD3E |
Whole mAb |
|
GMP-Bios-INN-922 |
Pre-Made Nacolomab Tafenatox
biosimilar, Fusion Protein, Nacolomab-Anti-MUC1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody fused with Staphylococcus
aureus enterotoxin A |
Nacolomab Tafenatox |
|
MUC1 |
Fusion Protein |
|
GMP-Bios-INN-923 |
Pre-Made Naptumomab Estafenatox
biosimilar, Fusion Protein, Naptumomab-Anti-TPBG
Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic
antibody fused with Staphylococcus aureus
enterotoxin E SEA/E120 superantigen
(synthetic) |
Naptumomab Estafenatox |
|
TPBG |
Fusion Protein |
|
GMP-Bios-INN-924 |
Pre-Made Naratuximab Emtansine
Biosimilar, Whole Mab Adc, Anti-Cd37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody Drug
Conjugate |
Naratuximab Emtansine |
|
CD37 |
Whole mAb ADC |
|
GMP-Bios-INN-925 |
Pre-Made Nebacumab Biosimilar,
Whole Mab: Anti-Endotoxin (Lipid A, Domain Of
Lipopolyaccharide, Lps) [Gram Negative Bacteria]
therapeutic antibody |
Nebacumab |
|
endotoxin (lipid A, domain
of lipopolyaccharide, LPS) [gram negative bacteria] |
Whole mAb |
|
GMP-Bios-INN-926 |
Pre-Made Nemvaleukin Alfa
Biosimilar, Fusion Protein targeting IL2RA fused
with human IL2RA (interleukin 2 receptor alpha
subunit, IL-2RA, TAC, p55, CD25) 139-303
(1-165): Recombinant therapeutic protein
targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55
|
Nemvaleukin Alfa |
|
IL2RA |
Fusion Protein |
|
GMP-Bios-INN-927 |
Pre-Made Nerelimomab Biosimilar,
Whole Mab, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Nerelimomab |
|
TNF |
Whole mAb |
|
GMP-Bios-INN-928 |
Pre-Made Nogapendekin Alfa
Biosimilar, Recombinant Protein targeting
IL15RA: Recombinant therapeutic protein
targeting CD215 |
Nogapendekin Alfa |
|
IL15RA |
Recombinant Protein |
|
GMP-Bios-INN-929 |
Pre-Made Nonacog Gamma
Biosimilar, Recombinant Protein targeting F9:
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Nonacog Gamma |
|
F9 |
Recombinant Protein |
|
GMP-Bios-INN-931 |
Pre-Made Odulimomab Biosimilar,
Fab Fusion, Anti-Itgal Antibody:
Anti-CD11A/LFA-1/LFA1A therapeutic antibody
|
Odulimomab |
|
ITGAL |
Fab Fusion |
|
GMP-Bios-INN-932 |
Pre-Made Olamkicept Biosimilar,
Fusion Protein targeting IL6 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
|
Olamkicept |
|
IL6 |
Fusion Protein |
|
GMP-Bios-INN-934 |
Pre-Made Omfiloctocog Alfa
Biosimilar, Recombinant Protein targeting F8:
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Omfiloctocog Alfa |
|
F8 |
Recombinant Protein |
|
GMP-Bios-INN-935 |
Pre-Made Onercept Biosimilar,
Recombinant Protein targeting TNF: Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Onercept |
|
TNF |
Recombinant Protein |
|
GMP-Bios-INN-936 |
Pre-Made Onfekafusp Alfa
Biosimilar, Fusion Protein targeting FN/FN1
fused with human TNF (tumor necrosis factor
(TNF) superfamily member 2, TNFSF2, TNF-alpha,
TNFA) - trimer: Recombinant therapeutic protein
targeting
CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF
|
Onfekafusp Alfa |
|
FN/FN1 |
Fusion Protein |
|
GMP-Bios-INN-937 |
Pre-Made Ontorpacept Biosimilar,
Fusion Protein targeting CD47 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting IAP/MER6/OA3
|
Ontorpacept |
|
CD47 |
Fusion Protein |
|
GMP-Bios-INN-938 |
Pre-Made Opinercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Opinercept |
|
TNF |
Fusion Protein |
|
GMP-Bios-INN-939 |
Pre-Made Oportuzumab Monatox
biosimilar, Fusion Protein,
Oportuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with Pseudomonas
aeruginosa exotoxin A |
Oportuzumab Monatox |
|
EPCAM |
Fusion Protein |
|
GMP-Bios-INN-940 |
Pre-Made Oregovomab Biosimilar,
Whole Mab, Anti-Muc16 Antibody: Anti-CA125
therapeutic antibody |
Oregovomab |
|
MUC16 |
Whole mAb |
|
GMP-Bios-INN-941 |
Pre-Made Oreptacog Alfa
Biosimilar, Recombinant Protein targeting F7:
Recombinant therapeutic protein targeting
SPCA |
Oreptacog Alfa |
|
F7 |
Recombinant Protein |
|
GMP-Bios-INN-943 |
Pre-Made Pabinafusp Alfa
Biosimilar, Fusion Protein targeting TFRC fused
with iduronate-2-sulfatase: Recombinant
therapeutic protein targeting
CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 |
Pabinafusp Alfa |
|
TFRC |
Fusion Protein |
|
GMP-Bios-INN-944 |
Pre-Made Pagibaximab Biosimilar,
Whole Mab: Anti-Staphylococcus Epidermidis
Lipoteichoic Acid therapeutic antibody |
Pagibaximab |
|
Staphylococcus epidermidis
lipoteichoic acid |
Whole mAb |
|
GMP-Bios-INN-945 |
Pre-Made Pascolizumab
Biosimilar, Whole Mab, Anti-Il4 Antibody:
Anti-BCGF-1/BCGF1/BSF-1/BSF1/IL-4 therapeutic
antibody |
Pascolizumab |
|
IL4 |
Whole mAb |
|
GMP-Bios-INN-946 |
Pre-Made Patritumab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody Drug Conjugate |
Patritumab Deruxtecan |
|
ERBB3/Erbb-3 |
Whole mAb ADC |
|
GMP-Bios-INN-958 |
Pre-Made Pelgifatamab Corixetan
Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody Drug Conjugate |
Pelgifatamab Corixetan |
|
FOLH1/GCPII |
Whole mAb ADC |
|
GMP-Bios-INN-959 |
Pre-Made Pexelizumab Biosimilar,
Scfv, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB
therapeutic antibody |
Pexelizumab |
|
C5/CO5 |
scFv |
|
GMP-Bios-INN-960 |
Pre-Made Pinatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug
Conjugate |
Pinatuzumab Vedotin |
|
CD22 |
Whole mAb ADC |
|
GMP-Bios-INN-961 |
Pre-Made Pivekimab Sunirine
Biosimilar, Whole Mab Adc, Anti-Il3Ra Antibody:
Anti-CD123/IL3R/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody Drug Conjugate |
Pivekimab Sunirine |
|
IL3RA |
Whole mAb ADC |
|
GMP-Bios-INN-962 |
Pre-Made Polatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody Drug
Conjugate |
Polatuzumab Vedotin |
|
CD79B |
Whole mAb ADC |
|
GMP-Bios-INN-963 |
Pre-Made Pozelimab Biosimilar,
Whole Mab, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Pozelimab |
|
C5/CO5 |
Whole mAb |
|
GMP-Bios-INN-964 |
Pre-Made Praluzatamab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Alcam Antibody:
Anti-CD166/MEMD therapeutic antibody Drug
Conjugate |
Praluzatamab Ravtansine |
|
ALCAM |
Whole mAb ADC |
|
GMP-Bios-INN-965 |
Pre-Made Priliximab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Priliximab |
|
CD4 |
Whole mAb |
|
GMP-Bios-INN-966 |
Pre-Made Pritumumab Biosimilar,
Whole Mab: Anti-Vim/Vimentin therapeutic
antibody |
Pritumumab |
|
VIM/Vimentin
|
Whole mAb |
|
GMP-Bios-INN-967 |
Pre-Made Ramatercept Biosimilar,
Fusion Protein targeting MSTN/GDF-8 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting GDF8/MSLHP
|
Ramatercept |
|
MSTN/GDF-8 |
Fusion Protein |
|
GMP-Bios-INN-968 |
Pre-Made Raxibacumab Biosimilar,
Whole Mab: Anti-Anthrax Protective Antigen (Pa)
[Bacillus Anthracis] therapeutic antibody
|
Raxibacumab |
|
anthrax protective antigen
(PA) [Bacillus anthracis] |
Whole mAb |
|
GMP-Bios-INN-969 |
Pre-Made Recifercept biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting FGF |
Recifercept |
|
FGF |
Recombinant Protein |
|
GMP-Bios-INN-970 |
Pre-Made Regavirumab Biosimilar,
Whole Mab: Anti-Hcmv (Human Cytomegalovirus)
Envelope Glycoprotein B (Gb) [Human
Betaherpesvirus 5] therapeutic antibody |
Regavirumab |
|
HCMV (human cytomegalovirus)
envelope glycoprotein B (gB) [Human betaherpesvirus 5]
|
Whole mAb |
|
GMP-Bios-INN-972 |
Pre-Made Retlirafusp Alfa
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human TGFBR2 (transforming growth
factor beta receptor 2) extracellular fragment
(20-136) via a peptidyl linker: Recombinant
therapeutic protein targeting
B7-H/B7H1/PDCD1L1/PDCD1LG1 |
Retlirafusp Alfa |
|
CD274/PD-L1 |
Fusion Protein |
|
GMP-Bios-INN-973 |
Pre-Made Rilonacept Biosimilar,
Fusion Protein targeting IL1B fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
IL-1/IL1-BETA/IL1F2/IL1beta |
Rilonacept |
|
IL1B |
Fusion Protein |
|
GMP-Bios-INN-974 |
Pre-Made Ripafollitropin Alfa
(Bovine) biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting Bostau FSHR fused
with CTP (C-terminal peptide of hCG) |
Ripafollitropin Alfa
(Bovine) |
|
Bostau FSHR |
Fusion Protein |
|
GMP-Bios-INN-976 |
Pre-Made Rolinsatamab Talirine
Biosimilar, Whole Mab Adc, Anti-Prlr Antibody:
Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic
antibody Drug Conjugate |
Rolinsatamab Talirine |
|
PRLR |
Whole mAb ADC |
|
GMP-Bios-INN-977 |
Pre-Made Romiplostim Biosimilar,
Fusion Protein targeting MPL fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
C-MPL/CD110/MPLV/THCYT2/THPOR/TPOR |
Romiplostim |
|
MPL |
Fusion Protein |
|
GMP-Bios-INN-979 |
Pre-Made Rosopatamab Tetraxetan
Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody Drug Conjugate |
Rosopatamab Tetraxetan |
|
FOLH1/GCPII |
Whole mAb ADC |
|
GMP-Bios-INN-980 |
Pre-Made Rovalpituzumab Tesirine
Biosimilar, Whole Mab Adc, Anti-Dll3 Antibody:
Anti-SCDO1 therapeutic antibody Drug
Conjugate |
Rovalpituzumab Tesirine |
|
DLL3 |
Whole mAb ADC |
|
GMP-Bios-INN-981 |
Pre-Made Rovelizumab Biosimilar,
Bispecific, Anti-Itgal;Itgb2 Antibody:
Anti-CD11A/LFA-1/LFA1A;CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7
therapeutic antibody |
Rovelizumab |
|
ITGAL;ITGB2 |
Bispecific |
|
GMP-Bios-INN-982 |
Pre-Made Rozibafusp Alfa
Biosimilar, Fusion Protein targeting ICOS fused
with human TNFSF13B (tumor necrosis factor (TNF)
superfamily member 13B, BAFF, THANK, TALL1,
TALL-1, BLYS, BLyS, B cell activating factor, B
lymphocyte activator, CD257): Recombinant
therapeutic protein targeting
AILIM/CD278/CVID1 |
Rozibafusp Alfa |
|
ICOS |
Fusion Protein |
|
GMP-Bios-INN-983 |
Pre-Made Sacituzumab Govitecan
Biosimilar, Whole Mab Adc, Anti-Tacstd2
Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody Drug Conjugate |
Sacituzumab Govitecan |
|
TACSTD2 |
Whole mAb ADC |
|
GMP-Bios-INN-985 |
Pre-Made Samrotamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Lrrc15 Antibody:
Anti-LIB therapeutic antibody Drug Conjugate
|
Samrotamab Vedotin |
|
LRRC15 |
Whole mAb ADC |
|
GMP-Bios-INN-986 |
Pre-Made Sargramostim
Biosimilar, Recombinant Protein targeting
CSF2RA: Recombinant therapeutic protein
targeting
CD116/CDw116/CSF2R/CSF2RAX/CSF2RAY/CSF2RX/CSF2RY/GM-CSF-R-alpha/GMCSFR/GMCSFR-alpha/GMR/GMR-alpha/SMDP4/alphaGMR
|
Sargramostim |
|
CSF2RA |
Recombinant Protein |
|
GMP-Bios-INN-987 |
Pre-Made Satumomab Biosimilar,
Radiolabelled Antibody: Anti-Tag-72 therapeutic
antibody |
Satumomab |
|
TAG-72 |
Radiolabelled antibody |
|
GMP-Bios-INN-988 |
Pre-Made Serclutamab Talirine
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Serclutamab Talirine |
|
EGFR |
Whole mAb ADC |
|
GMP-Bios-INN-989 |
Pre-Made Sevirumab Biosimilar,
Whole Mab: Anti-Hcmv (Human Cytomegalovirus)
Envelope Glycoprotein H (Gh) [Human
Betaherpesvirus 5] therapeutic antibody |
Sevirumab |
|
HCMV (human cytomegalovirus)
envelope glycoprotein H (gH) [Human betaherpesvirus 5]
|
Whole mAb |
|
GMP-Bios-INN-990 |
Pre-Made Sibrotuzumab
Biosimilar, Whole Mab, Anti-Fap Antibody:
Anti-DPPIV/FAPA/FAPalpha/SIMP therapeutic
antibody |
Sibrotuzumab |
|
FAP |
Whole mAb |
|
GMP-Bios-INN-991 |
Pre-Made Simlukafusp Alfa
Biosimilar, Fusion Protein targeting FAP fused
with human IL2 (interleukin 2, IL-2):
Recombinant therapeutic protein targeting
DPPIV/FAPA/FAPalpha/SIMP |
Simlukafusp Alfa |
|
FAP |
Fusion Protein |
|
GMP-Bios-INN-992 |
Pre-Made Siplizumab Biosimilar,
Whole Mab, Anti-Cd2 Antibody:
Anti-LFA-2/SRBC/T11 therapeutic antibody
|
Siplizumab |
|
CD2 |
Whole mAb |
|
GMP-Bios-INN-993 |
Pre-Made Sirtratumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slitrk6
Antibody: Anti-DFNMYP therapeutic antibody Drug
Conjugate |
Sirtratumab Vedotin |
|
SLITRK6 |
Whole mAb ADC |
|
GMP-Bios-INN-994 |
Pre-Made Sofituzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Muc16 Antibody:
Anti-CA125 therapeutic antibody Drug
Conjugate |
Sofituzumab Vedotin |
|
MUC16 |
Whole mAb ADC |
|
GMP-Bios-INN-995 |
Pre-Made Somatropin Biosimilar,
Recombinant Protein targeting GHR: Recombinant
therapeutic protein targeting GHBP/GHIP |
Somatropin |
|
GHR |
Recombinant Protein |
|
GMP-Bios-INN-996 |
Pre-Made Sonelokimab Biosimilar,
Bispecific, Anti-ALB;IL17A/IL17;IL17F Antibody:
Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1
therapeutic antibody |
Sonelokimab |
|
ALB;IL17A/IL17;IL17F |
Bispecific |
|
GMP-Bios-INN-997 |
Pre-Made Sontuzumab Biosimilar,
Whole Mab, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Sontuzumab |
|
MUC1 |
Whole mAb |
|
GMP-Bios-INN-998 |
Pre-Made Sotatercept Biosimilar,
Fusion Protein targeting INHBA/ACT fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting EDF/FRP |
Sotatercept |
|
INHBA/ACT |
Fusion Protein |
|
GMP-Bios-INN-999 |
Pre-Made Stamulumab Biosimilar,
Whole Mab, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Stamulumab |
|
MSTN/GDF-8 |
Whole mAb |
|
GMP-Bios-INN-1000 |
Pre-Made Sulesomab Biosimilar,
Radiolabelled Antibody: Anti-Nca-90 (Nonspecific
Cross- Reacting Antigens 90Kda Glycoproteins,
Granulocyte Cell Antigen) therapeutic
antibody |
Sulesomab |
|
NCA-90 (nonspecific cross-
reacting antigens 90kDa glycoproteins, granulocyte cell
antigen) |
Radiolabelled antibody |
|
GMP-Bios-INN-1001 |
Pre-Made Tabituximab Barzuxetan
Biosimilar, Whole Mab Adc, Anti-Fzd10 Antibody:
Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic
antibody Drug Conjugate |
Tabituximab Barzuxetan |
|
FZD10 |
Whole mAb ADC |
|
GMP-Bios-INN-1003 |
Pre-Made Tagraxofusp biosimilar,
Protein drug conjugate: Recombinant therapeutic
protein drug conjugate |
Tagraxofusp |
|
IL3 |
Protein drug conjugate |
|
GMP-Bios-INN-1004 |
Pre-Made Taldefgrobep Alfa
Biosimilar, Fusion Protein targeting MSTN/GDF-8
fused with human IGHG1 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting GDF8/MSLHP |
Taldefgrobep Alfa |
|
MSTN/GDF-8 |
Fusion Protein |
|
GMP-Bios-INN-1005 |
Pre-Made Talizumab Biosimilar,
Whole Mab: Anti-Ighe/IgE therapeutic
antibody |
Talizumab |
|
Ighe/IgE
|
Whole mAb |
|
GMP-Bios-INN-1006 |
Pre-Made Tamrintamab Pamozirine
Biosimilar, Whole Mab Adc, Anti-Dpep3 Antibody:
Anti-MBD3 therapeutic antibody Drug
Conjugate |
Tamrintamab Pamozirine |
|
DPEP3 |
Whole mAb ADC |
|
GMP-Bios-INN-1007 |
Pre-Made Tanfanercept
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting TNF-α receptor
|
Tanfanercept |
|
TNF-α receptor |
Recombinant Protein |
|
GMP-Bios-INN-1008 |
Pre-Made Taplitumomab Paptox
biosimilar, Fusion Protein,
Taplitumomab-Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody s |
Taplitumomab Paptox |
|
CD19 |
Fusion Protein |
|
GMP-Bios-INN-1009 |
Pre-Made Tarcocimab Biosimilar,
Whole Mab, Anti-Vegfa Antibody:
Anti-MVCD1/VEGF/VPF therapeutic antibody
|
Tarcocimab |
|
VEGFA |
Whole mAb |
|
GMP-Bios-INN-1011 |
Pre-Made Technetium (99Mtc)
Fanolesomab Biosimilar, Radiolabelled Antibody,
Anti-Cd15 Antibody:
Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1
therapeutic antibody |
Technetium (99Mtc)
Fanolesomab |
|
CD15 |
Radiolabelled antibody |
|
GMP-Bios-INN-1012 |
Pre-Made Technetium (99Mtc)
Nofetumomab Merpentan Biosimilar, Radiolabelled
Antibody: Anti-MS4A1/CD20 therapeutic
antibody |
Technetium (99Mtc)
Nofetumomab Merpentan |
|
MS4A1/CD20 |
Radiolabelled antibody |
|
GMP-Bios-INN-1013 |
Pre-Made Technetium (99Mtc)
Pintumomab Biosimilar, Radiolabelled Antibody:
Anti-Human Adenocarcinoma Antigen therapeutic
antibody |
Technetium (99Mtc)
Pintumomab |
|
human adenocarcinoma antigen
|
Radiolabelled antibody |
|
GMP-Bios-INN-1015 |
Pre-Made Tefibazumab Biosimilar,
Whole Mab: Anti-Staphylococcus Aureus
Fibrin-Binding Surface Epitope Clumping Factor A
(Clfa) therapeutic antibody |
Tefibazumab |
|
Staphylococcus aureus
fibrin-binding surface epitope clumping factor A (ClfA)
|
Whole mAb |
|
GMP-Bios-INN-1016 |
Pre-Made Telimomab Aritox
Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody:
Anti-LEU1/T1 therapeutic antibody |
Telimomab Aritox |
|
CD5 |
ADC |
|
GMP-Bios-INN-1017 |
Pre-Made Telisotuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Met Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody Drug Conjugate |
Telisotuzumab Vedotin |
|
MET |
Whole mAb ADC |
|
GMP-Bios-INN-1018 |
Pre-Made Telitacicept
Biosimilar, Fusion Protein targeting TNFSF13B
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Telitacicept |
|
TNFSF13B |
Fusion Protein |
|
GMP-Bios-INN-1019 |
Pre-Made Teneliximab Biosimilar,
Whole Mab, Anti-Cd40 Antibody:
Anti-Bp50/CDW40/TNFRSF5/p50 therapeutic
antibody |
Teneliximab |
|
CD40 |
Whole mAb |
|
GMP-Bios-INN-1020 |
Pre-Made Tengonermin Biosimilar,
Fusion Protein targeting ANPEP fused with human
TNF (tumor necrosis factor (TNF) superfamily
member 2, TNFSF2, TNF-alpha, TNFA): Recombinant
therapeutic protein targeting
APN/CD13/GP150/LAP1/P150/PEPN |
Tengonermin |
|
ANPEP |
Fusion Protein |
|
GMP-Bios-INN-1024 |
Pre-Made Tisotumab Vedotin
Biosimilar, Whole Mab Adc, Anti-F3 Antibody:
Anti-CD142/TF/TFA therapeutic antibody Drug
Conjugate |
Tisotumab Vedotin |
|
F3 |
Whole mAb ADC |
|
GMP-Bios-INN-1025 |
Pre-Made Topsalysin biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting proaerolysin fused with
hexahistidine |
Topsalysin |
|
proaerolysin |
Fusion Protein |
|
GMP-Bios-INN-1026 |
Pre-Made Toralizumab Biosimilar,
Whole Mab, Anti-Cd40Lg Antibody:
Anti-CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L
therapeutic antibody |
Toralizumab |
|
CD40LG |
Whole mAb |
|
GMP-Bios-INN-1027 |
Pre-Made Torapsel Biosimilar,
Fusion Protein targeting SELP fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
|
Torapsel |
|
SELP |
Fusion Protein |
|
GMP-Bios-INN-1028 |
Pre-Made Tositumomab Biosimilar,
Radiolabelled Antibody, Anti-MS4A1/CD20
Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Tositumomab |
|
MS4A1/CD20 |
Radiolabelled antibody |
|
GMP-Bios-INN-1029 |
Pre-Made Transferrin Aldifitox
Biosimilar, Protein Drug Conjugate: Recombinant
Therapeutic Protein Drug Conjugate |
Transferrin Aldifitox |
|
transferrin |
Protein drug conjugate |
|
GMP-Bios-INN-1030 |
Pre-Made Trastuzumab Beta
Biosimilar, Whole Mab, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody |
Trastuzumab Beta |
|
ERBB2/HER2 |
Whole mAb |
|
GMP-Bios-INN-1031 |
Pre-Made Trastuzumab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Deruxtecan |
|
ERBB2/HER2 |
Whole mAb ADC |
|
GMP-Bios-INN-1032 |
Pre-Made Trastuzumab
Duocarmazine Biosimilar, Whole Mab Adc,
Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Duocarmazine
|
|
ERBB2/HER2 |
Whole mAb ADC |
|
GMP-Bios-INN-1033 |
Pre-Made Trastuzumab Emtansine
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Emtansine |
|
ERBB2/HER2 |
Whole mAb ADC |
|
GMP-Bios-INN-1034 |
Pre-Made Trebananib Biosimilar,
Fusion Protein targeting ANGPT2 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
AGPT2/ANG2/LMPHM10 |
Trebananib |
|
ANGPT2 |
Fusion Protein |
|
GMP-Bios-INN-1035 |
Pre-Made Tucotuzumab Celmoleukin
biosimilar, Fusion Protein,
Tucotuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with human IL2
(interleukin 2, IL-2) Pr21-153 |
Tucotuzumab Celmoleukin |
|
EPCAM |
Fusion Protein |
|
GMP-Bios-INN-1036 |
Pre-Made Tulinercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Tulinercept |
|
TNF |
Fusion Protein |
|
GMP-Bios-INN-1037 |
Pre-Made Tusamitamab Ravtansine
Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody Drug
Conjugate |
Tusamitamab Ravtansine |
|
CEACAM5/CD66e |
Whole mAb ADC |
|
GMP-Bios-INN-1038 |
Pre-Made Tuvirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus)
[Hepatitis B Virus] therapeutic antibody
|
Tuvirumab |
|
HBV (hepatitis B virus)
[Hepatitis B virus] |
Whole mAb |
|
GMP-Bios-INN-1039 |
Pre-Made Upifitamab Rilsodotin
Biosimilar, Whole Mab Adc, Anti-Slc34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody Drug Conjugate |
Upifitamab Rilsodotin |
|
SLC34A2 |
Whole mAb ADC |
|
GMP-Bios-INN-1040 |
Pre-Made Urtoxazumab Biosimilar,
Whole Mab: Anti-E.Coli Shiga-Like Toxin 2 B
Subunit therapeutic antibody |
Urtoxazumab |
|
E.coli Shiga-like toxin 2 B
subunit |
Whole mAb |
|
GMP-Bios-INN-1042 |
Pre-Made Vadastuximab Talirine
Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Vadastuximab Talirine |
|
CD33 |
Whole mAb ADC |
|
GMP-Bios-INN-1043 |
Pre-Made Valanafusp Alfa
Biosimilar, Fusion Protein targeting INSR fused
with human IDUA (iduronidase, alpha-L-) (1:2):
Recombinant therapeutic protein targeting
CD220/HHF5 |
Valanafusp Alfa |
|
INSR |
Fusion Protein |
|
GMP-Bios-INN-1044 |
Pre-Made Vandortuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Steap1 Antibody:
Anti-PRSS24/STEAP therapeutic antibody Drug
Conjugate |
Vandortuzumab Vedotin |
|
STEAP1 |
Whole mAb ADC |
|
GMP-Bios-INN-1046 |
Pre-Made Vapaliximab Biosimilar,
Whole Mab, Anti-Aoc3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Vapaliximab |
|
AOC3 |
Whole mAb |
|
GMP-Bios-INN-1047 |
Pre-Made Vepalimomab Biosimilar,
Whole Mab, Anti-Aoc3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Vepalimomab |
|
AOC3 |
Whole mAb |
|
GMP-Bios-INN-1048 |
Pre-Made Verpasep Caltespen
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting
HspE7(Mycobacterium bovis HSP65-HBV E7) fused
with chaperonin 2 (HSP65 from Mycobacterium
bovis) |
Verpasep Caltespen |
|
HspE7(Mycobacterium
bovis HSP65-HBV E7) |
Fusion Protein |
|
GMP-Bios-INN-1049 |
Pre-Made Volociximab Biosimilar,
Whole Mab, Anti-Itga5 Antibody:
Anti-CD49eRA/VLA-5/VLA5A therapeutic
antibody |
Volociximab |
|
ITGA5 |
Whole mAb |
|
GMP-Bios-INN-1050 |
Pre-Made Vorsetuzumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-CD70/CD27-L
Antibody: Anti-CD27LG/LPFS3/TNFSF7/TNLG8A
therapeutic antibody Drug Conjugate |
Vorsetuzumab Mafodotin |
|
CD70/CD27-L |
Whole mAb ADC |
|
GMP-Bios-INN-1051 |
Pre-Made Votumumab Biosimilar,
Radiolabelled Antibody: Anti-Human Carcinoma
Associated Antigen Ctaa16 therapeutic
antibody |
Votumumab |
|
human carcinoma associated
antigen CTAA16 |
Radiolabelled antibody |
|
GMP-Bios-INN-1052 |
Pre-Made Yttrium (90Y)
Clivatuzumab Tetraxetan Biosimilar,
Radiolabelled Antibody, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Yttrium (90Y) Clivatuzumab
Tetraxetan |
|
MUC1 |
Radiolabelled antibody |
|
GMP-Bios-INN-1053 |
Pre-Made Yttrium (90Y)
Tacatuzumab Tetraxetan Biosimilar, Radiolabelled
Antibody, Anti-Afp Antibody:
Anti-AFPD/FETA/HPAFP therapeutic antibody
|
Yttrium (90Y) Tacatuzumab
Tetraxetan |
|
AFP |
Radiolabelled antibody |
|
GMP-Bios-INN-1055 |
Pre-Made Zanidatamab Zovodotin B
Zovodotiniosimilar, Bispecific/Biparatopic,
Anti-ERBB2/HER2;ERBB2/HER2
Therapeutic/Biparatopic Antibody Antibody:
Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 |
Zanidatamab Zovodotin |
|
ERBB2/HER2; ERBB2/HER2
|
Bispecific /biparatopic
|
|
GMP-Bios-INN-1057 |
Pre-Made Zilovertamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Ror1 Antibody:
Anti-NTRKR1/dJ537F10.1 therapeutic antibody Drug
Conjugate |
Zilovertamab Vedotin |
|
ROR1 |
Whole mAb ADC |
|
GMP-Bios-INN-1058 |
Pre-Made Zimbirelimab
Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zimbirelimab |
|
PDCD1/PD-1 |
Whole mAb |
|
GMP-Bios-INN-1059 |
Pre-Made Ziralimumab Biosimilar,
Whole Mab, Anti-Bsg Antibody:
Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF
therapeutic antibody |
Ziralimumab |
|
BSG |
Whole mAb |
|
GMP-Bios-INN-1060 |
Pre-Made Zolimomab Aritox
Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody:
Anti-LEU1/T1 therapeutic antibody |
Zolimomab Aritox |
|
CD5 |
ADC |
|